>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 1; Drug: Control Apo 0.5 然
bLcbLjbLcbLcbLcbLcbLjbLcbLhbLcbLjbRsLibRcbLjbLcbRcbRibRsbRcbRcbRjbRibR
jbLoRsbLcbLhRsbLjbRibLgbLgbLgbRibLsbLgbRcbRgbLcbRcbLsLjbRcbLobRcbLcbRc
bLibRibLjbLjRsbRcbRjRsmbRibLsRsbRgbLgLsbRgLsbRgbRoLsRsbRobRoLsbRobLsbL
ebLjbRgbLjbRibRgbRgbLjbLcbLsLsmbLobLjbRhbRibLhRsbRobLcbLibLcbLcbLcbRib
RebLibLobRsbRsbRibLsbLsRsLsbRiLsbRgbRsRsmbRsbLeRsbLjbLobRibLgLsbLcbLob
LgbLcbRoLsbLjbLgbRibRibLobLhbLibLgbRgLsbRsRsmbLsbLgbLsbRibRsbRhbLjbLjb
RiLsbLoLsmbLhbLsbLobLhbLjbLsRcbRhbRsbRibRobLcbLibRjbLobLibRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 2; Drug: Control Apo 0.5 然
bLjbLgbLgbRebLjbRobLgbRcLsbLibLcbLibLgbRibLcbRjRsmbRcbRibLibLibLibRgbL
obLcbRcbRsbLiLsbLjbLibLgbLibLcbLibLibLibLcbLcbLibLiLsbLibLgLsbLibLsbLh
bLibLgbRsbRcbRhbRibLgLsbLsbLhRsbLibLcbLibLibRsbRsbLibLibLgbLgbLcbLhbLi
bLibRsbLiLsbRsbRebRibRsbLcbLhbLibLcbRgbLoRsbLcRsbLibLibLsbRibLjbLgbLib
RcRsmbRcbRibRhbRcbRcbRgbLibLsbLgbRsbRebRibRsbLsbRsbLjbLcbLibLobRcbRcbR
jbLgRsbRgbRibRgbLsRsbRgRsmbRsbRgbRsRsRsmmbRsbRgbRgbRsbRgbRsbRsbRsRsmbR
sRsmbRgbRsbRsbRgbRsbRcbLibLgbRsbRsbRibLsbRcbRhbLibRsRsmbRjbLibLgbRcbRi
bRsLsbRsRsmbLsRsbLcbLibLcbRibRjbLibRcRsmbLibLgbRsRsmbRgbRibRcbRhbRibRi
bRibLcbLcbRcbRcbRsRsmbRibRcbRibLsbRgRsmbRcbRibRibRsbRibLib

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 3; Drug: Control Apo 0.5 然
bRgbRsbRgbRgRsmbRgbRsbRsbRsbRsRsmbRgbRibRjbRcbRobLsbRibRgbRibRgbRgRsmb
RgbRgbRcbRhbRsbLsbRiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 4; Drug: Control Apo 0.5 然
bLsbsbLsLsmbLsbLsbLsbLsbLsbLgbRsbLsbLsbLgbLsbLsbLsbLsbLsLsmbLgRsbLgbLg
bLibLgbLgbRsbLgbLgbLsbLsbRgbRgbRgbRsbRgbRsbRsbLsbRgbRgbRibRsLsbRgbRibR
gbLsbLgbRsLsbRgbLsLsmbLgbRsbsbRsLsbLsbRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 5; Drug: Control Apo 0.5 然
bRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 6; Drug: Control Apo 0.5 然
bRsbLibRibRibRsbRgbRibRibRsbLcbLibLiRsbRjbRcbLjbLiLsbRjbLeRsbRcbRiRsmb
RibLibRjbLhbLhbLjLibLhbLibRsRsmbRsbLhbRsbRjbLjbLhbRsbLgbLgbRibLgRsbLsb
RhbRhbRsbLsbLjbRgRsmbRsbRcbRhbRcbLjbLiRsbLibLhbRsbLjbRcbRhbRsbLobRsbLi
bLgRsbLoRsbLcbRjbRobRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bLsbLiRsbRcbRcbRhLsbRcbRobRhbLobLcbLcbRibRhbRobLiLsbRibLjbRcbLsbRgbRgb
RgbRgbLsbRsRcbRcbRjRsmbRcbLhLsbRhbLcbRobRoLsbRcbLcbRcbRiLsbLgbRibRsbLs
bRibRibRsbRibRsbRibRgbRgbRsbRibRhbRcbRcbRcbLhbRcbRobLoRsbLobLobRibRgbL
gbRgbLobRibLsbRjbRobLcbLjbRjbRcbLgbLjbLobLsRsbLsbRibLgLsbRjbRibLsbLjbL
cbRcbLcbRibRibRibRebRhbLhbRjbRibLjbRcbLsbRcbLgbRoLsbRcbRibsbLjbRibLibR
sbRjbRcbLjbRiRsmbRsLsbRgbRgbRgbLsRsbRgbRsbRcbLibRsbLgRsbRibRgbRgbRsbRg
bLsbRgbRsbRgbRibLsbRibRibRgbLjbRcbLgbRgRiLsbLsbRiRsmbRsbRhbLgbRsbRibRg
bRgbRsbRgbRgLsbLjbRibRsbRibRsbRgRsmbRgbLjbRgbRgbLgbRibLsbLsbRgRsmbRgRs
mbRgbRsbLgbRgbRsbRgbRgbLgbRibRibRgbRsRsmbLcbLsbRhbRhLsbLibRhbLibRibRcb
RcLsbRhbLobRibLibLibLgRsbLgbLgbLgbRsbLgbLgbRjbLobRibRgbRgbRobRibRibRib
RsLsbRiRsmbRibRsbRibLgbRgbLsbRgbRsRsmbRibRgbRibRgRsmbLjbRibLgbLjbLsLhb
RjbLgbRjbLibLiRsLsbsbLgbLgbLgbLjbRcbLobRhbRibRgLsbLobRhbLobRibLobRgbLo
bRiRsmbLgbRibRgbRgbLobLoRsbRcbLcbLibLobLobLhbRibRibRobRcbRibLibRcbLcbR
ibLjbRhbLjbLibLcbRhbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bRgbLgbLcLsmbLcRsbRoRsmbLibLgbRsbRibRsbLcbRcRsmbLcbRcRsmbRibLobLibRebR
jbLcbLibLgRsbRcbRibLgbRjbRgbRobLgbRcbRgbRgbRsbLgbRgbRgbRsbRgbRsRsmbRsb
RhbRsbLgbRgbLgbLgbLgbLgbRiRsmbLgbLgbLgbLgbLgbLgbLsbLsbLsbRsbsbRibLob

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bLcbLibLgbLcbLiLsbRibLobRiRsmbRjbRcbLcbRibRsbRgbRsbRsRsmbRgRgbRgbRsLsb
RsbRgRsmbRgbRibRibLobLjbLoRsbRhbRibRsbLgbLgbLgbLgLsbLsbLgbLsbLiRsbRjbR
obLgbLcbLgbRibLgbRsbRgbRgbRgbRsRsmbRibRgbRgbLibLiRsbRsbLcbLgbLibRjbLib
RgbLgbLibLsbLsLsmbLgbRsLsbLgbLsbLsbLsLsmbRsbRcbRoRsmbLcbLcbLcbLobRibRs
bLcbLoRsbRobRsRobRobRebLibRibLjbLgbLcbLcbRsbLgbLibLibRibLibLgbLsbLiRsb
RsbLcbRjbLcbLibLsRcbLibRobLcbLgbRibLsbRgbRgbLcbRcbLoLsmbRobRcbLibRibLj
bRjbLibRsbRgRsmbLjbRsbRjRsmbRjbRibLcbRibLcbLibRhbRsbRsbRsbRgbRsbRgbRcb
RebRobLcbLibRjbLcbLibRhbLgbRjbLibLsbRsbRsbLgbLgRsbLjRsLsbLgLsbRobRhbRo
b

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bRcRibRgbRgbRibLgbLsbRgbRgbRsbRgbRobRjRsmbLjbRebRibLibRibRsbLsbLsbLgbR
hbLibRcbRhbLcbRibRibLhRsbLgLsbRsbLsRsbLsbRcbLgbRsbLcbLibLiLsbLsbRsLsbR
gRsmbLgbLcbRcbRcbLibLgbLjLsmbsbLsLsmbLsbLgLsbRsLsbRsbLsbLgLsbRsRsmbLib
LsLsmbLsbLiRsbLiRsbLhbLjbRcbLiRsbLgbRcbLjbLcbRjbLsbLiLsLsmbRibRsbLibLi
bLibLsbLsLsRsmbRsLsbRibRsLsbLibRgbRsbLcLsmbLobRhbRcbLhbLsbLjbLcbLjLsmb
LcbRibRgbLsbLgbRhbRsbRsbRibLobLibRjbRjbRibRcbLibRhbLhbLcbRsRsmbRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bLhRsbLcbRgbLeRsbLebLibRibLiRsbsbLsbReRsmbRcLsbRsLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bRsbLjLsmbRjbLjbRobLibRibLgLsbRsRsmbRgbLsbLjbLibLibRjbLibLsbRobLcbLhbR
gbLobRobLgbRobLcbRobRobLjbRoLsbLibLjbRobLcbRgRsmbLgbLibRjbLgbLhbRebRoL
sbLsLsmbLibRgbRobLcbLebRcbRcbLibRobRibRgbLgbRgbRgbLsbRobLibRobLibRobLi
bRjbLcbRibRiRsmbLsbLsbRgRsmbRsbRibRsbLsbRibLgbRibRsbLjbLcRsbLibRcLsbRo
bRoRsmbLgbRsbRgbRsbLsbRjbLhbRjbRoLsbLgbRgbLgbRoLsbLibRgbRgbRibLsbRobLi
bLsRibRsbLsbRsbRsbRobRobRobRobLgbLjbLcLsmbRobLsbRobLgLsbRcbRobRsbRgbRs
LsbRgbRgbRobsbLcbLhbRibRebRgbRgbRgRsmbRgbLgbRibLgbRsbRebLiRsbLcbLibRgb
LjbRibRsbRgLsRsbLsbRibLebLcbLcbRjbRsLsbRobRoLsbLjRsbLebLhbRsbLhbRhbRsR
obRobLjbRibRcLsbRobLibRsbRjbLjbLcbLgbRibRobRebLgbLibRibLgbLibRsLsbLibL
cbRobRoLsbRebRhbLcbLcbLjbRcbLcbLhbRcLsbRibLobLcbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsRsmbLjLhbLiLsbLgbLcLsmbLcbLgLsLsLsmmbRobLgbLgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLobRoRsmbRobRobRobRoRsmbLcbRcbLcbLobRibRcbLgbLsLsmbRibLcLsmbRhRsRs
mmbRhbLobLobLobRhbLoLsmbLobLgbRcbRobLcbLobLoRsbRobRcbRobLoLsmbRjbRoRsL
smbLibRsbLjbRgbLobLobLobLibLobLsbRebLsLsmbLiLsbRebRsLsLsmbLgbRgbLobRjb
LgLsbLobRebLcbLhbRoLsbLobLsbReLsbLcbRibLibLobLcbLebLoLsmbRcbLibRoLsbLg
bRibRobLibRgbLjbLobRhbLjbRhbLibLgbLgbLsbLgRsbLsbLgbLgbLsLsmbLgbLobRcbL
ib

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRgbRsbRsbRsbRsRsmbLsbRsbRsbRsbsbRsbRsbRsbRsbRsbRsbsbLsbRsRsmbRsbsb
sbRsbsbRsbRsbLsbsbLsbRsbsbRsbsbsbsbRsbRsbLsbRsbLsbLsbRsbRsbLsbRsbRsbRs
bRsbRsbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bRhbRgRsmbLibLoLsRsmbRcbLcbLcLsmbLcbRibRgbLibRibRibRiRsmbRibLeLsbLcbLe
bLsbLiLsbLibLibLsbLiRsbLcRsbLibRgbLgbLgLsbRsRsmbRhLsRsbRcbRsbRcbRibRgb
RgbLobLiLsbLgbRhbLibRsbLsbLgbLsbLsbLgbLgbLsbLgbLsbLgbRsbLibLgbLibLsbRs
bRsbLhbRsbRsLsbLiRsbLgbRjbLhbRjbLibRjbRobRibRiRsmbLibRgbLgbLiLsbRsLsLs
mbLgLsLsmbRsbRobLebRobLsLsmbLebLoRsbRibLibRgbLibLiLsbRibLibRiRsmbRjRsm
bRibLjbRcbLibRiLsbRcbLhbRgRsmbRsbRiLsbRjbRibRiLsbRibRiLsbRsbRsbLcbLsbR
jbLjbRibRgbRgbRsRsLsmbRgbRgbLobLjbRcLsbLjbRsbLsbRsbLgbLsbRgbLcbRiLsbRj
bRjbLjbLoLsmbLibRibLsbLsbRjbRebLgbLcbRsbRgbRsbRgbRgLsbRgbRgbLsbRjbRsbR
gbsbLibLibRcbLhbLeLsbRibLsRsbLibLcbRibLjbRjbRgbLsbRiRsmbLgLsbRibLsbRcb
LiLsbRgbRjbLjbRjbRobLcbLgbLsRsLsbLgbLgbRsbLgLsbLgRsbLgbRsbLibRsbLsbLgb
LgbLibLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bsbLsbRsbLgbLgbLgbRsLcbLoRsLsbLibLsLsmbLebRobRebRgbRgbLibLgbLiLsbLsLsm
bLsLsLsmmbLsLgRsbLsbLgbLsRsbsbsbLsLsmbLsbLsLsmbLsbLsbLsbsbsbRsbLsbLsbL
sbsbsbLsLsmbLsbLsbLgbLsbLsbLsRsLsRsLsLsLsmmbRsLsbRsLsbLsbLsbRsLsLsmbLs
bLsbLsbLsbLsbsbLgbLsLsLsLsRsmmmbLsbsbLsbLsLsmbRsLsbLsbLsbRsbsbLgbLsbLs
bLsbLsbLsbLsbLsLsmbsbRsLsLibLsbLsLsLsmmbLsbLsRsbRsLsLsmbLsLsLsmmbLsbLs
bLsbLsLsmbLsLsmbLibLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bLibLgbRgRsmbLobRsbRobLgbRsbLhRsbRgRsmbLibLjbLsbLjbRsbRsbRhbLobRibLcRs
bLjbRsbRebLhbRgRsmbLjbRgbRobLobRibLobLgbLcbRsbLgbLgbLgbRobRgbLiRsbRgRs
mbLibLgbLibLcbLcRsbRgbLsbRcbLobLobRgbRibLobLsbLiRsbRgbLsbRgbRobLhRsbLg
LsbRjbLoRsbLgbLibLibRsbLebRgbLoRsbRsbRgbLcbLibRgbLgbLibLgbLcbLibRgbRsR
smbLgbLcbLibRgbLibRsbLhRsbRgbLobRgbRgRsmbLcbLebLobRcbLibLcbLgbLsbLibRg
bLgbLibRsbLgbLiRsbLiLsbLibLgbLibLgbLgbLgbRgbLgbLgbLgbReLsbRiRsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bLsbRsbLsbRsbRgbsbLsLsmbLsbRsbLsRsRsmbsbsbsbLsRsbRsbRsRsmbLsbRsbLsRsbL
sbLsbRsbRsRsmbsbsbRgbRgLcbRsbRsbRobRsbLsbLsbLsbLsbRjRsmbRsRsLjmbRsbLgb
RiRibLjLsmbLibRibRgbRsbRsbRsbRsbRsLsbLsRsbLjRsLsbRgbLsbRsbRsbLgbRsbRiR
cRsRsmmbRsLsbRjbLgbLcbsbsbLsLeRsbRsRsRsmmbLcbLsLsmbLibLgLsbLsbRsbLoRsb
RibRsRsRsmmbReRebRgRsmbRjbRsbRibRsLsRgRsmbRgbRsbRgbLsbRsbLsbLsbLgbRoRs
RsmmbRgbRsRsRsRsmmmbLgbRibRgbsbRsRsRsmmbRsbRsbRsRsmbRsRibRobLeLcbRibRg
bLcbReRcbLsRsbLcbLsLgbLgbRjbRsbLibLsbsbLsRsbsbsbsbsbLsbLsbsbsbsbsbsbsb
LsbRsbLsbRsbsbRsbLsbRsLsbLsLsmbsbRjbRebRoLgbRgbRsbLsbLebRibRsRsRcRsmmb
LiRsbRsbLebRgLsRsbRjbLibLgLsLcbRobLibLjbLebRcRsmbRgbLsbLsLeRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bRsLsbRsRsRsRsRsmmmmbRsRsRsRsRgRgmmmbRgbRsbRsbRsbRsbLsbLsbRsbLsbRibRgR
smbLgbLebRgbLsRgbRsLeLsRsbLsbLsLgbLsbRebLobRgRsmbLsbLeLibRgRgbRcbLeRsR
smbRjbLsbRgbRsbRgbRsbRsLsbLgLsbLsbLibRsbLsbLibLsbRgbLsbLeLsbRsLsRsbRsR
sLsmbLsbLgbLgbLsLsmbRgbLhbRsbRgbRgbRebLsLsmbRsbLsbRebRsbRibRsbRgbRsbRs
RsmbRsbRsRsmbRgbLgbLgbRsbRgbRgbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bRsLibRcbRgbLsLsmbRsbLebLsLsLsmmbLsbRsLsbRsRsmbLsbLsbLsbRsLhbRibRsbRsR
smbRebLobRsbLgLsbLsLsmbLsbLoRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRsbLsbRgbRsRiLsRsbLsRibRsRgbsbRsbRgRsmbLsbLgbLsLsmbLsLsLgmbRsbLsbLsbL
sLsLgmbRsbLibLsbLsLgLsLsLgmbLgRsbRsbLsLgbLsbLsbLsbRcbsbRjbLsbRgLsRsLsb
sbLsbRsLsbLsbRsbRiRsmbsbLsbRsbRsbRjbLgbLsLgLgbLsLsmbRsbLsLsmbRsbsbLsbL
sbRsbLsbRsbRsLsbLsLsmbRebLgRsbsbRsbLsRsbRsbLsLsmbLsLsmbLsLsmbLsbLsbLsL
smbRsbRsbLsbLsLsmbLgRsbLsbLsbRebLobLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bRibLgbRsbLsbLiRsbLiLsLsmbLsbRsbRsLsbRcbReRibRsbRcbRsbLsbRibRebLgLhbRg
bRgbLjbLsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bLgbLsbLiLoRsbReRsLsmbRebRgbRebRebLebLsbRsbLsLsmbLobLebLsbLsbLsbLsbRob
RsbRsbsbLsbRsbRsbRsbRjbLebLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 25; Drug: Control Apo 0.5 然
bLsLsmbRgRsmbRgbLgbRgbRgbRgbRsbRgbRsbRiLsbLsbRgLsbRsbRhLsbLgbRiRsmbRgb
LsbRibLsbRibRibRgbRgbLsbRsbLiLsbLibLgbLgbLgbLibRsbRsbLsbLibRcbRhbLgbRc
bLebLsbRcbLsbLiRsbLgbLsbRjbRibLjbLcbLibLhbLsbRsbRgbRgLsbLgLsbRibLjbLjb
RhbRibRiRsmbRjbLgbLibLiLsbLjbLgbLsbLsbLibLjbRsRsmbLsbLgbLibLsbLsbRsbLg
bLgbLgbLgbLcbLibLibLgbRjbRibLgbRsLjbLhbLgbLgbLgLsLsmbLibLsbLsbLgbRibLi
bLoRsLsbRsbLgbLgbLcbLibLsbLgbLgbLgbLibLgbLsbRsRsmbLgbLgbLgbLgbLsbLebLs
LsmbLsLjbRgbRjLsbRcbRjbLhbLjbLgbLgbLjRsbLibLsbRiLsbRibRsbRgbLgbRcLsbLj
bRgLsbRhbLibLgbLjbLjbLgbRjbLibRiLsbRjbLcbRjbLcbLibLgbLgbLgbLcbRgbRjbRg
bLcbRsbLsLjbRjbRgbLsbLiLsbLsbLsbLjbLgLsbLgbLibLsbLgbLjRsbLjRsbLsbRgbLs
bLsbLsbLgbLsbLgbLsbLgbLgLsbLsLsRsmbLsbRsbLsbLgRsbRjbRjbLjbLhbLibLibRsb
LibRsbRgbRgLsbRjbLhRsbLhbRjbLjbRsbLobRgRsmbLsbLibLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 26; Drug: Control Apo 0.5 然
bRcbRgbRibLgbRsbRgbRgbRgbLjbLibLibRcbRcbLjLsmbRcbLjbRcbRiLsbRgbLgbLsbR
gbRsbLebLibLoRsbRgbLibRibRsbRsbRsbRibLhbLjbLcRsbRgRsmbLiLsbLgbRjbRhbRi
bLgbRobLibRsbLgbRcLsbRcbLsbRobLsbRjbRibLibLgRsbLsLsmbRjbLhbRsRcbRhbLib
LjbRobRobRcbLgbLibRibRgbLsbLgbLibLgbsbLsbLgbLsbLsbLjbLsbRsbRhLsRsbRcbR
jbRibRcbRcbRgbLsbRgbRjLsbRhLsbLsLjbRcbLgLsbRibRibRsbRsRsmbRsbRsbRsbRgb
RibRgbRsbLibRgbRsbRgbRgbRcbRcbRjbRjLsbRcbLcbRsRsmbRsRsmbRsRgbRgbRsbRsb
RgbLsbRsbRsbRsbRsbRjLsLsmbRcbLibRgbLsbLhbRibsbRsbRsbLjbLibRibLibLgbLsb
LsbLsbRibRgbLsbLsRhbLjbRjbLjbRibRibLsbRibLcbLhbLobLhbLgbLsbLibLsbRsbRj
RsmbRhbLibLgbLjbLcbRgbLhbRibRibLibLcRsbRhbLhbRcbLcbLibLibRgbLgbLgbRjbL
cbRcbLcbLcbRgbLibLibRcbLsbRsbLibLgbRsLsbLibLgbRsbLgbRsbLgRsbLgbLsbLsbL
sbLsbLsbLsbLgbRsLsbRibRcbLhbLibLgLsbLhbRibLibLgbRsbRsbLibRjbLibLibLsbL
gLsbLsbLgbLsLsmbLsLsmbLsLsmbLsLsRsmbLsbLgbLsbLgbLsLsmbLsLgLsbLsbRgLsbL
gbLsbLsLsmbLsbLsbLgbLsRsbLsbRcbLjLsmbRcbLibRcbLjbRibLgbRoLsbRcbRcbLibL
ibRsbLgbLgbLsLsLsmmbLsbLsbRjbRibRibRgbLgbRgbLsbRibLjbLcbLgbLsbLgbRgbLs
LibLgbRsbsbLsLgbsbLsbLsbLsbLsbLsbLgLsRsLsbLsLsRsmbLgbLsLsmbLsbLsbLgLsb
LsLsmbLsbLsLsmbLsRsLsLsLsLsmmmbLsLsmbLsbLsLsmbLsLsmbsbLsbLsLsmbLsLsmbL
gRsLsbRjbRsbLcbLsbLsbLibRibRobRcbRcbLjbRjRsmbRibLhbLgbRgbLibRjbLgbRsbL
ibRcbRibLgbRibRcbRoRsmbLibRhbRcbLibRibRebRib

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 27; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 28; Drug: Control Apo 0.5 然
bRebRsbLibLgbRjbLsbRobRgbLhbLebLsbLgbLsbRsbLeLgbLebLsbLgbLgbRsRsRsmmbL
gb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 29; Drug: Control Apo 0.5 然
bLsRjbRcbRgbLsRsbRobRibLibLhbLibLgbRiRsmbRsbLcbRibLibRgbRcbRhbRibRibRs
bRgbLjbRgbLgbRibLsbRsbLgbRibLgbLibLibRibRgLsbRsbRjbRcbRcbRibRibLsbRjbR
cbRjbRiRibRibRhbRcbRhbRhbRjbRjRsRsmmbRjRcbRcbRibRjLsRibRibRcbRcbRibRiR
smbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 30; Drug: Control Apo 0.5 然
bLhbLgbRjbRhbRibLsbRibLsbLsbRibLsbRcbRoLsbRcbRgbRsbRgbRibRgbLgbRcbRjbL
ibLibRgbRgbRgRsmbRsbRgbLgbRibLsbRgbLsbRibRibLsbRgbLsLsmbRgbRgLsbLgbRib
RgbLgbRibRibRobRjbRiRsmbRhbRhbRjbLsbRjbLoRsRsmbRgbRgbRibRibRibRebLgbLj
bLibRjbRcbRcbRjbRjbRgbLjbLoRsbLobLibRgbLsbLobRgbRsbLibLhbRibLhRsbLobLs
bRsbRibLgbLsbRgbLgbLibLibLsbLgbLhbRibRsbRiRsmbRibRsRgRsmbLjbLcbRhbRjbL
cbLcbLhbRsbLsLcbRgbLibLoRsbsbLhbLobLsbRjbRibRgbLsbRibLgbLibLgbLibRibLi
bLsLiRsbRjbRobRhbLgLsbRcbLsbRjRsmbLibRibRsbLsbRgRsmbRsbRcbRgbRibLibRib
LibLgbRsbRsbRgbRibRcbRobRibRibRcbRgbLsbRhbRcbRgbRsbLobLobLsbRjbRjbRibR
sRsmbRgbLgbRibLsbRgbLsbRgbRsbRgbRgbLsbLjbLcbLhRsbLhbRibRgbRsbRgbLjbLiL
sbRsbLibLoRsbRibLgbRibRsbRhbRiLsbRibRjbLobLoRsbLcRsbLhbLcbLobRgbLsbRjb
RjbRobRiRsmbRgbRjbRcbLsRsbRgbLgbRjbLobRhbLjbRjbLobRcbRjbRgbRhbRgbRsLsb
RiLsbLsbRibRgbLiRsbLjbLcbRobRhbRgbLebLob

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRgbRibRgbLsbRibLhbRgbRibRhbLibRgbRgbRsbRgbRebRsLsbLjbRgbsbLsbRibLs
bRibLsbLsbRgbRgLsbRsbRgLsbRcLsLsmbLsbLsbLsbLsbLgbRcRsmbRcbLibRgbRgbLsb
RgbRibRgbLsLsmbRgbRgRsmbRgbRsbRibRsbRgbRsbRgbRsRsmbRsRsmbLsRsbRsRsmbRg
RsmbRsLsbRhbRiLsbLhbLobRhbRcbLjbLobRhbRibRgbRcbLsLsmbLibRiLsbRgbRgbLsb
RibLgbLobRibLgbLsbRibLjbLjbLgbRsbLgbLsbLsbLgbLgbLgbLgbLsLsmbLgbLsLcbRh
bLsbLsLsLsmmbLgbLgbLgLsbLsbLsbLsbLgbLsLsmbLgbLgbLsbLsLsmbLcRsbRsbLsbLs
bLobRibLsbLibRgRsmbRsLsbLgbLsbLsbLsLsLsmmbLsbLsbLsbLsbLsbLsbLsbRsLsbRj
bRobLcbRcbRhbRhLsbRibRcbLgbRsbLgbLgbLgbLsLsmbLgbLgbsbLgbLsbLgLsbRsLsbR
sRsmbLibLsbRsbLgbRsbLgbRjbLsbLsbLgbLsbLgbLsLsmbLgLsbLsLsmbLsbLsbLsbRcb
RibRiRsmbLsbLsbRsLsbRibRgbRgbLsbLgbRcbRgLsbRibRibLibLjbRibRcbRibLcbRoL
sbLhbLibLibRsbLgRsbLsbLsLsmbLsbLsbLsbLsLsmbRgbRcbRiLsbRibLsbRgbRgbRgLs
bLsbLgbRibRsbRgbLibRsbRsbLsbLoRsRsmbRsbRsRsmbRgbRoLsbLoRsbRcbLsbLcbLib
LsbRsbRsbLsLiRsbRsbLsbLgbLsbLsbRsbLibLgbLsbLsbLgbLsbRobLcbRibLjbRhLsbR
ebRhbRsbRibRsbRibRsLsbRibLsbRebLobsbRebRhbLsbLjbRibLjbLgbRsbRobLobLsbL
ibLgbLcbRsbsbRcbRcbLhbLsLsmbLsbLsbLsbLsLsmbLsbLiLsbLibRibLsbLsbRcbRibL
sbLcbRcbRhbLcbRjbRcbLibRibRgbRgbLjbRgbRgbRgbRgbLcbLsbLgbRsbsbRsbLgbLgb
LsLsmbLgbRsbRsbRobRoLsbRibRcbLcbRhbLcbRgbRcbLibRibRsbLsbLjbLibRsbRcbLj
bRobLcbRgbRobLibRgbLiRsbRgbRhLsbLgbRiLsbRibRgbRsRoLsbLibLhbRgbLhbLobRi
b

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLgbLgLsbLsLsmbLsbRsLsbLibLgbLgLsbLiLsbLhbLibRgbRsbRsRsmbRibRiRsmbRgRs
mbLibLgLsbLgbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bLcbLebLcbRcbLcbLcbRibLgbLgbRcbLgbRsbRcLsbLcbRhbRgbRcLsbLgbRgbRjbRcbLh
bRgbRibRgbRcbLhbRibLsbRsbRibRsRsRsmmbLebRcbLibRcbLsbLibRsRsRsmmbLsbLiR
sbRcbRibRgbLibRcbLsRsbRgbRgbRgbRgbRgbRgRsmbRgbRgRsmbRgbRgRsmbRsRsmbRgb
RgbRgbLsRgbRsbRgbRibRsbRgbRibRgbRgbRsbRgbRgRsmbRibRgbRobLgbRsbRsRsmbRg
bRibLsbRgbLsbRibRgbRgbRsbRgbRsbLgbRibRsbLjLoRsbRjbLhbLcRsbRcbLibLsLgbL
gbLjbRibRgbRgbRgRsmbRibRgbRgbRsRsmbRgbRsbRgbRgbRsbRsbRgbRsbLsbRibRsbRs
bRgbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbRsbRsbRgbRgRsmbRgb
RgbRgbLsbRgbRgRsmbRgRsmbRgbRgbRgRsmbRgbRgRsRsmmbRgbRgbRgbRgbLgbRibRibR
gbRgRsmbRgbRgbRgbRibLgbLebLjLgbLibLsbRibRibRhRsmbLgbRibRsbRsRsmbRsRjbR
jbRibRsbRsbRgRsmbRgbRsbRgbRgRsmbRgRsmbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbRg
bRgbRsbRgbRgbRsbRsRsmbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRsbRgbRgbRsbRibRsb
RgbRsbRgbRgbRgbRsRsmbRgbRgbRgbRgbRgbRsbRgbRgRsmbRgbRgbRgbRgbRsbRsRsRsm
mbRgbRgbRsRsmbRgbRsbRobLgbRgbRsbRibLjRsbLibLibLgbLibLhRsbLibRibRsbRgbR
gbLgbLsbRgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bLcbLcbRibRibLjbLobRgbRjbRgRsmbLjbLcbRjRsmbRcbLjbRibRsbLcRsbRjbLibRcbR
gbLobRhbRgbRoLsbRsbLgbLgbLibRsbRgbRebLibLibLhbRibRgbLebLcbRjbRobRhRsmb
LibLobLhbLcbLibRibRgRsmbLhbLjbLibLgbRibLcbRjbLgRsbLsLsmbLsRsbLgbRjbLgb
LgbRsbLsbLsbRjbRiLsbLjRsbLcbRjbLhbRibLibRsbLibRgbLgbLgbRgLsbRcbRcbLibR
ibsbRgbLgbRsbLsbLcbRjbLibLsLsmbLgbLsbRsbLsLsmbLsbLgLsbRsbLsbLgbRsLsbLs
bLsbLsRsbLsbLsbLsbLsbLsbLsbRsbLjbLibRibLibLgLsbRjbLhbRjbLcbRibRcbRibLi
LsbRiLsbLgbLgbRsRsmbLsLsmbLgbRsbLsbLgbLsLsmbLsbLgbRsbLgbLgbLhbRibLgbRi
bRibsbLibRsbRibLjbLibRsbLibRjbLibRobLibRiRsmbLhbLsbLjbLcbRjbRcbRibLgbL
hbRcRsmbLsbLsbRsbLjbLibRcRsmbRobLibLcbLibRgbLibLgbRibRjbLhbRobLhbRcbLi
bLhbRibRcRsmbLcbLcbLobRhbRhbLgbRhbRibLsbLcbLcbRibRhbRcbLcbLhbLcbRibRhb
LjbLebLobRibLcbLjbLibRhbLcLsmbRsRsmbRcbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bLibLsRsbLgbRgbRibRsRibLibLobRjbLjbLobLibRgbLsbRsbRgbLibLibLsbRsbLiLsb
RsLsbLibRsbLgbLsLsLsmmbRobLsbLgbLgbRsLsbLgbLgLsbRsbLsbLsLsmbLgbRgbLiLs
bLgRsbLgbLjLsmbLiLsbLjbRcLsbLibRibLgbRsbRsbLibLibLgbLibRibRcbLeLsbLgbL
ibLcbLibLsbLcbRsRsmbLsbLibRsbLsRsbRhbRibRibLgbLibRgbRsbLsbRgbLibLgbLjb
RsbLjbRhbRibLjbLiLsbLhbLgbLsbLsbLsbLgbRsbRiRsmbLcbLcRsbRcLsbRjbLibLsbL
gLsbLibRjbLjbRoRsmbLibLsbLsbLibLibLcRsbLibLibLsbRcbLsbRcbLibRgbLhbRibR
ibRsbLgbLsbLsbRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bRibLgbLobLcbLibRhbLgbLgbLgbLcbLcbLsLjbLhbLgbRobRcbLcbLcbRcbLcbLcbRjbL
obLcbRobRcbLibLibLcbLhRsbLobLobLobRjRgbLobLibLjbRibLibLjbLgbRebRjbLobR
ibRobRobLhbLibLgbRibLjbLhbRsbRoLsbRcbRobRsLcRsbLoRsbLcbLcbRgbLobLobRgb
LgbRgbLgbRgbLjbLibLjRsbRsbLjLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bLgbRgRsmbRgRgRsmbRgRsmbRgbLgbLsbRiRsmbRgRsmbLsRsbRsbRsbRgbRibRgbRgbRg
bRsRsmbRsbRsbRgbRiRsRsmmbRgRsmbRsRsmbRsbRsbRsbRibRgbRiRsmbRgRsmbRgbRiR
smbRsbRgbRgRsmbRebRgbRgbLobLsbLsbLgLsbLgbRsbLsbLgbLgbLgbLsbLsbLgbLgbRs
RsLsmbLsbLgLsbLsbRsbLsbLsbLgbRsbLsbLgLsbLgbLsbLgLsbLgbLsLsLsmmbLgbLsLs
mbLsbLsbRsbLsbLsbLsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsmbLsRsLsbLsbLiLsbLgbRebLsbRsRsmbReRsmbLjbRebRcbLgLsbLsbLoLsmbLgbR
hRsmbRebLcbLsLsLsmmbLjLiLsbRcbLsbLhLsbRibLcbRgRsmbLsbRsbLsbsbRgbsbRgRs
mbRsbLcbLobLoRsbLibRobRsLsbLsRsbLsbLsbLsLsRsmbRsbRebLobLsbLiLsLsmbLgLs
bLsbLgbLsbRsRsmbLsLsLsmmbRsbLgbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bLhbLcbRebLjLgbLgLgbRebLjbRibRobRiRsmbLsbLgLsbRcbRgRsmbRoLsbRoLsbLibRg
bsbLgLsbRgRsmbRhbLgbRoRsmbRibRgbRibLcbLhbRgbRiRsmbRibRsRsRsmmbLjbRcbLg
bsbLebRsLsbLgbRsbLibRsbsbsbsbLgbLibLibRsLsbLoLsLsmmbLcbLgbRsbLoRsbRsRg
bRiRsmbRibLgbRibRsRsmbsbLsRsLsbRibRgbRoLsLsmbLebRgbRgbRibLsbRgbLsbRgRs
mbLsRsbRgbLsbRjRgbRgbRiLsbLgbRgbRiLsbRjRsLsmbRgbsbLsbLgbRibRibRgRsmbLj
bRibLsbLoRsbRcbRoRsmbRebsbLgLsLsmbLsLsmbLgLsbRgbLibRsbRjbRjbRobRcbRibL
gRsbLebRcRsmbRcbLibRcbLsbLjbRibRibRibLgbRibLsbLsbRgbRsbLsbRgbRgbLsbRgR
smbLsbRgbRgbRgbRgbLsbRiLsbLsRsbRibRsbRgbRgbRibLjbRgbLebRcbLjbRjbRibRiR
smbLsbLjbLjbLibLibRsRsLsmbLibRgbRjbLcbRgRsmbLsLiLsbRhbRibRebLibRgbRgbR
sbRgbRgbRcLsbLsRsRsmbLsbRsbRhbLibRjRsmbRibLibRibRgbRibLgbRsbLsbRgbRsbR
gbRgbLgbRgbRsbRsbLsbRibLgbRgbRsRsmbLsbRgbRsbsbRsbRgbRgbRgbRsRsmbRgLsbL
jbRsbRibLjbRibRsbRgbRgbLgbRgRsmbRgbRgbRgbRsbRibRsbLhbRobRsbRgbRgbLhbLg
bLhbRibLjbRibRibRsRsmbRsbLsbRgRsmbLsLsmbRgbRgbRoLibLibRoRsmbLhbLibRhbL
sLsmbRibRibLgbRgbLsbRgbLgbLjbRoLsbLsbRsRsRsmmbRsRsmbRsRsmbRgbLgbLobRob
RobLibRoLsbRoRsRsmmbRhbLhbLobLobRibLhbRibLiLsLsmbRsbRjbLibRibRgbRibLib
RjRsmbLhbLhLsbRebRiRsmbLgbRgRsmbRsbRoLsbLibRhbLhbRibLobLobRibRsRsRsmmb
RibLcbRibLibRgbRhbLjbLibRjbRcbRhRsmbRsbReRsmbRsRiLsbLsbRsbLcbLoRsbLhbR
ibRjbRibRgbRcLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsRsmbLsbRsbRsRsmbRsbRsbRsbRsbRsbRsbRsRsmbRsbRsLsbRsbRsbRsbRsbRsRs
mbLsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsbRsRsRsmmbRsbRsRsmbRsbsbRsbRsR
sRsmmbRsbRsbRsbRsbLsRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsbRs
RsmbRsbRgbRsbLsRsbRsbsbRsbRsbRsbRsbRsbRsbsbRsbRsRsmbRsbRsRsmbRsbRsRsLs
mbRsbRsRsmbRsbRsbRsRsmbRsbRsbsbRsbLsRsbLsRsbRsbRsbRsbRsRsmbRsbRsbRsbRs
bRsbRsRsmbRsbRsbRsbRsRsmbRsbRsbsbRsbRsbRsbRsbRsRsmbRsbLsbLsbsbLsRsbLsb
RsbRsbRsbRsbRsbLsbRsbRsbRsbRsbRsbRsbLsbRsRsRsmmbRsbRsbRsRsmbRsbRsRsmbR
sbRsRsmbLsbRsbRsLsbLsRsbLsRsbRsbRsbRsbRsRsmbRiRsmbRiRsmbLsbRsRsmbRcbRi
bRgbRsbsbRsbRsbRsbRsLsbRsRsmbLsRsbLsRsbRsbRsbRsbRsbRsLsbRsbLsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsmbLgbLsLsmbLgbLsLsmbLsbLsbLsLgbLsbLsLsmbLsbLsLsmbLsbLsbLsLsmbsbsb
sbsbLsbLsbLgbLgbLsLsLsRsmmbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bLgbRjRsmbLibLjbLcbLgbsbLibLibRgbRibRgbLgbLgLsbLibLsRsbLgbLsLsLsLsmmmb
RsbLgRsbLgLsbRsbRgbLibLcbLgbRcbLsbRibLgbRibRsRsRsmmbRgRsmbRgbRgbLsbRib
LcRsbLibLgbRgbLeLsbRsbRgbLgLibLgRsbLgbLgbLiRsbLgLsRsbLibRsbLsRsLsRsLsR
sbLsLsmbRsLsLsmbLibRsbLsLsRsmbLiRsbLgbLibsbLibsbLgbLgRsbLsbLsRsbsbLgbL
sbsbLgLsbLibLiLsbLiLsbRsRgbRgRsmbRsbRsbRiRsmbRiRsmbLsbRgbRibRcbLibRsRs
RsRsmmmbLsbLsLsmbRsRsmbsbLsbRsRsRsLsmmbLsLsmbRsbRgbLsLsmbLsbRsbsbLebLc
bLjLiLsRsbLibLibLgbLgbLgbLgbLgbLgLsbLibRibRsbLiRsRsmbLibLib

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bLcbLebLobRobRob

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bRjbLgRsbLsRsRsmbRibRhbLsbRsbLcbLgbsbLebRsbLsLgRgbRsbLsbLhbRsbRsRgRsRs
mmbRsRgbRiLebRgbRcbRibRcLsRsbLsbRgRsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLgRsbLgbLsbLgbLgbLsbRgbRsbRobLsLeLsbLibRsLsLsmbRsbLgRsbLsbLgbLsbLs
LsLsLsmmmbLsbRsbRsLgbLsRsbLgbLgbRsbRsbLgbLsLgLsRsbRsRsmbLibRsbLsLsmbLs
LgbLgbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRobLgbLsLsLsmmbLsRjbRgbLhLsbLgLsbLgbLgbLgLibLsRsLsbLsbLsbLobRebRsb
LsbRsRgRsmbRsRsRsmmbLsbRibRsRgRgbRsbRobLgbRjRcRsmbLgLsbLgbLibRsbRobLsL
sLsmmbLsLsmbLgbLsbLsLsmbLsRsbLsbLsbLsLsmbLsLsmbLsbLsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLgbLsLeRsbRgbRebLsbLsRsbLjbLibLeLsbRibRebRgbRibRiLsRsbRsRsmbLgbLgb
LebRjbRibLibLsbRsRsmbRsbRsbRoRsmbLgbLjbsbLsRobLsbRhRgRibRgbRhRsRgmbReb
RsRgbLgbRibRsRsReRsmmbRsbRsbRibRsbLgbRsbLjbRsbRsbRsbLjbLhbLsbLsbLsbLsL
smbLgbRsLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 121740; End: 122240;
Recording: 1-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bLgLsbRsRsmbLeLgbLsbLsbRsbLsbRsbLsbLebLgbLebLebLgbRsbsbLobLgLsbLebLsbR
sbLgbLibLsbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 1; Drug: Control Apo 0.5 然
bLobRsbRiRsmbLjbLcbLhbLcbRcbLcbRcbRsRgRsmbRgbLsbRgRsmbRsbRgbRgbLebsbRi
RsmbRibLibLobRhbRibLhbLcbLcbLcbLobLsLcbLobLobLgbLsbLgbLgbRsbLjbRiLsbRs
bRsbRsRjbRsRjRsmbLobLibRsbLcbRhbLsbRibRgbLjbLibRsRcbRjbRcbLobRsLibRjbR
ibRobLgLsbLcbLcbLjbRcbRgbRgbLebLgbRgbRibLebLcbRgRsmbRobRoLsbLjLsmbLgbR
jbRibLjbLobLobRibLjbRcbRibLibRsbLibLibRibLsbLsbLgbLsbRsbRsbRibRobRebRg
bRcbRobLibLgbLibRgbRgbRhbRsbLibLgbRjbRsRsmbRgRsmbRibRgbRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 2; Drug: Control Apo 0.5 然
bLobLiLsbRcbRcRsmbLcLsmbRibRebLobRjbRibLibLsbLoLcLsLsmmbLgbRobRhbLjbLc
bLibRobLgbRsbLibRcbLibRhbRcbRcbRjRsmbRiRsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 3; Drug: Control Apo 0.5 然
bRgRsmbRgbRgbRsbRgbRsbRgbRgRsmbRjbRcbRcbRsbRibRhLsbRgbRibLgbLsLsmbRebR
hbsbRiLsbRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 4; Drug: Control Apo 0.5 然
bLsLsLsmmbRsbLsLsmbLgbRgbLsbLibRoLsbLhbRsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbLcbRiRsmbRgbLsbRsbRsRsmbsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 6; Drug: Control Apo 0.5 然
bRoLsbRjbRobRibLjbLcbLobRsbRsbRjbRobRsbLsbRgbLjbRibRsbLjLsmbRgbLobRcbR
sbLibRcbRibLiLsbLibLjbLcbRobLjbRcRsmbLiRsbRsbRsbLsbLsbRoRsmbLcRsbLsLcb
LcbLsbLjbLcbRcLsbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bRibLobRcbLibLjLsmbLjbRcbLcbRobRcbRhbRhbLibLgbRcbLgbLsbRgbRibRebRcbLib
RcbRcbRhbLjLgbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bsbsbLgLsbRsRsmbLsbRsbLsbRsRsRsmmbRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bRgbRjbLjbLcbLsbLsbRgbRsbRgbRobLsbLsLjbRjbRcbRibRjbReRsmbLgbRgRsmbLsbR
jbLgbLgRsbLibLjbLcbLobRsbLcbLiRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bLjbRgbLibLcbLcbLjbRjbLcbRcbLjbRibRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRsbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bLcbRcbRjbLhbLgLsbRobLcbLjbLjbRcbLcRsbRcLsbLhbLhbLobRobLcbLoRsbLjbLibR
ibLobLgbRobLcbRcbLibLhb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bRobRgbLobLobRsbsbRsLsbLibRsbLiRsbLsbLobRebLsbRobLgbRobRiRsmbRhbRobLib
LsbLsbLobRgRsmbRsbRibRgbLgbLsbLiRsbRoLsLsmbLcbLsLsLsLsLsmmmmbLsbLibRsL
sbLgRsbLiLsbLiLsbLsRsbRsbLobRibRobRobLhbRsbRhLsbLebLobRcRsmbRgbLibRsbR
sbRsbsbLiLsbLiRsbRsbLobRgbRsbRobRsbLsLsmbLibLobRsbRebLcbLgbLibLgbLsbLi
LsLsmbLsbLibsbRsLsbLiRsbLgbRsRsRsRsmmmbLibLhbLsbLibLgLsbLibLibLgbLsbRs
bLiRsbRjbRoRsmbRsRsRsmmbLgbRjbRcLsbLobRobLibRsbRobRhLsbLsbRgbRoRsRsmmb
Rcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bRcbLjLsmbRibLoRsbLobRobRcbRibRobRobLobLoLsmbLhbRobLjbRobLcLsmbLiRsbLg
bRibLcbLoLsmbLcbLjbRcbRibRoLsbLgbRibRobRobLibLobLjbRoLsbRobLibLgRobRhb
LsbRibLcbRhbLjbLcLsmbLibLoLsmbRobLhbLiLsbRcbLoLsmbRhbLgbRobLgbLgbLsbLo
RsbRcbLgbLobLobLib

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bRgbRsbRsbRsbLsRsbRsbRsbRsbLsRsbsbLsbRsbsbRsbLsbsbsbsbRsbRsbsbsbLsbsbs
bsbRsbsbsbsbsbsbsbsbsbRsbRsbsbRsbsbsbsbRsbsbRsbsbRsbsbsbsbRgbRsbLsbRsR
smbRsbRsbRsbRsbRsLsbRsbLsRsbRsbRsbsbRsbRsbRsbRibRsbRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLibRsbLiLsbLgbLgLsbLgbLsbLibLsbLsbLgbLsLsmbRcbLcbLebLhbRobRibRhRsm
bRgbRsbsbLiRsbLibRcbReRsRsRsmmmbRibLsRsbLibRiLsbRoLsbLibLcRsbRhbRibRiL
sbRgbLsbRsbRsbRgbRgbLsRgbRgLgbRibRsbRgbRgbLcRsbLobLobRibRgbRibLsbRgbLg
bRiLsbLjbRjbLgbRjbRcLsbLibRgbRibLgbRibRsbRgbRjbLgbRibLcbLhbRiRsRsmmbLi
LsbLsbLcbLcbLsbLsbRgbLsbRebLibRebRsRsmbRhbRgRsmbRsbRsbLjbRsRjbRsRebRib
RibLgbRibRibLjbLjbLibRjbRsRsmbRsbLcbLgLsbRoLsbRgbLibLsbRgbRgbLhbLgLsbR
jRsmbLcbRhbRcbRibRibLgbLsbLgbRibRsbRgbRgbRiLgbRibRsRsmbRiLsbRcLsbRsbRc
bRsbLsLobRibLhbLgbLgbLsbLhbLsbLibRcbLobRhbLibLibRgbLibRsbLiLsbLgbRsRsm
bLoLsmbRsbLsRsRsmbLiLsbLibLcbLcbLsbRjbLobLjbRcbRcbRibRibRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLgbsbLsbLsbLsLsmbLsbLsLsRsmbLsRsbLsbLsbLsbsbsbsbLsLsmbRsLsbsbLsLgb
LsLsmbLsbLgbLsbsbRsbRsLsbLsbLsbLsLsmbLsLsmbLsbLsbLsRsLsLsRsmbRsLsbsbLs
RsbLobLibsbLsbLsLsLsLsLsLgmmmmbLsLsmbLgbLsLsRsLsmbRsbLsbLsLsmbLsbLgLsR
sbLgbLgbLgbLsbRgbsbsbRsbRsRsmbsbRsLsRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bRgbRgbRgbsbLsbLsbsbsbsbRsbLsRsbsbsbRsbRgbLgbRgbRgbLibRibLgbRibRgRsmbR
gbRgbRsbRgbRgRsmbRsbRgbRsbLebLibLsbLibRibLcbRibRgbLgbLcbLgbLhbRibRsbLc
bRobRcbLibLsRobRgRsmbsbRobRgbLsbLibLcbLgbLgLsbLsbLgbLgbRsbLgbLgbLobRoL
sbLobRgbLiLsbRgbRoLsbLgbLiLsbRgbLiLsbRsbLibLgbLoRsbRobRsbLsRsbLcbLcRjb
LhbLibLibRsRsmbRgbLibLgLsbLgbLjbLsbLsbRgbLcbLobRsbLibLibRsbLgbLsbRoLsb
LgbLobLobLoLsmbLobRoLsbRcbRcbLobLhbRgbLibLoRsbLcbRgbLcbLibRjbRgbLgbLsb
LgbRobRobLgbLcbLsLsmbLsLibLgbLgbLgbLgbLibLibLgLsRsbLgbLibLgbLiLsbLgbLi
bRsbLibLgbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bRebRgbRgbRsbLsRsbRsLeRsbRsRsRsRsmmmbLebLsLjbRgLsbRjbRsbRsbRsLsbsbLgbR
sbLgbLsbLsRgbLebRsLsLsmbLeLsbLsLiRsbLsLibLcRsbLsRiRsmbRsbRiRsmbRgLgbLs
LhbRsbRgbRsbRebRjRjbRgRsmbRgbLsRcbLcbRsbRsbLibLsRgbRgbRsRgLsbRiRsmbRsR
smbRsRsmbRsbRsRgbLcbLeLcbRsRsRsmmbLibRsbLsLsmbRcbLiLgbRebRgbLsbLsRsbRc
bLsLebRsbLgbRsbLsbRsbRsbsbLsbLsRsbLsbLcbRgbRsbsbLgbLobLgbRcRsmbRcbRibL
obRsbLgbReRsmbRsLsbRgbLcbRhbsbRsbRsRsmbLsbRsbRsbLcbLiRsbLsLsLsmmbLgLsb
sbsbsbLsbLsLgbRcbRibLebRgLsbLjbRsbRsRgbRsbRsRsRimbRebRhLsbRcbRsRgbLsbL
gbRebLcLsmbLgbRsbRcRgbRsbLibsbLsbRibRsRgbRsRjRsRsLsmmbRibLsRhbLibRgRob
LebRgbsbRsbLsbLsbLsLsmbRsbRsLsRsbLsLsLsmmbRsLsbRsbLsbsbRsbsbRhbRcbLsbL
oLebLeRgRsmbRjbReLsbRsbLibLgbRjbRsRsmbLebRsbRibRsRsmbRsbRgbRebRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLcbRgbLsbLsbLsbRsRsLsLsmmbLsbRsbLsbLeLgLsRsbLsRebRiRsmbLsRgbRgbRgb
RsbRgbLsbRgLsbRgbRsbRsbRibRebRcbLobLobRsRsmbRsbRgbRsRsRgmbRsRgbRsRsRsm
mbRsbLsRsRsmbRgbRsbRsRgbRiLsbLsRsbLsbRsbLgbLsbLsRsbRsbLsbLsbLsbRgbRsbL
sbLsbRsbLsRgbRjbRgbRebLsbRgbLgbLjbLcbLibLsbRgbRsLsbRgbRibLsbLsbRgbRsLj
bRobRobLgbLobRsbRsbRgbRiRsmbRsRsmbRibRjbRsbRgRsmbLobRibLsbRsbRsbLsbRgb
RsbRsRsmbRsbRsRsmbRsbRoLgbLsbLibLcLsLsmmbLsbRsbLebLgbLsbLgbLgLsLgbLsbR
sbRgLsbRibRsbRgbRgRsmbRsbRsbRsRsmbLebRhbRsRsRsmmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bReRsmbRsbLsRsbsbRsbLsbRibLsRgbLcbRoLsbLjbLiRcbLhbRsbRiRgRgbRsRsmbLsRg
bLjbRgLsbLsRsbLsbRsbRsRsmbLsRsRsmbsbRsbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRcLsbLjbLsbLsLsmbRsbsbsbsbLsbLcbLgbLgbsbLsbRebRsRsmbsbsbsbLsbLgbLsLsm
bLsbLsLsRsmbRhbLibLgRsbLobRhbLoRsbRsbsbRgbRsbRsbRsbLebLsLsmbLsLsLsLsmm
mbsbLsRsbLsLgLsbLsbRsbLgLsbLsbRsRsmbsbLsbLsLsLsRsmmbLsRsbRsbLsbLsbRsbR
sLsbLsbLsRsbLsLsRsmbLsRsbRsbLsbRsbLsbsbLsbRsbRsbLsbLjbLsbLsbRsbsbsbRsb
Rsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bLgLgbsbLeLsLsmbLcLsLsmmbLgbRgbLebLebLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbLsbRsbRjbLoLsmbRsbRsbLsbRsbRsbLsbLhbLsbRebLsLsmbsbLibLgbLsbLjbL
sbLgRsRsmbRgbLjbRsbLsbLsbRcbRcbLsbLjbRcbLibRibRsbLjbRobRsRsmbRhLsbRibR
obRgbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 25; Drug: Control Apo 0.5 然
bRebLjbLiLsbLsbLsbLiLsbLgbLibLgbLgbLhbLgbRibLjbLgbRsRsmbLibLgbLgbLibLg
bLibLsbLgbRhbRsbLjbRjbRjbRjbRhbRobLibLgbRibRjbLgbRjbLsbRhbRsLsbRgbRsbR
gbLsRsbLsbLjbLhbLgbRibRsbLgbLsbLsbLgbLgbLibLgbLsbsbRcbRibLsbRjbRgbRgbL
sbRgLsbLsbRgbRgbRgbRgbRsbRjLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 26; Drug: Control Apo 0.5 然
bRcbLcbLcbLcbLibRsRsmbLsbLsbLsbRjbRsbRibRgLsbRgbRibRgbRsbRsbRibRsbRibR
gbLgLsRsbLcbLhbRjbRjRibRcbRiRsmbRgbRsbLebLcbRibRiRsmbRsbRsRsmbRgbRgbRg
bRsbRgbLsbLgbRgbRsbRgbRsbRgbLjbLcbLcRsbRjLsbLcbRgbRgLsbRsbRibLibRibLjb
LcLsmbLhRsbLcbLibLsbLgbRsbLibLsLsmbRcbRcbLgbLgRsbRibRobRcRsmbLjbLjRsbL
hRsRsmbRjbsbRsbRgbRsbRibLsbRiRsmbRgbRsRgbRibLcbLhbLibLgbRsRsmbRsbLibRj
bLcbLhbLgbRsbRibLcbRgbRgbLcbLhbLibLgbRobRgbLsbLsbRjbRibLcbLibLgbLgbLsL
smbLsbLibRgbRhbLebLiLsbLcbLgbRibRsRsmbRgbRsbRgbLibLcbLibLjbRcbLsbRoLsb
RibRcbLgbRsbRsbLsbRgbRcbRgbRgbRgbLsbLjbRibRsbLgbRcbRcbRjbLibRcbLibRsRs
mbLgbRsbRjbRiLsbLcbRcbLjbRobLgbLjbRibLjbLjbRcbRcbRjbRgbLgbRibRibLsbRgb
RgbLsbRsbRgbLgbRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 27; Drug: Control Apo 0.5 然
bLobRobLibLebLsbRobRobRibLobRcbRcbRobRobRebLcbLhbRobRibLobRobRobLibLcb
LibLgbRebRobRhbLobRobRcbRobRsbRobLcbRibRobLgbLibRobLobLebRobRibRcbLobL
ebLobRobRcbRhbLcbLsbLhbLibLobRebRjbLobRebRobRobRcbLgbLcbRjbRobLibLobLs
bRebRobLebRhbLobLobLgbRebLobRebRobLebRobLcbRibLibRcbRobLobLobRebRcbReb
LsbRobLebLobRcbRobLobRcbLobLcbRebRobRcbRgbRobRobLebLobLibRcbRobLibRebL
ebRhbRibLebRebRobRobRobRcbRobRcbLsbRsbRobRobRebLobLobLhbLobLobLobRobRc
bRcbLcbLobRgbRgbLobLcbRibLobRobRobLobRibRsbRobLobRebLcbLobRobLibLibRgb
LobLibLcbLibLibRibRobRebRibRebLobRobLebRebRcbRhbRibLebLcbLebLobLcbLibR
cbLebRibLobRcbLebRobLobRobLebLobRebRibRebLobRobLgbRibRobLobLcbRobRobLo
bLobRobRebLobLcbLcbRebRebLebRebRobLobRebRsbLcbRsbLibLebLobLibLobLobRob
LobRobRcbRcbLebLobLsbRobRobLibRobLobRgbLebLobRcbRobRobRebLgbRobRcbLibL
obLgbRobLibRcbLgbLebLobRcbLebLebRobRobLobLgbLobLgbLobLibRebLobRcbRibRo
bRgbRebLsbRcbRcbRibLobLhbRobRhbLobRsbRobLebRgbRobLibRobLcbLobLsbLobReb
LebRcbLgbRobRebRobLsbRgbRcbLobLobLcbLebLcbRobRobRebLebLobLebLgbLobRgbR
obRebRibRibLebLibRibRhbLcbRobLebLobLobRcbLobLobRcbLebRibLcbRgbLcbLebRg
bRcbLcbLobLhbRcbRebRobLobRgbLgbRobLobRobLebRcbRobRobRcbRebRobRebLebRob
LcbLgbLcbLebLobLcbRobLibLibRebRibLgbLgbLibRcbLobRobLobRobLibRobRobLebL
obLobLobLebLobLsbRobRebRibLcbRebRobRobLebLibLebRobRcbRcbLebLibLobLobLo
bRebLjbRcbRobLobLebRebLebLibRebRobLobRcbLsbRobRobLobLobRgbLgbRgbRebReb
RobLobLibRebLsbLsbLobLgbLobLebLibRebRobLebRcbRcbRobRcbRebLobLebLebLhbR
gbRhbLobLgbLobRcbLobRhbLcbRcbRgbRebLcbLobLobRebRobLobLebRobLebRebRobRc
bRebLebRobLhbLobLcbRobLebRgbLebLobRobRobRebRgbRebRcbLobRobRibLgbLcbLeb
RebRobRobRgbRibLobRibRobLibLcbLobLibLhbRobLcbLcbLobRobLobRobLebRobRebL
ebLobRsbLebLobLobLibRebRobRobLebRgbRcbRobLobLobRcbRobRobRcbRobRobRebRi
bRcbRcbRcbLebRobRebRcbLobRobRebLobRobLobLebRibRobRobLgbRibLcbLobLobLeb
RcbLobLebRhbLebRsbRobRebLcbRobRobRcbLcbRobLgbRobRgbRsbRcbLsbLsbLebLebR
ibLebLebRgbLobRebRebRebRsbRebRsbLebRobRobLebRibLebLcbLcbLebRobRebLjbLo
bRibRebRobLebRibLebLgbRibLhbRebLobRibLobLobLibLcbLobRebRobLobLhbLcbRob
LibLobRobLobLibLobRobLibLgbLcbLobRcbRcbLobLcbRobLibRobLobLibLibRhbLebL
obLebRebRhbRsbRobRibRibLcbRcbLobLebLobRobLibLcbLebLebRobLobLcbLcbLebRo
bRobLobLgbLobLcbLsbLgbLcbLebRobLobRebLobRebLgbLgbRebLsbRebRhbLcbRebLob
RgbRobLebRcbLebRibRcbLebRgbRibLgbRibLebRibLebRobRcbLobRibLebRobLcbRobR
ibLobRebRobRibRobRobLcbLebRobRsbRobRebRjbRcbLsbLebLobLobRcbRsbLebLsbRs
bRsbLebRobLgbRcbLobRobRobLebRebRobRebLebLcbLobRebRobLcbRibLebLobRobRcb
LebRebRebLibRebLobRebLebLhbRobRsbRebRcbRobLobRcbRobRobRobLobLgbRobRcbL
obRhbLebLebLebLcbLobLobLgbRebLobLobRebLobRebRebRobLobLcbRibRebLobRobLe
bLebLobRobLjbRgbRobLebRsbRibLebRibRcbRobRobRcbLibRobRobLcbRcbLobLobLcb
LebLibRsbRibLebRibLobLcbLobRebLcbLebRcbLobLcbLcbRobRobRobRobRibLcbRobR
ebLibRobRobLebRibRibRcbLibLebLobLgbRgbLibRsbLobRcbLobRobLobRobRgbRjbLs
bLobRgbRobLebRcbLobRobRgbRobLobLebRobLibRobLcbRcbLebRobRobRobLibLsbRob
RcbLobLebRcbLobLobRibRgbRibRhbLobLibLcbRgbLobRibRcbRgbLgbRibLgbLibLobR
sbRhbRcbRsbRgbLibLobRibRgbRobRibRibRgbLebRcbLebRebLobLgbLhbRebLobRebLo
bLobLebLobLgbRibLcbRobRobRhbRcbLgbLcbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 28; Drug: Control Apo 0.5 然
bsbLgbLsLsmbRgbLiLgLsbRgbRsbLsbLsRsbRjRsmbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 29; Drug: Control Apo 0.5 然
bLibRcbLhRsbRobRibRibRgbRiLsbRibRsbRcRsmbRjRibRcbRcbRhRhbRcbRibLsbRjbR
cRsmbRcbRcbLcbRjRsmbLgbRgbRjbRjbRebRcbRcbRobRiRsmbLsRsbRobRhbRcbRcbLoR
sb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 30; Drug: Control Apo 0.5 然
bRgbLsbRibRiRsmbLcbRjbRhbRsbRgRsmbRsbRibLgbRiRiLsbLgbRgbLcbLhbRgLsbLob
LibLcbRhbRcbRiRsmbLobLhbRjLsbRoLsbRjbRhbRjbRjLsbRhbRibLobRjbRibLibLgbR
obLobLjLsmbLhbLobLobRcbRibRibRsbLjbRjbRobLobRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bLsLsRsmbLsbRcbRhbRibRibRibRsbLgbRcbRhbRiRsmbLsbLibRsbLsbRgbRgbRibLsbL
sbRgbRiLsbLjbRgLsbRsLjbLhbRsbRjbLobLobLoRsbLsbLsbLsLsmbLsbLsbLibLgLsbL
gbLsbRebRibLhbLcbRibRcbRiLsbLhbRiRsmbLsbRibLsbRgbRcLsbLibRgbRibRgLsbRs
bLsbRsLsbRsbLjbLibRsbRsbRsRsmbRsbRiLsbRgbRsbLsbRobLjbRcLsbRcbRhLsbRcbL
iLsbLsbRcLsbLcbLsbRibRobLgbRcbRhbRibRcbLcRsbLjbLcRsbLcbLsbRobLhbRsbLsb
LsLsmbRjbRhbRjbRoLsbRobRobRobRibRibLgbRibRibLibLgbLsbLgLsbLgbLibLhbRhb
RgbLhbLjbLibLsbRobLsLcbRjbRibLjbRgbRgbLsbRibRiLsbLibLsbLgbRcbRibRcLsLs
mbRhbRobRcLsbLobRobRobLobRibRibLoRgbLjLgbLsbLsbLcbLgbRibRgbRsbLsbLibLs
bRcbRhbRibRibRibLibLsbRcbRobRobRibRsbLsbLibLibLsLsmbLgbRcLsbRibRcbRgbL
sbLsbRibRhbLjbRobLibRcbLcbRhbRobLoRsbRobLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLcbLibRsbRcbLcRsbLebRcbRiRsmbLsbRsRsmbLjbLibLgLsLsmbLibLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bLsLgbRoRsmbRcRsmbRsRsmbRsbRsRsmbRsRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bRobRobLobLobRobLobRgbLebLcbRebLcbLobLobRsbRebRebRebLebRcbRobRcbLgbRcb
LcbLobLobLobRobRcbLobRobLobRobLjbLhbLcbLobRobLobRsbLibRebRobLobRobRobL
gbLibRsbLobRobLebRobLobLobLhbLobRobRibLcbRobRcbLobRobRgbRobRhbRjbLobRo
bRebRobRobRsbLcbRebRgbRebRcbLsbRebRhbRsbRobRebLsbRcbRsbLsbRgbLcbLobRob
RgbLebLobRobLobRobLeRobLobLobRjbLobRebRsbLobLsbLobLebRobRibRibLobRobRs
bRobLebLobLobLhbLebLobRebLobLibLobRobRobRjbLobLsbLgbRgbRobRebLobLobLob
LobRobLsbRebRebLobLcbLobLsbLsbRsbRsbLebLobLcbLebLebRebRhbRebLcbRcbLebL
obLobRobLsbRebRobRsbRobLibLobLobRcbLobLobLsbLobLgbLgbLobRsbLobRebRobRh
bRobLobRgbRobRebRsbRhbLobLobLgbLobLobRhbLsbLsbRhbLobLcbRcbRebLebLobReb
RobLebLibLebLsbLebLobLebLobLcbRcbLebLobRcbLobRobLoLebRebLebLjbRobLibLe
bLobRobLcbLibRjbRobLjbRibLcbRobRcbLebRcbRsbLebLjbLgbLobRobLobLjbRgbLeb
RobLobRsbRobLsbLobLibLsbLebLobRobRebLobRobLjbLobLsbRobLsbRobLobLobLobR
obLcbLobRgbRobLobRobRibRgbLsbLgbLobLobRibRobRsbRobLobRobLobRsbRebLgbLo
bLcbLgbRsbRsbLobLobLcbRhbRobRebLobLobRobRsbLebRobLobLobLobLcbLgbLsbRsb
RebRcbLobRobLcbRcbLjbLobLobLobRibLebLcbLobRoRebRebLobLibLobRobRobLsbLo
bRobRibRcbLobLibRobLcbLhbLobRebLobLobLobLobLsbRibLobRobRobLgbRebLobRsb
RjbLsbRhbLobLebLobRjbRobLebLsbRsbRobLcbLobRcbLcbRsbRebLobLebRobRsbLibL
cbRobRebLebLjbRibLobLobRebRobLcbLobLobLebRgbRobRebRjbRjbLobRobRebRsbRo
bRebRebRebLobRcbLobLcbRebLebLobRhbRebLobRebRobRebRobRobLgbRobRebRobRob
RebLobLcbRebLobLobLobLgbRebLobRibLebRobLcbLobRobRobRsbRgbRebLhbLebLcbR
obLobRobLcbRgbLobLsbLebLcbRcbLobRobLobRebLcbLebLobRebRobLhbRebLobLebLi
bRobLsbRgbRibLobRobLobRcbLcbRibLobLsbLobLebLebLsbRcbRebRebRcbLibLebLob
RobLebLebLobLobLobRobRhbRebLobLjbRebLebLebLibLjbRobRobLcbLobRcbLibRobL
ebLobRobLobRobRobLibRgbRgbRebLibLebRobLibLebRobRgbRebLobRcbLcbRcbRobRc
bLsbLobRobRhbLobLhbRobRebLobRsbLgbLcbRebLcbLobLobRobLebRcbRebRebLcbLgb
RcbRobRebLgbRobLsbLcbLobRibLhbRobLgbRobRcbLgbRobRobRcbLobLobRobLobRobR
obRebLebLsbLhbLobRobRobLsbLobLobLobRobRobLgbRobRsbLobRobRobLsbRcbLobLc
bLsbRcbRebRobRebLobRobLsbLsbLebRcbLsbLcbRibRobRebLebRgbLjbRobLebRgbReb
LobRobRibLobRcbRobLobLobRebRjbRobRsbRobLobRjbRobLcbRsbRobLebLobRobRebL
hbLibLsbLcbLobLjbRcbRobLobRobLobRgbLgbLobRobRsbRobRobLibLobRobRobRcbRo
bLgbLobRobRebLobLobRobLobLobLjbRobLsbLjbRsbRebLcbRobRobLhbRsbLobRobLsb
LcbRsbLobRsbLebRobRobLobLobLobRobLobRsbRsbLebRsbRobRsbLebLobRobRsbLsbL
obRjbRsbLcbLobRobRobRebRobLobLgbLjbRebLsLebLsbRibRobRobLebRobLobRobLob
LebLobRsbRibRoRsmbRgbRebRobLjbLobRobRobLsbLebLebLcbRobLobRcbRebRobRjbR
obLebRobRebRobRsbRobLsbLobRobLgbRsbLobLsbLcbRebRgbLjbLebRobRebRsbLobLo
bLsbLobLsbLobLobRgbRsbRjbRcbLobLjbRsbLsbLebRobLsbLobRjbLebRobLobRobLcb
LebRebLebLebLsbLsbLobLobLebRoRsmbRobLobLebLsbRebLoLebRobLsbLcbLobLebRs
LebRobRobLebRsbRobLcbLebLsbLobRobLebLobRjbReLebLsbLobRsbLebLobRjbRobRg
bReRebRebLebLcbRebRebRobRobLcbRobLobRobLobRebRibRhbLcbRobRsbRebLebRebL
cbLgbRobRebRobRobRcbLobRebLobRibRobRsbRsbLjbLjbRibRsbLobLsbLgbLobLsbRo
bLibRcbRibRgbLobLjbLebRebLobLobRsbLsbLjbRibRcbRebLcbLebRobLob

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bLibLjbRsbLsRebReLsbRsRgRsmbLibLsbRebRobRsbLsbLsbLsRsbRgRsLsmbLobRobLg
bLibLgbLibRebLiRgbRibRgbRsbRibRcbRibRgLsbLebRibLsLsmbLibRgRsmbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bLsbRsbLsbLgbLgbLgLsbRsRsmbsbLsRsbRsLsbLsbsbLsbLsLsmbLibLsbLsbLgbLgbLh
bLsbLsbLsbLibLgbLsLsmbLgbLgbLgbLgbLhbLgbLsbLcbLibLgbLcLgRsbRsbLgbRgRsm
bRsbRcbRgRsmbRsbRgbRgRsmbRgbRsbRsbRgbRgbRsbRgbRsRsmbRsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLsLsmbLsbLhbLsRsLsbLobLibLsbLgbLgbLgbLibRgbLgbLgbLsLsmbLgbRobRgRsm
bRgbRgbRgbRgbRibRgbRgbRgbLsbRgbRgbRibRgbLebRjbRgRsmbRsRsmbRiLsbLsbRibR
iRsmbLibRgbLsbRgbRiRsLsmbRibRibRibLsbLgbRibRobRcbLcbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bRibLobRibLobLcLsmbRebRobLibLobLcbLibRjbRobLobRobLjbRibRibLgLsbRoLsLsm
bRgbRgbLgbRhbLibRcbLibRibLcbRcbLcRsbLcRsbLsbReRsmbLibRjbLgbRjbRibRhbLs
bRsRgRsmbLobLiLsbRobRobLhbLcbLobRcbLgbRibLibLibRibRcLsbLobRebLibRibRib
LhbLibRsRsmbRcbRobRgbLibRebRcbRobRibRibRibRibLobRcbLcbLgbRhbRsbLsRsbLj
bLjbLsbLgbLsbRebRcbRibRhbLsbRobLobRobLibLibLsbRgbLgRsbLgbLoLsmbLibRcbL
hbRsbRgbRsbRiRsmbRibLsbRsRgbLsbRgbLsbRibRsbRsbRibRibLibRibRhbLgbRcbLib
RhbLgbLsbRcLsbLibRibLsbRiRsmbRgRsmbLsbRgbRgbLgbRoLsLsmbLibRgRsmbRibRjb
LibLgbRibRjRsmbLsbRiLsbLjbRoLsbRcbLcbLhLsbLhRsbRjbRobRibLobLiLsbRobRib
RobRobRibLgbRgbLjbLcbRcbLobLobRibLsLsmbLibRibRibLibLsbRsbRsbRibLsbRgRs
mbLgbRgbRiLsRsbLsbRgbRsbRgbRgLsbLsbRibRgbLsRsbRgbRibLgbRibRsRsmbLgbRgb
RiLsbLgbRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsRsRsmmbLsbRsbRsbRsbRsbRsLsbRiRsmbRsbRsbRibRsbLsRsbRsbRgLsRsbRgRs
mbRsbRibRgRsmbRsbRsbRsbLsbRsbRgbRsbRsbRsbRsbRsRsRsmmbLsbRsbRsbRsbLsbRs
bRsbRsRsmbRsbRsRsmbRsbRsRsmbRibRgbRcbRibRgRsmbRsbLgbLibRsRsmbLgbRsbLsb
LsRsRsmbLsLsRsmbRsRsmbRsbLsRsbLsbRsbRsbLsbRsbRsbRsbLsbRsbRsbRsbRsRsmbL
sbLsbLsbRsbLsbLsbRsbRgbRsbRsbRsRsmbRsbLsbRsbLsbRsbRsRsmbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bLebRsbLsLsmbLsbLobRsbLsbRsRsmbRsbLsbLsRsbRsbRsRgbRsbLsbLsbRsRsmbLsbLs
bLsbRsRsmbRsRsmbLsbLsbRsbLsbRsbsbRsbLsRsbLsbLsLsmbsbLsbLsbsbLsbRsbRsbR
sRsmbRgbRibRgbLsbLsbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbLsLgRsbLgRsbsbLcbsbLibLgbLibLgbLsLsmbLgbLgbLsbLibLebRsRsmbLsbLs
LsRsmbLgbLiLsbLgbLsbLoLsLsmmbLsRsbLibLsRsbRsbsbLeRsbLgbLiRsRsmbLiLsbLg
bLoRsbLsLsmbLiLsbRcbLgbLebLcbLiLsbsbsbLsbLcLsmbLsbLibLibRsRsRsmmbRsRsm
bLgbLcbRcbRsbRsbLgbLobLhbLibLgbLibRsLsbLsbRsbRibRsbLsRsRsmbRcbRgRsmbLs
RsbRibRibRgbRhRsmbLgbLibLibsbsbLsbLsbLgbLsbLiLsbLgbRsbLgLgbRsbLsLsmbLs
LsmbLsbLgbLgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bLob

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bRsbLgbLsRjbLjbRcbLjLsmbLoRsbLebLobRsRsmbRsRsmbsbRgbRiLsRsRsmbRgbRibsb
LsLsmbLsbLsbRibRsRebRjRgbRiRsmbRjbRsbLsbRsRebRgbRiLsbRibRgbRsbsbRsbRsR
smbsbRjRcLsbLsbLiLsLsmbsbsbsbLsbLsbLsbRsRiRsmbRobLsbsbLoRsbRsRsmbRsbLj
RsbRobLsRsbLsbRsRsmbLsbRebLebLeRsRsRsmmbRgRgbRiRsmbsbLjbLjbRsbLsLsRsmb
LebLeRsbLsbRsLgbReRsRsmmbRgRgbLjLebLebLsRsRsmbReRsRsmmbRsbRsbLsbsbsbsb
sbRsbsbsbRsRsmbRsbRsbRsbLsRsbRsLsbLjRsRsLsmbRsRgRsmbLsbRgbRsLsbLsbRsbL
sbRebLib

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bLsRsbLsbLgRsbRsbLsRsbLsRsbLsbLebRibRsbLsbRsbRsLsbRsbLgbRsLgRsbRsbLsbL
ebRsbLgbRsbRsbLgbRsbLgbRsbLsRsbLsbRsbRobLgLsbLgbLgbRsbLsbLsRsbLgbLsRsL
sbLgRsLsbRsbLebLobLsbLgbLiLsbLsbRsbLgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bLsLsmbsbsbsbsbsbsbsbLsbsbLsbsbLsbLsbsbLsRsbLsLsmbLsbLsLsRsmbLgbLsLgRs
bLsbLgbLibLibRgLsbLibLgbLsbLobRsbRgbRgRsmbRebRgRsmbRgbRsbsbRsRsmbRsRsR
gRsRimmbRsbRsRgRsmbRsRhbsbRsbRsRsmbLsbRgbReRsmbRsRsmbRsRsmbRsRebRebLib
LgLsbRsbRsbsbLsbLsbLsLsmbLsbLsRsbRsbLsLibRsRsmbRsbRsRsmbRgRibRsbLsbRib
LiRsRsRsmmbLgRibsbRsbRsbRgRsmbRsbRsRsLembLcbLhRsbRsbRsRjbLcLsmbLcLsRim
bRgRibLsRhRsLsmbRsRsmbRsRsmbRgLsLsmbLgLsbRsbRibsbsbsbRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLsbLsLsmbLsbsbLsLsRsLsmbsbRsbLsbsbLsLsmbLjRsRsLsmbLsbLgbLsLsLgmbLs
bLsbLsLsmbLsLsmbLsLsmbLsLgbRsbLebRebLsbRgbRebRibLobLsbRebLgbRgRsmbRgbL
ebRebRsbRsbLebRjbRebLobRsLsbRsbLsLsmbLgbRcbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122242; End: 122742;
Recording: 2-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bLoLgbLgbLgbLsbLsbLcbLobRjbLcLsmbLsbLgbLibRobLsLobLsbLgbLhbLebLsbRsRsm
bLibLgbLsRsbRsbLgLgLsbLsbRsbLebLeLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 1; Drug: Control Apo 0.5 然
bRiLsbRobRhbRcLsbLjbRcbRobRsbLibRgbRobLibLsLsmbLibRsbRebRibRobLsbRcbRs
bLcbLgbLcbLcbLobLiRsbLiRsbLcbLcbRibLcbRgbRhbLgbLibRibRsbRhbRhbLibLobLg
bRsbLgbRsbLgbLgRsbRsLsbLgbLgbLsLsmbLsbLsbLsbLgbLsbLsbLsbLsLgbRsbsbLgbL
sbLgbLgbRobRibRobLibRgbRsbLibLsbLsbRgbLsbLoLsmbLibRjbLcbRsbRgbRsbRgbRj
LsbLibRsbRsbRibLobRiLsbLibRgLsbLsbLgbLsbLsbLsbLgbRsbLcbRoLsbRsbRgbRsbR
gbLgbLjRcbLibLcbRibLgbRsLsbRgbRsbRsbRgbRobRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 2; Drug: Control Apo 0.5 然
bLjbRibRsbRgbRcbRibLgbRgbRsbRgRsmbRsbRgbRibLcbLcbLcbLibLibLjbLibRjRsmb
RoRsmbRobRibRgbLgbLjRsbLibLobLsbLcbLgbLiLsbLgbLgbLobLibLobLhbLcbLsLgbR
sbLgbRsbLobLcbLobRibRibRsRsmbRsbRgbRgRsmbRgRsmbRgbRibRgbRcbRiLsbRgbLgb
RsbRsbRibRgbRgbRsbLsbLcbLibLgbRibLgbLiRsbLsbRgbLcbRsbLobRgbLgbRgbLgbRc
bLsbRobRibRjbLgbLjbLcbLgbLgbLcbLcbLibRjRsmbLgbRsbRgRsmbRibRsbLcbRjbRib
RgbRsbRsbLsbLsbLjbLobRgbLcbLhbLgbLsbLibLgbRsRobRcbRibRgbRsbLebLsbLibLi
bLhbLibLsbLsbLgbLgbLgbLibRsbLobRgbRhbRibRgLsbLsbLjbLgbLgbRcbLcRsbLcRsb
RsbLcbRibRsRsmbRsbLcbRibRcbRibLibRsbRibLibLgbLgbLgbLobRjRsmbRgbRiLsbRi
bRgbRgbRgbRgbRsRsmbRsbRsRsmbRsbRsRsmbRgRsmbRsbRiLsbLcbLobLcbLgbRsbRjbR
sbRgbRsbRsbRsbLsbRgbRgbRsbRgbLcbLgbLgbLsbLsbLibLsbLcbLgbRcbRibRsbRgbLs
bRgbRiRsmbRgbRsRsmbLsbRjbLcbLcbLgbLibLibRsbRibLhbRsbLgbLsbRsbLcbLsbRcR
smbRobRsbRcbRibLhbLibLgbLibRsbRsbLsbLibLsbLibRebRcbLgRsbRhbLsbLsLsmbRg
bRobRibLibLsbLsbRgbRsbRgbRibRgbRsbRgbRsbRsbRcbLibRsbLibLibLiLsbLgbLgbL
jbLibLgbRibRsbRsLgbLibLibLgbLgbLcbRsRgbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 3; Drug: Control Apo 0.5 然
bRibRgbRsbsbRgbRcbLcbLibLcLsmbLsLsmbLsLsmbLsbRsRsmbRsbRsbLsbRgbLsbRoRs
mbRobLgbRobLgbRibRob

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 4; Drug: Control Apo 0.5 然
bLgbRgbLsLsmbLsLsmbRobRebRgbRsbRibRibRcLsbRsbRsbLsbLsLsmbRgbRgbLgbRgbR
sb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 5; Drug: Control Apo 0.5 然
bRobRobRcbRebLgbLgbRsbRebRebLobRobLibLobRibRebLobRgbRebLobRebLgbLebReb
LcbRebRobLebLobRcbLgbLibRjbRebLcbLebLobLcbRebRobRobLobLobRjbLcbRobRobR
obLcbRobRobLibRobLebRobLobRobRcbLsbLebLobRobRhbRobLebRobRobLobRcbLebLc
bRobLobLgbLebLgbRobLcbRcbRobLcbRobLobRebLobLebLcbLcbRebLsbRebLobLebLeb
LcbLibRgbRobLsbLcbRjbRobRobLobRobLobRebRebRibLobLebLebLcbRobLobLebLhbL
ibRgbLobRobLobLobLobRobRobRgbRobLebLobRobRgbLobRobRobRcbRsbLcbLcbLcbLg
bRebLobLsbLebRcbLebLobRgbRebRebRebLebRcbLobLebRobRcbLebRebRgbLobLebRcb
RhbRsbRebLgbLcbLsbLobLsbLibLobRobLebLobLebRgbLgbLobLobRcbRobRebRobRobL
obLcbRobLobRobLgbLjbLobLibLobRjbRcbLebLobLibLebLobLobLhbLobLgbRcbRgbRg
bLobRebRobRebRhbRgbRobLobRobLebRobRcbRebRsbRobRsbRsbRcbRibRcbLgbRibLcb
RebRjbLobLibRcbRebLebLebRebLobLebLobRibLcbLobRgbLobRibRcbLobRobLobRobR
ibLobRobRebRhbRobLcbLgbLobRobRebRcbRgbLgbRebLcbLobRebLcbRcbLcbLobRebLo
bRebRobLobRebRebRjbRjbRobRgbLjbRjbRobRobLobLebLibRebRcbRobRebLebLcbReb
LcbRobRebRebRobRebLgbRobLobLobRcbRebRobLobLebRcbLcbLcbLobLgbRebLobLebL
obLobLibRobLebRebLebLcbRebLcbLcbRsbRgbLhbLobRgbRgbRobRobLobRhbRobRebRg
bRsbRobRebLjbRibRobLgbLebRobLobRebRsbLebLsbRgbLobLobRhbRebRibLobRobReb
LsbRebLcbLgbLebLobRsbRgbRsbRobLobRebLebLibRcbRebLobRcbLjbRcbRebLcbLebR
obRebLebLibLebLgbLebLebLcbRobRibRobLebLobRobLcbRebRebRobLcbRebRobLobRo
bLcbLobLcbLobRobLebLcbLobRibRebRobRibLebRobRebRebLcbLgbRibLebLebRcbLcb
LebRebLobLobRobLobLobLobLsbRobLobLsbRcbRebRebRebLobLebLcbLibLobRgbRjbR
ebLebLobRebRobLsbRgbLibLcbRobLhbLebRjbLgbLebRobRebLibRobLhbLebLobRsbLc
bRobLgbRsbRcbLobRobLebLcbRobRebLebLgbLcbLobLebLsbRebLcbLobRgbLsbLcbReb
RebRibLgbLebRjbLebRobLobLcbLobLobLibLobLobRjbRebRcbLibRobRjbLebLobRcbL
obRobLobRcbRebRebRobRebRibRsbLcbLcbRobLcbLcbLgbLebRibLebLebLcbRobLobRe
bRibLebRobLsbRobRobLcbRcbRebLgbLcbLobRcbRcbRebLsbLobRsbRgbRobLobLibRob
LobRsbRebLcbRebLobLgbRebLsbRobRobRebRobRebLobLebRsbLobLebLobRobRobRcbL
cbRcbLebLobLgbRobRgbLsbRcbRebRobRobLcbRobLgbRcbLebLjbLibLobLobLebLebRi
bRobRsbLobRebLobLebRebRebRobRgbLobLobLebRebLcbLcbRebRibRhbLebLebRjbLgb
LobRebLobLgbRebLcbLcbLsbRebRsbLobRebRobRgbRobLobLsbLebLobRobLibLobLcbR
cbRibRsbRobLebRcbLibLsbRebLobLcbRobRibLebRibLobLjbLobLobLebRcbRebLibRe
bRcbLebRobLgbRibRhbLgbLebLobRobLhbRebLcbRcbRcbLebRobRebRibRobLobRebRsb
LebRebLebLebLebLhbRobRcbRcbRobLobLibLibRobRobRibLobRobRhbLhbRsbLebRgbR
ibRjbRcbLhbLebLobLcbLsbRcbLobRebRcbRgbRebLibRsbLebLsbLobLebLsbRsbRebRi
bRibLobRobRobRsbLcbRhbLebRcbRebLebLobRcbLhbLobRobLibLebLsbLebLhbLsbRob
LcbLcbRebLgbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 6; Drug: Control Apo 0.5 然
bLjbRcbLgbLiRsbRgRsmbRibRsbLhbRsbRgbLgbRgbLiRsRsLsmbRcbRjbRcRsmbRjbRjb
RibLcbLiRsbRcbRiLsbRsbLjbRsLcbLoRsbLgbLjbRsbLobRgbRcbLgbLgLsbRibRsbLgb
LhbRhbLjbLjbLibLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bLcbRobRibRcRobRhbLjbLiLsbRcbLibRcRsmbLibLjbLsLsLsmmbsbRsbRhLsbLobRibR
ibLobRcbRibLhLsbRibRibLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bRsRsmbLobRsbLjLsLsmmbLgbRsbRsRsmbLsLsmbRsbLgbLsbLibLsbLgbRsbRsbLsbRsb
RsbRgbRgbRibLsbRcbRcbLcbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bRgRgbRjbRgbLgbLjbLsbLsLsmbLgbsbLgbRibLibLjbRibRibRsRsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bRsbLibLibLibLibLibLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bLiRsbRsRgbLibLibLjbLobRgbReRsmbRcbLobRebRsbLobRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bLobRibLjbLebLcbLibLcbLcbLjbLibLhbRsbLcbLjbLcbLcbLjbRobRibLobLibRcbLcb
LsbLgbsbLgbLsLsmbRsbLcbRcbRoLsbLobRobRcbRobRgbRobLibRgbRhbLgLsbRgbLjbL
jbRcbLcbRjbLhbRjbRobRobLjLsmbLcbRjbLcbRobLhbRobLobRibLcbLibLoRsbRibLgL
sbRibLgbRhbLgbLjbLibRobRobLgbRgbLibRgbLibRsbLsbRhbLcbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bLsbRobRsbLsbRiRsmbRgbLsbRobLcbRobRjRsmbLsLsmbRibRiRsRsmmbLobRcbRcbLgb
LgbLjbLsbRobRebLhbRibRcbRsbRgbRhbLgbRibLibLhbRobRcbLobRgbRsbRobRebRobR
gbRcLsbRebLobRgbLcbRsbLcLsmbLjbsbLsbRsbLibRsbLgbLcbLibLgbLsbRjbLhbRibL
oRsbLibRgbRsbLcLsmbRoLsRsbRibLsbLsbRhbLibRiRsmbRgbLebLobLcbLcbLobLoRsb
LsRsLsRsbRsbsbsbRsbLsbLsbsbRsbRsbRobRcbRsLsbRibLsbRebRsbLjbRibRibLobLo
b

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bLobLobLobRsbLobLjbRobRoRsmbRhLsbRebRoRsmbRobLgbLobLcbRsLsbRobLoRsbRsb
LobRcRsLsmbRibRcbRobRibLcbRhbRhbLcRsbLebLcbLcbLcbLgLsbRsbLibLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bLsbRsRsmbRoRsRsRsmmmbRsbLsbLgbLsbLgbLsbRsbLsbRgbRsbRsbRgLsRsbRsbLhLsb
LsbLjbRjRsmbRsRgbLobLibRcbRcRsmbLsbRsbRsbRsbRgLsbLgbLobRsbRsbRgRsmbRsb
sbLobRsbLsLsmbLsbsbLsLsLsmmbLsRsbRsRsmbLcbRsbRsbLsbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRcbLebLgbLsbLgbRsbLsbLgbLgbLsLsmbLcbLgbLsbLcLsmbRsbLsbRsbLsbRcbRib
LibRobRsbRobRsbRsbRgbRsbLsbLsbRhbLjbRsRhbRsbRgbLgbRsbRoLsbLgLsbRibLsbL
ebRoLsRsbLsbRcLsbRsbRsbLgLsbRcbLcbRobRobLgbLsLsmbRsbRcbLebRibRgbRcbRib
LibRobRoRsLsmbLibRsbRcbLebRcbLhbLibLsbRibRcRsmbLsbLsbRsbLcbLgRsbLiLsbL
cbLjLgbLsbLhRsbRoRsmbLibLgLsRsbLgbRjbRcbLsLsmbRhbLiLsbRobLibRobLgbLjbL
cbLibRjbRibLcbLcbLsbLiRsbsbLebLiLsRsbRcbRibRhbLsLsmbLsRsRsmbsbsbsbRsbL
sbLibLiLsbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bRsbLsRsLsbLsRsRsmbRsLsbLsLsmbRsbRsRsmbLsRsbRsRsRsmmbRsRsmbRsRsRsmmbRs
bLsbRsLsLsmbLsRsRsmbLsbRgRsmbRcRsmbRoRsmbRgbRsbRsbLcbLsbRoLsLsmbLoRsbR
ebRoRsmbRgbRsbRibRobRsLsbLsRebRsRsmbRgbRcRsmbRsbLsRsbLsLsmbLsbLsbLsLsL
smmbLgbLgbLsbRsbRsbLsbsbLsbLsbLgbLobLsRsbLebsbLsbLsbLsLsmbLsLsmbRsRsmb
LgbRsLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bRgbRjbLsbLjbLobLobLhRsbRibLjbLcbLgbRsRsmbLcbLsbLgLsbRsbLcbRgbLsbLsbLi
bLgbLgbLgbLjbsbLgbLsbLiLsbLibLobLobRoRsmbLobLiLsbRobLibLjbLhbLcbLobLib
LibRobLgbLhLsbLsLsmbLibsbRjbLgbLgbLcbRgRsmbRobLobRsbLcbRebLeLsbLibRsRs
mbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bLibRjbLebRsRsRsmmbLsRcbLsLibRiLsbLsLsmbReRhbRibRgbLsLcRjbRcbLebLcbRgR
ebRsLsRsbLebsbLeRsRgbsbsbsbRsbRsbRsbLebLgRsbLcRsRsmbLeRsbRjbLibLebLsbR
sbLsbsbLsbLobLsbRcLjbRsbRcbsbLcRsbLsLsmbLsbLibRsLsbLsbRcbRebRgbLeRsbsb
sbRcbRsbLibRibLsbLsRsbLgbRsbRsbLgbLsbRhLsLsmbRebLibLibLeRsbRgbRhbLobsb
LsbRsRcbLcRgbLjbRgbRsbRgbRsRjbLsLsLsLgmmbsbRobRebLsLiLsbRsbsbRebLsLgbR
gbRsbRjbRsLjbRgRsmbRebRhbRjbLcLsmbLjbLeRsbReRsmbLcLsmbLcLsmbRsbLiRsbRi
bLcbReRsmbReLsbRgbLsbsbRjbLjbReRsmbRsRsLsmbRsRsRsmmbLgRsbRgbRsLgLsbRsL
sLcbLsRcbLsbRsbRgRsmbsbLgbRebLcbLcbRsbLgbRsbRgbLcbRibRjbRgbLcbLcbLsbRg
bLsbRibLobRsbRcLebsbRgbRcbRebLsLgbRjRibsbRsLsLsmbRcbLebRsRgRsRsLsRsmmb
RsLeLsbLsbsbRsRgbRsbLsbRsbRsbRobRoLjbRibRgbRsbRsbRcbLcRsRsmbRsRsLgmbRe
bLcbLsbRebLcbRibRebLcbLsLsmbLibLsLsRsRembLjbRcRsmbRebRebLcRsRsLembRgRh
bLcbLjbRsRsRsmmbLjbLebRoRsRsmmbLsbLgbRsbReRcRsRsmmbLsbReRsmbLsLiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLsbLsRsbLeLsbLsbLsbRsRgbRsbLgbRsbRsbRibLcbLsLsmbLsbLsbRsbLibRsbLgb
LsbRsbRsbRsbLsbLsbLsbLsbLgbLsbLiRsbRebLgLjbLobLeRsbRibLsLsmbRebRsLsbLs
bLibLsbRebRsbRsbRsRsRsmmbLsbLsbRsbLoLobRgRsmbLobRsbLsbLsbLsLsLgmbRsRgb
LgbLsbLsbLsLsLsmmbLsbLsbLsLsmbLsbRsbLsbRgbLsbLebLhbLgbLcbLebLsbRsbLgbR
sbLsbRsbRsbRsbRsbRsbRgLsLsmbRsRsmbRsLsbRsbLebRsbLsRsbRsbLsbLsbLsRsbLsb
LsbLsbLsbsbLsbReLsbLsRsRibLsLgbRsbRsbLsbLsbLsbRsbLsbRsbRsbRsbLsbLebRsL
sLsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bRsRsmbsbLsLsmbLsbRsbLsLsmbLsbLgbLsLsLsmmbsbLsLsmbLsbsbLgLsbRebRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRsbLsbLsbRsbRsRsmbLsLsmbLsRsLsRsbRsbLsRsbsbsbsbLsbLsbLsbLsLsmbLsbLsRs
bLsbLiLgLsLsmbLsbRsLsbRsbLjbLoLsmbsbsbsbLsLsmbRsLsbLjbLsRsbsbRsbsbRibL
sbLsbLsbRhbLsbLsbRsbLsbsbLsLsRsmbLibRsLsLsmbRsbLsbRsbLsbRsbRsbLsLsmbLs
bLsbLsLsmbsbLsbRsbRsbRsbRsbLsbLsRsbRsbLsbRsbRsbLsbLoLsmbLsbLsbsbLsbRjb
RgbLsLsmbRjbRibLsbsbLsRsRsLsLsLsmmmbRsRibLjLsmbLsRsLsbRsbRsbsbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bLobReRiLsRsbLibLgbRgRsLsmbLgbLobLjbLebLebRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRhbLebLsbRebLjbRcRsRsmmbRgbRsRsmbLgLsbLsbLsRsbRsbLcbRsLsbLgbLgLsbL
gbLcbLsbLsLgbLsbLsbLsbLgbRsRsmbLcLsmbLibLobRsbReLsbLgLsLsmbLsbLebLgLsb
LgbRsbRsbRsbRgbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 25; Drug: Control Apo 0.5 然
bLibLsbLsbLsbRiLsbLebRcbRgbLgbRcRsmbRjRcbRsbRibLsbRsbLsbLsbLgbLsbRcLsL
smbRjbLjbLcbLsbLgLsbLgLsLgbLsbLsLsmbLsbRjbLibLibLsRsbLgLsbLsbLibLsbLob
LsbLibLsRsbLsbLjbsbLgbLjbLibLgbLgbLgbRjbRoLsRgbRibRsbRiLibLsbRibLjbLib
LgbLgbLgRsLcLsRsLgmbRibRgbRgbRsbRgbRsbRsRgLsbLsbRgbLgbRcbLiLsbRhbLjbLc
bLsbLobLhbLibLibLsbLgbLgbRsbLsbLgbLgbLsbLgbLsbLgbLgLsbLgbLsLsmbLgbLgbL
hRsbLsbLsbRsbLsbLgLsbLgbLibLsbLsbLsbLsLsmbLjLsmbLsLibLgbLsbLgbRjbRibRg
bRiLsLsmbRiLsbRiLsbLsLsmbLgRsbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 26; Drug: Control Apo 0.5 然
bLjbRiRsmbLjbLibLgbRjbRhbLjbRibLsbRgbRsbRgRsmbLsbRibLgbRsbRibLsbLsbRgb
RsbRgbRgbLgbRcbLgbLibRsbRibLsbRgbLgbRsbRsbRgbRgbRgbRsbRgbRgbRiLsbLgLsb
LgbRjbRibRcbRibRhbRcbRjLsbRcbLibLgbLsbRgbRsbRgbRgbRibRgbRibLjbRjbRjbRo
bRibRhbRcbsbLibRsbRibRsbRsbRsbRgbLsbRsbRgbLsbRiLsbRcbRsbLsbLsbRibRibsb
RibLsbLjbRcbRhbRjbLcbLgbRcbRibLjbLjbRoRsmbLgbRcRsmbRcbRgbRsbRcbLibRhbL
iRsbRsbLsbLcRsbRcbRgbLjbRibLsbRgbRsbRsRsmbRsbRgbRgRsmbRgbRibRsLsbRgbLg
bRibLibRcbsbRjRsmbRjLsbRgbLgbLsbRibLibRcbRcbLjbLjbRjbRgRsmbLsbRsLsbRib
RsbRsLsbRsRsmbRgbRsbRgbRsLsbRgbLgbRsbRgbRgbRsbLsbRsbRhbRsbRibRgbLjbRob
RibRsbLibRsbRgbRgbRsbRgbRgbRiRsmbRsbRgbRsbRcbLjLsmbRobLgbRibLcbRebRibR
sbRibLgbRsbLgbRibRsbLjbLibLgbLgbLibLsbLobLibLibRhbRgbRgbRgbLgRsbRsbRsb
LjbLiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 27; Drug: Control Apo 0.5 然
bRobRebRibLobLobLobLebRibRhbRibRcbRcbRobLibRcbRcbLobRebLcbRsbLcbLobRob
RcbRgbRgbRobRcbRebLobLebRobRibRsbRgbLhbLobRebRobLcbRcbRobRobRebRobRebL
obRobLebRgbRcbRsbLsbRcbLobRibLibLibRsbRcbLobLhbRobRcbLobLibLebLebLcbLe
bRcbLibRsbLebLobLobRobLcbLcbRebLsbLobRobRobLsbRcbRebLhbLobLgbRebLcbLeb
RibRobLgbRobLobRibRebLebLebLobRebLebLobRcbRobRobLibRcbLobLcbRobLibLgbR
ebRobLsbLebLobRibLebLobLcbRebRcbRobRebLcbRhbRobRebLebLebLcbRebLebRobRo
bLsbRebLebRobRcbLgbLsbRobRebRcbLobRebLobRobLebLcbLobLobLebLcbLobLcbLib
RebRobLobLhbRebRgbRobLgbLobLobLobLibRobRobRobLobLcbRebRobLcbLcbLcbRebR
obLsbRsbRobRobRebRobLsbRebRobRcbLibRobLebRgbRobLobLobLibLobLebRhbRibLi
bLcbRebLobRobRibRobLebRebRebLobRobLebLobRebLobLobRibRobLcbLhbLsbLobLsb
LobRebRebRobLobRsbRobRobRgbRobLgbLebRobLcbLjbLibRgbRobLibRgbLobRobLobL
obLsbLobRsbRcbLobRobLobLcbRcbRcbRobLobLibLobRibLobRobLebLebRgbLgbRgbRo
bRebLsbRgbLobLobRcbLebRcbRcbRebRobRcbLebLibRebLobLebLobRhbLcbRgbRebLob
RcbLgbLebRobLcbRobLobRobRebRebRobRobRibRcbRobRobLibLebLibRobLobRebLgbR
sbRgbRhbRibRebLobLebLebLgbLebLebRobLcbRobLibLhbRcbRgbLobLobLobRcbRebRc
bLobLcbLobLebRebLebRobRcbLebLibLobRcbLhbLobRcbRcbRcbRsbRcbLcbRebRibLeb
RebRcbRibRebLobRhbLebLobRobLebRebLobRcbLcbRsbRobRobLcbLobRcbRcbLobLcbL
obRobLebLibLibRcbRobRcbLcbRgbRobLebLebRobRibLebLebRibLcbLcbRibRcbLebLg
bRhbRcbLebLebRebRebLobLgbLibLobRebRibRcbLebLobRobRcbRebRcbRcbLcbLcbRob
RebRgbRobLsbRcbRibRobRobLobRgbRebRebLobRibRcbRcbRobLgbLobLebLcbRcbLhbL
ebRibLsbLgbRobLebLobLgbRebRcbLobLibRobLhbLcbRcbLobLjbRibLobLebLobRebRg
bLobRebRcbRobLebLibLobLcbRebLobLibRobRobRobRobRibRgbRobLsbLobRebLhbLob
RcbRobRibLobLebRobLobRjbLobLebLgbLobRobLgbRobLibLcbLcbLobRobLebRebLibR
ebLobRcbRobRobLcbLcbRobLobRobLobLobRobRcbLgbLsbRobRobRobRsbRobLobRgbRs
bRgbRibLobLobLebLcbLobRobLebLobLsbRobRobLebLobLibLibLcbLebLobLebLobLcb
LobRgbRobLobLcbRobLibLgbRebRobRobRcbLobLsbRebRobLsbLhbRobLcbLcbRcbRibR
obRgbRobLcbRobRobRibRobRcbLobLobRobLobLobRobLibRobRcbRebRcbLcbRobLobRe
bLobLebRobRobLobLsbRhbRibRobRebLobRobRebRobRobRcbRobLobLobRobLibRobReb
LcbLcbRcbLgbLebRsbRhbRgbLjbRebLibRcbLibRobLobRobLobLhbLibLobLobLebRcbR
obLobLobLcbRsbLobLsbRibRebRobLobLobLobLsbLsbLsbLobLebRobLgbLcbLcbLcbRc
bLibRebLobRcbRebLobLibLcbRebLobLebRebLcbLobLcbLcbRobLobRcbRobRobLobRob
LebRebRobRgbRsbLobLobLgbRebRebRebLibLibRobRebLcbRhbLebLsbRobLcbRobRgbR
obRcbRobRobLobRcbRebRebLobRobRcbLobLgbRibRobRobLcbRcbLobLebRsbRobRibLo
bLebLibRobRobLobRobRebRobRebLobLhbLobRcbLcbRcbRebRebLhbLobRcbRobRobLcb
LobRgbLobLobRobLobLobLcbRcbLebRcbLhbLgbRobRebLobRgbRebRhbRibLcbRebLcbR
obRcbLcbLebRgbRobLobRgbLobLgbLobLcbRobLobRgbRebLebLibRebLgbRsbRobLebRo
bRsbLhbRobLebRobLobLcbRobLhbLebLgbLebLobRcbRcbLobLobLcbRobRsbLobLobRob
LobLcbLibRebRibLobLebLibRobLcbLobRcbLobLibRebLcbRebRobLobLebRebLcbLebL
obRcbLebLsbRcbRhbRobLcbLcbLibRebLobRobRobLebRobLebRebRcbRobRsbRobRobLo
bRobLobRebLgbLobRebLobLgbLobRibRcbLsbRebRobRsbLobLobRcbLobRebRebRobLeb
LobRcbRcbLgbRobRobLcbRobLebRsbLcbRebRobLobLgbRcbRobLebRsbRcbRobLhbRcbR
sbRhbRebLcbLobLobRibLobRebRobLobLobLgbLibRobLebLcbLobRibLobLebRobRsbRe
bRcbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 28; Drug: Control Apo 0.5 然
bLiLsLsmbLibLibLgbRsRsmbsbsbRgbRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 29; Drug: Control Apo 0.5 然
bLiLibRcRsmbRcbRibRobLgLsbLgbRobLsbLsRjbLobLsbRcbRibLsbRjbRgRsmbRsbRiL
sbRibLcbRgbRibLjbLibLibRjbsbRcbRcbRjbRibRjbLcRgRsmbLjbRjbRebRibRibRhbR
ebRcbRibRgbRgbRibLsbLgbRsRsmbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 30; Drug: Control Apo 0.5 然
bLsbRibRjLsbRcbRcbRibRibRgbRibRgbRgbLibLjLjLgbRibLgbLibRsRsmbLobRibLib
RjLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bLcbRcbLjRsbLjbRcLsbLhbRsRsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLjbLhbLgbLsbsbLsbRsbRsbLiLsLsmbLibLebLsLsmbLcbLsbLsLsmbLiLsbLsbLiLsbL
hbLibRibRjbRsbLsbsbLgbLebLibLgLsRsbLsRsbLsbLiLsbLgbLcbRsRsmbLgbLcbLsbR
sbLhbLsbRsbLgbLsLsmbsbLgbRsRsmbLgbRsbLobLsbRsbRgRsmbRgbLsRsbRsbsbsbsbs
bsbRsbLcbsbRsRebsbLcbLeLsbLhbRsbsbLibLgbLsLsmbLsbLgLsbLsLsmbLsbLgbLgbL
sbLsLsmbLgbLsbLgLsbsbLgbLsbLgbRsbLibRsbLibLibLibLsbLibLgbLobRsbRsbLsbL
ibRsbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRsbRgbRgbRsbRsRsmbLsbRsbRgbRsbRsbRgbRgbRsbRsbRsbRsbRgbRsbRsbRsbRsR
smbRgbRgbRsbRiLsbRibRgRsmbLgbLgbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bRobRcRsmbRcbRibRgbLobLobLobRhRsmbRcbRcbLibLcbRgbLoLsmbRjbLobLjbLjbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bLgbLgbRsbsbLibLsLsmbLgbLsbLgbRcbRcbRsbRcRsmbRcbRobRgbLibRcbRcbRsbRibL
ibRjbRibRhbLgbLibLibLibRcbLsbLsbLobsbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bLjLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbLsbLsRsbLsLsmbRgbRsRsRsmmbRgbLsbRgbRsbRsbRsbRgRsmbRgLsbLsLsmbRg
RsmbRsRsRsmmbLsbRsRsmbRsbLsbRsRsmbRgRsmbRgbRsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bLebRsbLibLhLsbLibLgLgbRsbLsbLibLibLibLobRgbRiLsbRcbLibRgLsbRobRiRsmbR
iRsmbLsLsmbRibLsLsLsmmbLgbLsRsbLsbLcbLibRibRgRsmbLibRcbLsbRgbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bRobRoLsbLhLsbRcbRcbLcbLibRibRcbRcRsmbLjbLcbRgbRoRsmbRcbRgbRcbLgbRcbLo
bRhbLibRjbRgbRibLsbRgbRgbLjbRgbRibRsbLgbRgbRsbRgbRsbRsbRsbLhbRobRobRgb
LgbRobRoLsbLibRgbRhRsmbRsbLgbLibRsLsbLibRgRsmbRiRsmbLgbRebLcbRjbRobRhb
RobLibRgbRibRoLsbLcbRobLobLoRsbRcbLcbLibRibRibLibRibRsRsmbLibLcbRobRib
LsbRobLjbRgbLiLsbRjbLibRobRgRsmbRsRsmbRgRsRsmmbRsbLsbRgbLsbRibRibLsbRi
bLjbRgbRjbRibLgbRhbRobLobRobLibLibRibLibRhbRgRjbRibLsbRibRcbLsbLgbRibR
obLibRcbRcbLcbLobLoRsbLgbRsLibRgbRjRsmbLsbLjbRcbRebLsbLobLobRgbRibRibR
gbRgbRgbLsRsbLsbRgbLsRsbRhbLgbRibRsbLsbRgbRsbRgbRibRcbRgRsmbLsLsmbLoRs
bLcbLibRiLsbRobRhbRsbRcbLsbRibLgbRobRhbRcbLobLibRjbLcbRgbRgbLibRobLibR
cbLgbRibRjbLgbRebLgbRjbRibRsbRsRsmbLsbRcbLibRebLibRcLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsbRsbLsbLsbRsRsmbRsbRsLsbRsbLsLsmbsbRsRsRsmmbRsbRsbRsbRsLsbLsRsbR
sbRsRsmbLsbLsbLsbRsbRsbRgbLsbRiRsmbRgRsmbRsbLgbLsLobLsbLgbRebLhbRsbRsb
RsRsmbLsbLebLsbRsRsmbLhLsbLsbLsbLsLsLsRsRsmmmbRgbRgRsmbRsRsmbRsbLsRsbs
bRsbRsbRsbLsbRsRsmbRsbLsbRsbRsbLsRsbLsbRsbLsbRsLsbRsbRsbRsbRsbRsRsmbRs
bLsbRsbRsbLsRsRsmbRsbRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bRhRsmbRgLsbLsLsmbLobLsRsbRgRsmbLsbRgbRibRgbRsbRsRsmbLsLsmbRgbRibRebRi
RgbRibLsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bLiRsbLgbsbLgbLsbRsbsbLgbLgbLsbLsbLgLsbLobRsbLiRsbLoRsbLsLibLsbLgbLibL
sbLgbLgLsbLgbLgbLgbLiRsbLsbRsbsbRsLsbLsLsmbRsbLsbRsbLgbLibsbLsbsbRsbLo
bRgRsmbLiRsbLsbLgRsbLsLsLsLsmmmbLgbLgbLgbLibRsbLgbLgRsLsbLsbLibLebLsLs
LsmmbLsbLibLgbsbLsbLsRsLsbRsLsbLjbLsbLgbRsLsbLsbRsbLsLsRsmbLgLsbsbLsLs
mbLobLsbLsbLibLcRsbRsRgbLibLiLsbLgbLsLsmbLsRsbLgLsbLsbLgbRsbLjbLsbLsbL
sbRsbRgbRgbLcRsbLibLgLsbLgbRsbRgbRsbRsbLsRsbLsbRgbLsLsmbLcRsbsbLsbRcRs
mbLobLiLsbLsbsbRsRsmbLibLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bLiLsbLcbRebLobLsRsRsRsLgmmbRsRsLsmbLibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bLgRgbLiRsRsmbLebLgRsbRsRgbRsRgRsRsmmbLebLobLebRsRsRsRsmmmbLsbLjbRgbRs
bRsRsReRsmmbRgRsRsLsRsmmbRiRsmbRsRsRsRgRsmmmbRgRsmbRiRgRsmbLgLgLgbRgbR
ibLjbsbRgbRiRsmbLebRjbLsbLsbLgbRcbRsbRsLsRsRsmbRgRgLsbRgbRgbLgLiLgLsLs
mbRebRsRsRembLgLsbsbLjbRcRgRsmbLibLcLsLgLsRgRsmmbLsbLobLibsbRsbsbLsbLs
LsRsRsmmbLsbLsRsRsmbRsLsRsbsbRsbsbRsbsbsbLsbRsbsbRebLsRsRgbLsbLsbLsRsR
smbLsRsLsRsRsmbsbRsbsbRcRsRsmmbLgbRiLsbRsbRjbRsbRsRsLsmbRjRebRgRhbRsbR
sRsRsRsmmmbsbsbRebRsbRcbRebLgbLibLsbsbRsbsbLjbRhbsbLibRcbRibLsLebLjbLo
LibRjbRebRibLeRsbLeLsLsLgLsLsLsLsLsLsmmmmmmbReRgRebLsbLgLjbLiLsRsRsLsL
smmbLsLsmbRibRsRsRiRsRsRiRiRgRsRsRgRsRsRgRiRsmmmmmmmmbRgRibRsbLebLhLsb
LsbRsRsmbLsRgRjRgRgRgRgRsmbLsbRiRhbRgbRgRsmbLjbLjbLsbLiLsRsRsmbLgbRsbR
gbRsbLobLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bLsbRsbLsLsmbLsbLsbRsLsbLsLsmbLsbLibLsbRgLsLsmbRsbLsRsbLsRsbLgRsbLhbRs
LsbLsLgbRibRgbRsbLgLsbLsbLsLsLsLsmmmbRsbRsbRsbLgbLgbLgLgbLgbRebLsLsmbR
sbLsbRsbLsLsmbRsLsbLebLebRobRgbLjLsLsLsLsmmmmbRsLsbLsbLgbLgbRsLgbLsbLs
bLibLsbLsLsmbRsbRsbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bLgRsbRsbRibLoLsRsRsRsmmmbReLhRsbRcRsRsRsmmmbRsRsmbRsRsRsmmbRsRsmbsbRs
RgbRobRgRsRhRsmmbLgbRsbRgbRsbRibLsbRobLcbLgLsbRgbRgbRsLsRsbRgbRsbRsLsb
LsbRsbRsbRsLsLsmbRsbsbRgRebLobLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLsbRsRsmbRgbLsbLjbRgbLsbLsbRjbLobLebLsbRjbRgbRibRsbRsbRgbRsbRgbRsbLsb
LgRsRsmbRsLiRsbLebLjbRibLibRibRgbRebRoRsmbRsbRgbRebRgbLgbRibRgbRcRsRsm
mbLsLsmbLsbLsLgbLsbLibRsRsmbLsbLgbRebLsbLsbLsbLsLsmbLsbLobLibLgRsbRsRs
mbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 122744; End: 123244;
Recording: 3-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bLsLgbLgRsbLsbRebRobLsbLgbLgLsbLsbLeLsLsLsmmbLgbRiLsbLsbLeRsbLibLibRsb
LeLsLsmbLgRsbLsbRebRsLebLsbLiRgbLsLsmbLjbLeRsRsmbRebRobLsbRoLsbLsLibLi
LsLsmbLobsbLjbLebReLsbLgbLsbLsbLsLsmbLsLsmbRebLhLsLsRsLsLsmmbLjbLcLiLs
LsmbLsbLgbLgbLsRsbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 1; Drug: Control Apo 0.5 然
bRcRsmbLhbRjbLibRsbRgbRsRsmbLgbLjRsbLgbLjbRjbLjbRjbRgbRgbLibRibRibsbRi
bLibLibLsbRhbRgRsmbLibRsbRgbRsbRsbRgbLibRibRgbLjbLobRobRgbRebRibLobLgb
LibLgbLgRsbRsbRjbRibRibLcRsbLibRcbRibRiLsLsmbRobRibLibLcbLgbLibLgbLsLs
mbRsbLibRsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 2; Drug: Control Apo 0.5 然
bRcbRibRgbLiRsLsbLgbLgbLcbRgbLibLgbLsbLsbLgbLibRjbRobLsbRobRiRsmbRibRs
bRsbRibLjbLcbRsbLibLcbLgbLgbRsbLibLjbLgbRjbRobRcbRibRibRsbLgbLgbLibLsb
RsbLgbLcbLcRsbLgbRgRsmbLobLcbRsbLibLibLgbRsbLobRgbLgbRsbLsbRgbRgbRgbRg
LsRsbRgbRgbRgbRcbRibLjbRibRsbRsbLsbLsbLjbLgbRsbRcbRibLjbLcbRsbLibLgLsb
RsbLcbLibRsbLgbRgbLgbLhRsbLgbLgbRcRsmbRibLsRsbRiRsmbLsbRhbLsbLgLsbLjbL
cbRjRsmbLiLsbLsbLsbLgLsbRsbLibLibLcbLsbLsbLcbLjbLsbLsbRibRibRcbRhbRibR
gbLjbLibLsbLgbLgbRsbLhRsbLcbRcbRibRgbRsbLhbLibLiLsbRobRcbRgbRcbLibLsbR
gbLsbRgbRsbLiRsbLibLibRgbRgbRsbRibRgRsLsmbRgbRsbRgbRgbRsRsmbRsRsmbRsRs
mbRgLsbRgRsmbRsbRsbRgbRibRcbRibLcRsbLjbRibLibRgbLsLsmbLgbRsbLsbRjbRibR
cbRcbRibRsbRjbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 3; Drug: Control Apo 0.5 然
bRcbRcRsmbRibRibLgbRsbRgbRsLsbRcbLsbLsbRhbRoLsbRhRsmbRiLsbLsbLsbRobRsL
sbRibRcbLjbRibRhbLcbLobRcbRcbLcbLobRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 4; Drug: Control Apo 0.5 然
bLsbLsbLsbLsLsmbRobRoLsbRiRsmbRjbRibRgbLsLsmbRebRibRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 5; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 6; Drug: Control Apo 0.5 然
bLgRsbRsRsmbLgbLgbLgbRgbLsbLgbLjLsmbRgbRibLobLobRibLsbLcbRsbRsLibLibLh
bLhbRgbLcLsmbRibLobLgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bRsLsbRcbLgLsbRhbLiLsbLibLibRhbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bLsbRsbLsRsbLsbLgbLsLsmbLsLsmbLsbLsbLhbRobLgbRsbLibLhLsbLsbLgbLgbLgbLs
b

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bLsbRgbLjbLjRsbLcbRjRsmbRibLibLibLgbRibRgbLgbRgbRsbRgbLsbRibRsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bRjbLoRibRsRsmbLibRobsbRsRsmbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bLgbRgbRiLsbLobRjbLsLiRsbRgbLsbLgRsRsmbLibLhRsbLsLibLiRsbLobLjbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bRobRcbRoLsbLsbLsbRgbLiRsbRgbLgbLsbLjbRobLgbRsbRsbLgbRgbRgbRsbRebLibRh
bLgbRibRsbRobLgLsbLsbLsRsbRsRsmbRgbLgbLsbLibRoLsbRobLgbRsbLgbRgRsmbRhb
RobRsbRibLgbRobRobRobLjbLcbRibLibRsbRgbLebLibLgbLjbRibLjbRjbLgbRibLibR
hbLgbLsbLjbRsLsbLcbLcbRsbRgRsmbRgLgbRsbRhLsLibRgbRiLsbRgbRgbRiRsmbRiLs
bLibRsbRgbRsbRsbRgLsbRsRsmbRibLsbRsbLjbLjbLhbRobRobLgbLsbRgbRibLgLsbLj
bLsbLibRjbLibLgbLebLoRsRsmbLgbLsbRibRgbLsbRsbRgbLsRsbRsbRgRsLsmbRsbRgb
RgbLsRsbRgbRgRsmbRgbRsbRhbLsbLsbRsbRgbLsbRsbRiLsbLgbRgbRgbLsbRsRsmbRgb
RgbRgLsbRsbRibLjbRibLsbRobLgbRibLsbLjbRobLsbRsRoLsbLgbLsbLjbRcbRcbLgbR
sbRibRgbRsbRibRsbRsbRsbRibRsbRgbRsbRibRsbRsRsmbRibRgbRibRobRcbLsRsbLcb
RoLsbLcbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bRsLsbLeLsbRsRsmbRibRobRcbLsLsLsmmbRebLibLibRsbLoRsbLcbLibLibRibLcbLib
LsLsmbLsbRibLiLsbLibLoLsmbRibRibLgbRsbRobRobLcbLgbLibRsRsmbRiLsbRjbRhb
RiRsmbRiLsbLgbLobRjbRhbRoRsmbLibRoLsbLcbLobRcbRebLcbRgbRebRhbRsbLjbRjb
LsbRsRsmbLebRibRobRcbLebLibRsRsmbLibLgLsbLibRsbRhbRibRibLcRsbLobRebLib
LibLhbLgbLsbLiRsbRcbRsbRibRobRjbRobLcbRsRsmbRibRgbLcbLibLibRiLsbLsbLsR
sbsbLiRsLsbLgbsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bRhbRhbRibsbRcbRobRcRsmbRgbRcbRobRibLobRibLoLsLsmmbLsRsbLebLcbRibRsbRe
bLcbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsLsRsbLgLsbRsbLsLsmbLiRsbRsbLgbRgLsbLsbLsLsmbLsbLsLsmbRsRsLsmbLsL
gLsLsmbLibLobLjbRgbLsbRsbLobRsLsbRsbRsbLsLsLsmmbLsbLsbLsbLsbsbRsbLgbLi
bRsbRsLsbLsbLcbLsbRsbRsbRsbRibLoRsbLsbLiRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bLiLsbLsbLsbLgLsbLhbLobLsLsmbLiLsbLsbLgRsbLgbLgbLiLsbLhLsbLgbLhLsbLibL
gLsbLibLobLsbRgbLhbLcbLsbLhbLibLsbLcbLsLsmbLhbLsbRiRsmbLsbLsbLobRsRsmb
LcbLsbRgbRsbLcbLibLsRsbRsbRobLebLgLsbLobRgbRgRsmbRibRibLgbRsbRsbRgbLsb
LjbLobRgRsmbLgLsbLibLcbRgLsbRsbLsbLcbLgbLgRsbRobRobRjbLibLsbLsbLgRsbLj
bLobLibRsbRsbLhbLsRsLsbLibRjbRsbLgbLhbLebRibRjbRgbLibRsbRsbLhbLsbLgLsb
LibRsbsbLgbLibLsbRjbLcbLgbRjbLcbLhbLibLsbLgbLgbLgbLsbLibRhbRjbRobLoLsm
bRjbRibRsbRiRsmbRgRsmbLgbRibRibLgbRibRgbRsbLgbLobRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLsLsmbLgLsbLsLsLsmmbLsLsmbLsbLsLsLsLsmmmbLsRsbLsbLsbLgbLsLsmbLsbLs
bLsbLsLsmbsbRsLsRsbLsbLsbLsbLsbLsLsLsRsmmbLsbLsLsmbRsLsLsmbLgbRsLgbsbR
sbLsbRsbLsRsbLsbLgbLcLsLsmmbLcbLibLibLgLsbLcRsbRiRsmbRoRsmbReLsLsmbLsb
LsbLiLsbsbLsLsmbsbsbLsLsmbsbLsLsmbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bLibLobLobRgbLgLsbRobLgbLcbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bsbLsbLsbRsbLsLsmbsbLgRsbRsbRgRsmbRsbLcbLcLiLsbRgbRsbLjbLsbLsRsbLsbLgb
RsLsLsLembLsLgbRcbRgbLiRsbLsRhbLsRgbRsRsmbRsbRsbRsRebRgbReRsRcRsmmbRsb
RgLgbRsRsRgLcLsmmbRjbRjbReRsmbRgbLibLgRobRsbRsbRgbRebLobLobRibRcbRsLsR
sbRsbLebRgbRsLgbRcLjbReReRgRsmbLiReRsRjmbLibRcbLcbRebRsLjbLobLibLcbRjb
sbLjbLcbRjRgbRcbRobLsbLsbRoRgRsmbRsbsbRsbRcRcLeLsLcLsRsmbLsbLibLsbsbLi
bsbRsRsmbRsRgbLobRsbRebRcRcLeLsbRsbsbLgLsbLgLgLsbLsLsRsmbLcbLsLsLgmbLi
bLjbLsLsmbLsLsmbLebRcLeLsbLsbReReLibLsLsmbLsbsbRsbLsbLobLsLsLsmmbRcbLe
bRsRebRibLsbLgbRgbRhRebRhbRhReRgbLebRebRgbRsLsbLsRsRsmbLsbsbRsbLgbRobR
hLsbRgRsmbRsbRsbRjRgbLsbLsbRebLjbRibRgbRgLgbRcbRsRsRembLsbRsReRibLsbRs
bLsbLjbLsLebRjRebRsbRcbRgRsRsRsmmmbLcbLsLcbsbLibsbLibLsbLjbLeLsbLiRjRs
mbRsbLcbRibLsLsmbLsRsbRebRsbRobsbRsbRjbLsbsbRebLsbLsbLsbRjbLebLsLjbLjb
LjbRgRhbRjbRcRsmbLsLsmbLsbLebLsLcbLjbLgbLgbReRibLcLebRebsbRsbRcbLobLsL
smbLsLsmbRsRsmbLsbRsRjbLebLcbLibsbRsbsbsbsbsbsbLsbLsLeRjbLjLsmbLgbRjRs
mbRcReRebRsbRibLgbRsRsRsRiRemmbLebReRjbRsRsmbRsRgLsbRibLebRebRsbLeLiLs
bLgbRsRibLsRibRgbRebLsLeLibLgRsbRebRgLsbLhbsbRebLsLsLeLhRsmbLgLcbRsLob
LobRjLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbRsbLsbRsbRgLsbLsbRgbRsRgbRsbRebRgbLgbRsbRsbLsbLsbLcbRhLsLsmbLjb
LobLsLgLibLgbLsbRsbLsLsmbLobLgbRsbLjbLsbLobRsbLgLsbLsLsmbLsLsLsmmbLsLs
LsmmbLsbLsLsmbRsbRsbLgRsbLsLsmbRsbLsbLsbRsLgbLsbLgbLsRgbRgbRobRibRjbLs
bLsRsbLsbLsLsLsLsmmmbLsbRsRsmbLsbRgRsmbLgbLsbRebRgbLgbRsRgbRsRgRsmbRsb
RgLsbRsRgbRgLsbRsLsbRsbRhLsbRgbLobLsbLgbRsbLgbLsbRgbLgbLebLsLsLsmmbLeb
LsbRsRjbLsbLsLsmbLsRgbsbsbsbLsbLsbLsbLsbRgRsmbLibLsbRsLsbRgbLeLsLsLsRs
mmbRsbLsbRsbLsbLsbRsLsLsLsLsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bRhbRgRsmbLsLsLsRsmmbLibRjbRjbRsbRgbLsbLsbRsbLsbLsbLibLsRsRsmbRsRsmbRs
bRsLsbRsbRsbsbsbRsRsmbsbsbRsbRsbLsbRsbLsRsbRsRsmbRsRsmbLsRsbRsbRsbRsbL
sbRsbsbLsRsRsRsmmbRsRsmbLsRsRsmbLsbLsbLgLsRsbRobRsLsRsRsLsLsmmbLsbLsbL
cbsbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRsLsbRsbRsbRjbRgbLsLsRsmbsbLsLsmbLeLsbLsLsmbLsbLgbLsLsmbLgLsbRgbRsRgR
sLsmbRsbRebRiRsmbRsbLsLsmbRsbRgRsmbRsbRsbLsRsbRebRhRsRsmmbRsbLsLsmbLsb
LgLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bRsbLhbRsRsLgmbRjbRebRsbLobRiRsmbRsbRjbLobRcbLoRsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bLgbRsbLebLgbRjbRsbLoRsbRebRebLobRjbLgbRgbRgbRobLebLibRobLobLsbLsbRgbR
ebRiRsmbLgbRsbLjbLobLebLebLjbRobLsbLibLebLebLebRobLgbLebLsbLobLsbRsbRg
bLsbRsbRibRsbLhbReLsLsmbLsbLgbRsbRjbRsbLsbLebRgbLiLibLgbLgbRjbLgbLibLi
Lgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 25; Drug: Control Apo 0.5 然
bLsbRgRsmbLsbRgbLsbRiLsbLsRsbLjbRibRgRgbRgbLgbRibRgbLgbRsbLsbRiLsbRsbR
gbRgbLsbLjbLjbLibLgbLsbLobLibLibLibLsLjbLsbLobLsbLibRsbRebRiRsmbLgbLgb
RobRgbLjbRgbRibLsRsbRgbRgbRsbRiLsbLgbRgbRsbRgbRgLsbLsbRgbLsbRhLgbLgbRc
bRgbLsbLjbRibLjbRibRsbRibRibLgbLsbLgbRcbRiLsLsmbLjbRibRiLsbLgbLhbLcbLs
bLibLsbLsbLsbLgLsbLsLsmbLsbLsbLgbRsbLgbLgbLhbRsbRsRsmbRsbLibRgbLhbLibL
sbLjbLsbLgLsbLsbLsLsmbLjbLibRsbLgbLgbLibLjbLgRsbLgLsbLsbRgbLgbLsbLsbLg
bLsbLibLibLsbRsbLsbLcbRsbLjbRsbLgbLsbLjbLhbRsLsbLgbRsbRiRsmbRgbLsbRhbL
ibRsbRibLsbRibRibLgbRsRgbRgbLsbRgbRibLsbLsbRsbRgbLjbLibLsbLsRsbRsbLhbL
cbLibRsbLjbLcRsRsmbRsbsbRsbRibRjbRcLsbLjLsmbRsRsmbRiLsbLcbLcbRjbRgbLjb
RjbRhbLjbLjbLibLcbRsbLsbLgRsbRjbRibLjbLjbLibLgbLgbRcLsbRhbLjLsmbRibLiR
sbLjbLibLibRsbLgbRsbRobRibLcbLgLsbLsbLgbRjbRibLhbRsbLgLsbLcbRgbLgLsbRo
LsbRgbRsRsmbRgLsbRgbRsbRgbLobLibLcRsbLibLsbLsbLsbLsbLsbLibLsLsmbLsbLgb
LsLsmbLgbLgLsbLgbLjbLsbLjRsbRsbLgbLgbRgLsbRsbRgbLibLgbRsLgbLsbRjbLibRe
bRcbRibRibLgbLibLgbLibLibLsbLgbLsLsmbLhbLsbLibLsbLibLsbRsbLgbLgLsbLgbL
gbLgbLgbLgbLgbLsbLsbLsLsLsmmbLgbLgbLsbRsbRjbLjbRjbLjbLgbLibLsbLibLsbLi
bLgbLcbLsbLsbRgbLgbLibLgLsbLsbLsbLgbLsbLgbLsbLgbLsbLgbLsbLgbLsbLgbLgbL
gbLgbLgbLsbLsLsmbLgbLsbLsbLibLsbLsLsmbLgbLsbLibLgbLsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 26; Drug: Control Apo 0.5 然
bLsbLsbRsRsRsmmbLibLsbLibRcbLcbLgbLcbRgbRgbRsbLibRsbLjbRjbRibRibRsbRcb
LibRjbLgbLjRsbLcbRcbRibRsbRgRsmbLgbRcbLsbLgRsRsmbLsbLsbRhbLgRsbLjbRibR
ibRgbLjbRgbRgbRgbRgbLgbRsbLibRcbRhbLjbRibRgbRgbRsbRsbLebLibLibRhbLcLsm
bLsbLsbRsbLsbLsbLcbRgbLsbLjbLibRibRhLsbRsbRsbRsbRgbLsbRgRsmbRgbRgbRgLs
bLsbRgbRjbLsLsmbLibLsbLibRebRibRhbRgbLgbLhbRhbRjbRebRcbRibRgbRebLsbLcb
LsbRebLgLsbRgbLgbLsbLgLsbLsbLjbLsbLsRsbLsbLjbRsbRsbRgbRcbLiLsbLsbLgbRs
bsbLgbLibLibLsRsbLgRsRsmbLsLsmbLibLgbRjRsmbsbLjbRcLsLsmbRibLgbRsbRibLs
bRgbLsbRsbRgbLsbRgRsmbRgbLgbRgbRcbLcbLcbLobRjbRjbLcbLhRsbLibRgbLibLibR
sbLibLsbRjbLgbLibLibRsbLibRibLibRjbLjbRcbLjbLgbLibRjRcbLjbLibLibRobLgb
RgRsmbRsRsmbRsbLjbLcbLcbLsbLsLibRgbRgbRgbLgbLibRgbLibLsbLgbsbRgbLgbLgb
LgbLsLsmbLsLsmbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 27; Drug: Control Apo 0.5 然
bLsbLebLibLebRgbRcbLebLobRebLebLobRibLobLcbLebRcbRebRebRobRebLebRgbLeb
RebLobRebLibLobLobRjbRibLobRobLcbRcbLcbRjbRobRebRebLebRobLobLcbLsbRobL
cbLobLebLobLgbRobRsbLibRobLsbLibRcbRcbRebRibRhbLobRebLsbRcbLgbLobLcbLg
bRgbRibRobLobRcbRobRgbLobLobLobRjbRcbLgbLibLobRebRebRobRobLobLjbRobRcb
LgbLcbLobRobLsbLcbLobLebRibRobLsbRjbLobRibLobLobLebRobRobRgbLobRsbLebL
sbRcbRobRcbLobLebRgbRgbLcbRobLebRobRobLcbLcbLgbLcbRobRcbRibRobLebRgbRe
bLobLobRcbRcbRebLobLsbRebLobLcbRibRhbLebRcbLibRobLebRebLebRobLebRgbLcb
LobRgbLibLobRgbRobRsbLcbRobLcbLebRebLebRcbLcbLcbLobRgbLebLgbLobRobLobL
obRcbRobRobLobRibRobLobLobRcbRibRobLgbLcbLobRebRobLcbLcbLobLobRgbLebRo
bRobRobRibLobLhbLobRibRebRibRobLebLibRcbRobLibLebLebRjbRebLebLebRebLeb
RgbRobLebRebLebLhbLobLgbRobLobRcbRcbLobRebLebRsbLhbRobRebLcbRcbRebLobR
obLobRobLobRobLibLobRobLebRobLobLobLjbLjbRebRobLibRobLebLobLebLcbRobLe
bRobRobLibRobRgbLsbRobLebRebLebRebLobLebLebLebLebLibRcbRgbLobLcbLgbRob
RobRcbRobRobRebRobRobLibRibRobRobLcbRobRobLobRjbLobRibRebLjbLobRibLjbR
obLibRebRcbLobLobRgbLebRibRcbLibLsbLebLobLebLobRibRjbLobRebRcbLobLcbLe
bRobRebRebRsbLcbRobRjbLibLobRgbLibLcbRobLebLobRobRobLobLgbLebLcbLhbLgb
LjbRobRobRgbRobRobRjbLebRsbLobLebLcbRcbLcbRibLobRibLobLsbLobRobLebLobR
obRjbLobRsbLebRcbRobLebLobLobLcbLcbRibLjbLebRebRsbLibRcbLobRobRibRcbRc
bRobRsbRebRebRibRcbLjbLobLobRsbRebRobLobLebRsbRobRebLobRebRebLcbRgbRob
RcbLebRjbLobLobLcbLebRobLobRobRjbLebRcbRobLhbRebLjbRobLebLobRobLobLjbL
obLobLsbLcbRobLibRsbRobRjbRebLobRobRobRobRgbLobRgbLhbLgbLibRgbLebLobLe
bLcbRobLebRobLebLebRcbRebRobLebLebRobLobRebLibLsbRibLobRobLobRebRobRob
RebLobRsbRsbLgbRcbRcbRobLobLobRobRobRibRgbRobRebRobRgbRibLobLobLebRebR
ebLibRcbLsbLebLobLobRcbLebLibLcbRobRobRgbRebRob

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 28; Drug: Control Apo 0.5 然
bLgbReRsmbLsLsmbLsbLgLcbRgbRgbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 29; Drug: Control Apo 0.5 然
bRgbLibRibLcbRiLsbRjbRcbLobLib

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 30; Drug: Control Apo 0.5 然
bLibRibLgbLobRibRsbRsbRcRsmbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bRcbLobLiLsLsmbLgbLgbLibLsbLsbRcLsLsmbLsbRhbLsLsmbLgbLgbRsbLobRgbRsbRg
b

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLhLsbRsRsmbLeRsbLcLsmbLhbRgbReLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bRcRsmbRcbRjbLsbRibRsbRibRiRsmbRcbRcbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bRsRsmbLobRgRsmbRsbLsbLhbLobLsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsbLsbRsbRsbLsbLsbRgRsmbRsRsmbRsbRsbLsLsLsmmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsmbLsLsmbLgLsbRsbRgRsmbRsRsmbRsRsRsmmbRsbLcbRsbLgbLsbRsLsbLobRibLh
bLgbLsLgbsbLgbRgbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bLcbLibRobRibRhbLhbLhbLoRsbLiLsbRibRiRsmbLgbLibRobLjLsmbLgLsbLjLsmbLjb
LgbReRsmbRibLgLsbLsbLibRiLsbLsbLgbLsbRibLsLsmbLgbRcbRobRjRsmbLibLibLib
LobLibRibRsbLgLsbLibRiLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bLsRsbRsbLsbLsRsLsbRiRsLsmbLsbRsRsmbRgbRsRsmbRsRsmbRgbLsbLsLgbLsbLsbLs
bLsbLsbRgbRsbRsbRsbRsbRsRsmbRsbRsbLsbLsLsmbsbLsLsmbRsbRsbRsbRsbLsRsbRs
bRsbLsRsbLsLsmbRsbRsRsmbRsbRsbRsbRsbRsRsmbRsbRsRsmbRsbRsbRsbRsRsmbRsbR
sbRgbRsbRsbRsbRsbRsRsmbLsbRsbLsRsbRsbRsbRsbRsRsmbLsbRsLsbsbRgbRsRsmbsb
LsbRsRsmbRsbLsbRsbRsbRsbRsbLsbLsbRsbRsbRoLsbLgLsbLhbLsbRsbLgbLcbRgbLsb
RgbLsbRsLsbLebLhbLsbRsbRgRsRsmmbLsbRsbRsRsmbLcbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bRebRobRoLsbLsbRsRgbRsRsmbRgLsbRsRsmbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bLjLsLsLsmmmbLsbLjLgbLsLsmbsbLsbLsbLsRsbLcbsbLsbLsbRsLsLsmbRsbLsbLsbLs
bLsbsbRgLsLsmbRsbLsbLibRgRsmbLcbRibRcbLsbRcbLibRsLsbsbRjbLsbRsbRsRsmbR
sbRgbRsRsmbRsbRibRsbLsRsbRgbRibRibRoRsmbLibRibLsRcLsRsbLsbsbsbRsbsbsbL
sbRobsbLsbLsbLsbsbLsbRsbsbRsbRgbsbLsLgLsbsbsbLgbLsbRsbLobLsbLgbLgbsbsb
RgbLgLsbLibRgbLiLsbLsbLibLsbsbLsbLsbsbsbLsLsmbLsbLsbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bRobRsbLsbRjbRebLebRsbLobRsbLsbsbLsRgLsbRsRsRsRsmmmbRsRsRsRsRsRsmmmmmb
RsRsRsmmbRsRsmbRobLebRobRibRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bRsLeLsbLsbRjbLiLiLsLebLgLsbLcbRsbRcRsmbRhRsRsRsmmmbRgbLeLsbRibRhbRibL
ibLeLsLsLsLsLsmmmmbLjbRiRgRsmbRsbLibLgbLiLsbRgbLsLsmbLgLsLsLsLsLsLsLsm
mmmmmbLiLgbLsLgbLgbLebLcbLjLsmbRobLgLsbRgbRgbRibLsRsbRsRsmbLgLgLsLsmbL
gbRcRsRsRsmmmbLsbLebLsbsbsbRhbRiRsmbRibRhbLsbLgbRgbRibRebLsbLibRebRgbL
gbRsbRjbLobLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bLibRsLsbLcbRsbLobLgbLibLgLsbLsbLibRsbLsbLebRiRgbRgbLgbLgbLsbRsbLsLsmb
RsLsbLgbLsbRsbLebRibLobLsLsmbRsbLsbRsLsLsmbLsbRsLsLsmbRsbLsbLsLsLsmmbL
sbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bRsbsbsbRsbLsRsbsbLsLgbLsbLsbRsbLgLsLsmbLsLsLsmmbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bRgbRgbRobLsbLgbLgRsbRgbLebRsbRgbLsbLgbRsLsbLibRobRcbRebRsbRsLsbLibRib
LgLsbLsbRsLsbLhbLibLjbLsbRoLsbLsLeRsRsRsmmbLsbRebLjbRebRsLsLibRgLsbLcL
smbLebLibLgbLibLibLebLsLiRsbRsbRebLebLsRsbsbRsbRsbRjbLsRobLgbLsbLsbLjb
RgbLibLibRjbRibRsbLcbRjRsmbRgbRsRsRgmbLgbLjbRibRgLsLsLsmmbRsbLsbRobLsR
sRebRobRobRsRsRsmmbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 123245; End: 123745;
Recording: 4-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bLsbRjbLgbRibRsLibLsLsmbLsbLsLsLgmbRsLsbLsbLgLibLgLsLsRsmbLjbRobRgbRsb
sbRsRsRembRjbRsLjbRibRsRgbRgRsmbLsbLsbLgbLsbLsLsmbLsLsLgmbLibReRsmbLhb
LiLsLgbLsLsmbRsbLcbRjbLiLgbLebRobLebLsLsmbLsLsLsLsmmmbLibRjbLcbRsLibLs
LsLsmmbRibLsLgbLgbLsLsLgLsLsLsLgmmmbRsbLhbLsLsmbLgbRgbRjbLebLsLsLgLgmb
LsbLsLsLgmbLhLsbLsLsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 1; Drug: Control Apo 0.5 然
bLcbLoRsRsmbRobRibLeLsbLgbLsbLgbLibRgbRgbLibRibRibLgbLhbLibRjbRcbRjbLj
bRibRgRsmbLsbRjbLgbLcbRcbLibLcLsmbLgbLsbLgbLjLsmbLibLobLiRsbLobRiLsbRs
RsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 2; Drug: Control Apo 0.5 然
bRobRebRcRsmbLiRsbRsRgbRgbLsbRibRsbLjbLobLhbLjLsmbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 3; Drug: Control Apo 0.5 然
bLgLsLsmbLsLsmbRoLsbLsRibRcbLgbRcbRsbLcbRcbLebRcbLsbRcLsbRhLsbRhLsbLsb
RgbRsLsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbRgRsLsmbRibLgbRgbRibLhbRcbLgLsbLsbRgbRgbRgbRgRsRsmmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 5; Drug: Control Apo 0.5 然
bRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 6; Drug: Control Apo 0.5 然
bLsbLgbLsbRsRsmbLcbLgbRgRsmbRiLsbRcbLibRibLiLsbRobLibRsbLgLsbLcbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bLgbRhbRibRjbRhbRhbRibRhbRhbLibLsbLgLsbLsbLgbLsbLsbLgRsbRsbLhbLcbLibRi
bRgbRsbRibLjbRibRibRsbRibRsbRgbRgbRibRibRgbRhbLgbRgbRgbLgbRibRhbLibLsR
obRibLgbRibRcbLebRobRgRsRiLsmbLcbLcbRsbLgbRjbRhbRibLhbRebRobLcbRibRsbR
ibRgbLjbRhbRibRsbRibLibRsRsmbRsRcbRhbLgbRsRcbRsbRgLsbRsbRibRibRibLibRg
bRsbLibLgLsbLoRsbRibRsbRiRsmbLsbRobLobLcbRjbRhbRcbRcbRcbRobLibRibRib

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRsbRsbRgbLgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bLgRsbLgbRgRsmbLgbRsRsmbLjbLoRsbRsbRsbLsbRobLsbLibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bLjbLoLsmbLjbRcbRgbRgbRsbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bLcbLobRsbLjbRsbRibLeLsbLgbRjbLsbRjbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bRcbsbLobRobRobRoRsLsmbLjbLibLobLcbLcbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bsbsbLobLiLsbRgLsbLibLjbLobRoLsbLiLsbLibLgbLebRgLsbRibsbsbLcbsbLsbLgbR
obLebLsbLjbLibRiRsmbLibLcbRebRgbRsbRsbRobLobRobRobRcbRoLsbRsRgbRsbRgbR
sRsRsmmbLebRebLibsbsbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bLhbRibsbLjLsmbRibRebLsLsmbRibLibLsLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bLgbLsLsmbLsbLsbLsLsmbLobRsbLsbLsLsmbLjbLsbLsRsbLibRsRsmbLobRsbRsRsmbR
gbLibLgbRsbLgbRsbLsbLsbLsbLsbLsLsmbRsbLgbLsbLibRsbRsbLgbLibLibRsbLsbLs
bLsbLsRsbLsLsmbLsbLsLsmbRsLsbLsLsmbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLhLsbRgbLhRsbRsLsbRjbLibLsbLsbLgLsbRsbLibRgbLibRgLsbLibRgbLcbRgbLc
bRgbLgbLsbLsbLgbRsbLibLsbLiLgbLsbLsbLgLsbLgbLgbLgbLgbLsbLgbLgRsbLhbLob
RgbRcRsmbLiRsbRibRsbLiRsRsmbLsbLgbLgbLsbLibLsbLsbLgbLibRsRsmbLgbLibRsb
LgbLcbRgbLhbRsbLsLsmbLibRgRsmbLibRsbLgbLiRsbRgbLsbLiRsbLibRibRgbLhbRob
RobRcbLsbRjbRcbLibRgbRobLsbLibRibRgbRibRibLjbLsbRgbRibRiLsbLibRgbLjbRo
LsbLebRibLcbRobRgRsmbRgbLsbLgLsbRcRsmbRibLgRsbRibRgbRgbRsbLsbRsbsbLsbR
gbRgLsRsbLjbRibRoLsbRiLsbLgbLsLsmbRgbLcbRobRgbLsbLsbRcbRgbRsbLsbLsbRib
RibRibRcbLibLgRsbLgbLsbLsbLsLsmbRoLsRsbRgLsbLsbRibRsbLsbRcbRgbLjbRibRi
RsmbRgLsbRibRibLsbRgbRibLiRsbRibLsRsLsbRibLhbRibRibLgbRibLgbRibLsLsmbR
gRsmbRsbRgRsmbRgbLsbRgbRsbLcbLoRsbRsbRiRsmbLibRhRsmbRcbRgbRibRgbRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bLgLsbRsLsbLsLsmbLsbsbRsLsLsLsLsmmmbsbsbsbRsRsmbLsbsbLsLsmbLsLsRsmbLsL
smbLobLoLsLsLsLsLsLsmmmmmmbLsbLgLsbLsRsbLsbLsbLsLsmbsbLsbLsLsmbLsbLsLs
mbLsbRsbLsbLgbLgbsbLgbLsLsRsmbLsLsLsLsmmmbLsbLsLsmbLsbLsbLsLgbLsLsmbLs
bLsbLsLsmbLsbLsbLsbRsbRsLsbLgLsbLsbLsLsmbLsLsmbLsbRsLsbLsbLsLsmbsbLsLs
mbLgbLgbLsbLsbLsLsmbLsbsbRsLsbsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbsbLsbRsbsbRsbRsbRcbLgbLobLhbRibLibRgbLibRgRsmbLibLgRsbLgbLgbLcb
sbLcRsbRebsbLoLsRsmbRoLsbLcbRgbLgbLgbLobRgRsmbLibRsbLibLgbLgbLobRgbLoR
sbLgbLibLgbLibLsLsmbLibRsbLibLgLsLgbLgbLiLsbLsbLibLgLsbLgLsbLobRcLsbRo
LsbRsbLgRsRsmbLsbRgbLobLobRjbLcbLsbLgbLibLiRsbLgbLibLsbRgbLsbLgLsbLgbL
sbLebRgRsmbRgRsmbRgbRgLsbLgLsbLibLgbRsbLibRjbLibLiRsbLsbLobLibRgbLobRg
RsmbLgbLibLibLibRobLebLhbRsbLibRgbLibLgLsbLgLsbLibLibLgbLibLgbLsbLobRo
bRebLsbRjbRgbRibLcbRgbRgbLcbLgbLsbLgbLgLsbLgbLgbRcLsbRibRobLjbLobRsbRs
RobRibRgbLhbLcbLsRsbLeRsbLiRsbRsbLiRsRsmbRhbLjbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bLsRsbRgbRsbLgbRsbLgRjbRcbRsRebRiRebRsLeLibLeLebLhbLsbRsLebRgbRibRgbRs
bLebRjRsRsRsRgRcRsmmmmbRsbRibRobLsRsRsmbLsbRsRsmbsbLsLsmbRiRsmbRgbRibL
cbLobRsbRsbLsbLgbLjbLeLsbLhLcLsLgmbRgbRebRcbRgbRiLibLebLiRebRgbRgbLobL
sbLjbLgLsLsLcLembRjRiRsmbsbRsbRgbRsbRsbRsRsmbLsbRsbLeRsbRsbLgbLeLjbLcL
iLsLsLsmmbLsLsmbRsbRebRibRgbRsbRgbRsbRcbLoLsRimbRsRsLeRsmbLsbLjbLsbLeb
LgbLsbLibLibLebRsbRebLcLsmbLsLsmbLsLsLsLemmbLsbRsRibRsRcRebLcLibLhbRsb
RiRsReRsmmbLgRsbRjbRgbRsRsRhRsmmbRsbLeLsLsLgmbLibRjbReRsmbRgbRobReLsbL
sLsmbLgbLcLhbRhReRsRsmmbRsLeLiLsbLsbReRhRsmbRsRsmbRsbRiRibRcLsRebRsRsR
gmbLebLcbRsbsbsbLjbRebRsbRgbReRsRsmmbLeLgbLsLsmbLebLibRsLebLeLsbRiRsmb
RgbRgbRsLsLgbRgbRsRebLibLjbLjbRgbRsRgRsRhRsmmbRibRhbLcLsmbRhRgRgbRsbRi
RsmbReRsmbLsbLeLsLsmbRhbRobLsbLsLsLsmmbLsbRhbRsbRsRsRimbRjRsmbRiRebLgb
LiLsbLcbRcbRsbRgLibReLebLobRsbLebLibLjbLebLsbRebRcbLsbLsLebRsRsmbLsbLs
LgLgRsbLsRsbLgbLcbLsRsbRebLgLsbLeLsbRsLeLgLgLsbRsbRcbRgRgbRgRsReLsmbRi
bLgbLeLsbRebRhLsLgbLsLibLsRiRsmbRebRgbRcRgRgbLjbRgbRibRsbLeLibRebRsbRg
bRibRibLcbReRsmbRsRgbRibLoRsLsbLjbLibLsLsmbLsLsLgmbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLsLsmbRsbLgbLhbLiLsbLsLsmbRsLsLsmbRsRjRsmbsbRsLsbLsLsmbRgbLgLsbRsL
sLsLsmmbRjbRibLebLsLsmbRsbLibRsRsmbLsLsLsmmbLsLsmbRjbLjbLibReRsRsmmbsb
RsbLjbLibLsbLsbLsLgbLsLsmbLiLsbLgbLsbLibLgbLsLgbLibRibRgbLjbRibLibRsLs
bRsRsRsRsmmmbRsLsbLebRobRcRsmbRcLsbLsLsmbLsbReRoLsbRsRsRsmmbRsRsLsmbRg
bLsbLsbLsbLsLsmbLsLsmbLibRgbRcbLsLsmbRebRoLgbLsbLgbLjLsmbLsbLsbLsbLsbR
eRsRsmmbRsRsmbRgRsRsLsmmbRsRsmbRsRsRsRsmmmbRsRsmbRsbsbLsLsRsRsmmbLsbLs
bLsbLgbLsbLsbLsLsRsmbLsLgLsbLgbRgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLgRsbRsbRobRsLsbLsRsbRgbRsLsbLsLsmbLsLsmbLsLsmbLsLsLsmmbLsLsLsLsmm
mbLcLgbRjbLebRobLsRgbLcRsbRgLobLebLibRsbRsbRsRsmbRsbRgRsmbRsbRsbRgbLoR
obLobLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRsbsbLsbLsbsbLsbLgbLsLsmbLsbLobRjbLsbsbRsbRsbLgbsbRsbsbRsbsbLsLsmbLsb
LgLsbLhLsbLsbLsbRsLsbLsLsmbRsbRoLsbLgLsLsmbLgLgLsLsLsmmbLsbLsLsmbRsbRg
bLsRsbLsRsRsLsmbLsLsmbLgbLsbLsbLgbLgLsbLjRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bRcbRcRsmbRsbLeLsbLobLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bLjbRobLsbLobsbsbsbsbLsbsbRibRibLcbRiRsmbRsRsmbLgbRsbLibLjbLsbRsbRobLs
bLebLiLsbLsbLebLhbRjbLebLebLjbRgbRgbRgbRcbLgbLjbsbsbRsbRsbRjbRgbRsRsmb
RsbLobLsbLebRebLsbLibRobRobRibLgbLjbLeLebRobLgbLsbLibRjbLjLsmbLcbRsbLs
bRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 25; Drug: Control Apo 0.5 然
bRiLsbLsbLsbLgbLgbLhbLsbLsbLcbLhbLgbLibRibLsbLsbLsbLibLgbLsLsmbLebLibL
gbLgbLiLsbLibLsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 26; Drug: Control Apo 0.5 然
bRobRgbRgbRgbRgLsbLgbRgbRsbLsLsmbRgRsmbRgbRgbRsbRgbRgbRgbLcbLjRsbLibLh
bLjbRibLsbLsbLsbLsbLjLsmbLibLgbLsbLgRsbLsbLsbLsLsmbLgbRsbLsbLgbLgbRsbL
gbLgRsbLsbLgbLsbRsbRjbRibLsbRibLsbRibLsbLhbRibLcbLibRebRibLsRsbRgbRibR
ibLgbLsbRhbLjbRibRsbLgRsbRsbRibRsRsmbLibRgbRgRgbRjbLhbLgbLgLsbLibLsbLo
bLsbRgbLhbLsbLgbLgbRsRsmbRcLsbRiRsRsmmbLjRsbRcbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 27; Drug: Control Apo 0.5 然
bLsRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 28; Drug: Control Apo 0.5 然
bLgbLsbLsLsLsmmbRobLgLsLsmbRebLcLsLsmmbLsbLibRsbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 29; Drug: Control Apo 0.5 然
bRjRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 30; Drug: Control Apo 0.5 然
bLhbLobLibLhbLcbRcbLibLcLsmbRjbRibLjbRiLsbRcRsmbLsRsbRcbRibLhbLgLsbRcb
LjbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bRgbsbLsbLsbRsbRiLsbLsbLgbLsbRgbRibRsbLsbLgbLjbRobLiLsbLsbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bRgbLibRebRibLsLsmbLcbLebLibLsbLsLsLsmmbRsbLsbRsLsbLsbLcRsbRebLcbRsbRs
LsbRgbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bRgbRsbLoRsbRibLsbLgbRibRgbRgbRsbRgbRsbRsbRsRsmbRhRsmbRsbRgbRgbRsbRsbR
sbRsbRgbRsbRsbRgbRibRsbRgRsRsmmbRsbRsbRgbRgbRibRsbLsbRsRsmbRibRgbRsbRs
bRsbRgbRsbRsRsmbRgbRsbRsbRgbRgbRgbRsbRsbRsbRibRgbRsbRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bRibRcRsmbRcbRhLsbRhbRibLcbRcbRcbRibRibRiRsmbRobLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRgRsmbLsbLgLsbRibRsbRsbLsbRgbRgbLibLgbLsbLibRjbLhbRsbRobRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbRsLsLsmbRsbLsbRsRsmbLgLsbRgbLsbRsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsRsmbRsRsLsmbRsbRsbRgbLgbRgLsbLhbLebRibRgbRibLgbLgLsbRgbRebLgbLgb
LiLsbRcbRgbLsbLsLsmbRsbLgRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bLjbLiLsLsmbLiRsbLibRiRsmbLsLsLsmmbLibLgbRhbRibLibLcbRobRobLsbRgbRgLsb
LgbRibRgbLgbRsbRcbLibRgbRgLsbLgbRibLgbLjbRcbRoLsbLhbRjRsmbRibLgLgbRibL
gbRgbLibLgbLgbRobRcbRjRsmbRobRjbRhbRobRhbRibLgbLibRhbRobLibRjbRgbRibRg
bLibRcbRgbLcbLhLsLsmbLgbLgLsbLhbRibRsbRgbRibLibRhbLsLgbLibLsbRibLjLsmb
LgLsbRibRibRib

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bLibLibLcLsmbRiRsmbRsbLsbLsbLsRsbRsbLsbRsRsmbRsbLsbRsbLsbRsbRsbRsRsRsm
mbRsbRsRsmbLsbRsbsbRsbLsbLsbRsbLsRsbRsbsbRsbRsbRsbLsbRsbRsRsmbRsbRsbRs
RsmbRsRsmbRsbRsbRsbLsbRsbRsLsRsbRsbRsbLsRsbRsbRsbRsbRsbRsbRsbRsbRsbLsR
sbRsbRsbRsbRsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsRsmbRgRsmbRsbRibRh
bRoRsmbRcRsmbRcbLsbRibRcbRcbLiLsbRsLsbLobRsbRsbRsRsmbLsbRsbRsbRsRsRsmm
bRsbLsbLsLsmbRgbRsbRgbRgbRibRoRsmbLsbLobLsbLcbRcbRsbRsbRsRsRsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bLgLibLsLsRsmbRhRsmbRhbRebLsbLsbRsbLsbRsbRsbRgbRsbRsbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bsbRgbRhbRiLsbRsbRibLsbLsbLsbsbRsbRsbRsLsbRsbLsbLsbRsRsmbLibRebRsbRsRs
mbRsbsbsbLsbLsbRgRsmbRsLsbRsRsRgmbRgbLsbRgbsbsbRgbRsbRsbRgbRgbRibLsbRo
bLsRsbsbsbRgbsbLjbLsbLgbLgbLjLgbLsLsmbLgbLsbsbLsbRgbLibLibRcbLibLibReb
RoLsbRibLcbsbLsbsbsbsbRsbRsbLcLsmbLgbLsbLgbsbsbsbLsbLsbRsLsbLiRsbRsLsb
LsbLsbLsLsmbLsbLsbsbLsbLgbRsLsbLsLgRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bRgLsbLsbLebLsLsLsLsLsLsmmmmmbLsLsLsLsmmmbLsLsmbLsbRsbLsbRibRsLsbRjbRj
bRgRsmbRsRsmbRgbRgLsbLibLhbLebRsLsLsmbLgbRsRgbRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bRobRibRhbRsbLhRgbRcbRgbLobLjbLsRsbRsRsLsLsmmbRsbRobLobLjbLsbLsbRsbLsR
sbRsRsRsmmbLobLsbLsbLsRsbRsLsbLsRsRsmbRsbLsRgbRsRsRgRsmmbLsRsbRsRgbLgb
RhbLsbRibRsbLsbLgbLsRsbsbLsLgbLgRsbRsbLsbRsbRsRsLsmbRsRsmbsbsbRsbRsRsm
bRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLgLsbLsRsbRebRsbLgbLsbRcbLobRsbRcbLoLsmbLobRsbRgbLsbLhLsbLsbLibLgb
RsbLsbRsbRsbLsbLsbLsbLsbRsbRsbRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bLsbRsbRsbRsbLsbLeRsRsRsmmbRsbRgRsmbRgbLobLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLsRsbRsbRgLgbLobRgbLsLsmbLibLgbLsbLgbLgLsbRsbRgbLcbRsbLsbLsbLsbRebReb
LgbLgbRibRgRsmbRsbRiRgbRibRsLsLebReLsbLebLgLsbLsbRsbLebLgbRsbRebRsbRhb
RibRhbRsbRiRsRsRsmmmbRgRsmbRsbRgRsmbRsRsmbRobRebRhbLsRsRobRgbReLsbRhbR
sRsRsRsLsmmmbRsbRsbRgbLsbRcbRjbLhbRsbRgbRsRsmbRjbRoLsbLgbRgbLibLsbLsLg
bRgbLsbRsbLiRcRsRimbRibRgLsbRgRsRsmmbRgRsmbRiRsmbRsLgbLsbRsbRsbRgbRsbR
sbRsRsmbRebRgLsbLsLsLgmbRsLsLgbLibLsLsmbLibLibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 123747; End: 124247;
Recording: 5-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bRibLgbLgLsLsmbRsbLgLsLsmbLibRobRsbLsbLsbRjbLgbRgbRsbLsbRsbLsbRgbRjbRo
bRobLeLsbLibLsbLsLsmbLiLsbLhbRsLsLsLsmmbLsbLsbLgLsLsmbLiLsRsbRjbRgRsRs
mmbRsbLsbLibRgbRsRsmbLebLiLsLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 1; Drug: Control Apo 0.5 然
bRobLobRiRobRiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 2; Drug: Control Apo 0.5 然
bLjbLhbRebLebRobRjbLjbLobRsbRjbRjbRebLsbLjbLebLsbRjbRebLjbLobLjbRjbLsb
LebRjbRebLsbRjbRsbLgbLsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 3; Drug: Control Apo 0.5 然
bRgbLsbRsbLsLsmbLcbRgbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbRgbLgbLsbRsbRgRsmbLsbRsRsmbLsbRibRsbLgRsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 5; Drug: Control Apo 0.5 然
bLsRsbLeLsRsLsRsbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 6; Drug: Control Apo 0.5 然
bRcbLhbRsLibRgbRibLiRsbRgbLsLsmbLgbRjRsmbLjbRjbRobLgbRoLsbLibLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bRoLsbLjLsmbLgbRibRibLobRebRob

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bRsLsbRobLjbRgbRsbRiRsmbRgbRgbRgbRgbRgRsmbRsbRsbRsRgbRsRsmbRgRsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bLcbRsbRoLsbRsbLibLcbsbLiRsRsmbRsbLgbLcbLhbLgbLjbRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bLiLsbLibRobLhbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bLcbLobLsbLcRgRsmbLsbRebRjbRsbRcbLgbLgbLibsbLobLgRsbLsbLsbLsbLobRobRcb
LoRsbLcbLebRobRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bLhbRcbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bRgbRiLsbLebLsbRcbLcbLibLsbRjLhbRobRebLobRibRobRobLgLsbLcbLiLsbLibRgbL
ibRgbLibRgbLhbLjbLsRsbRobRhbLcbRobLjbRobRgbRobLcbRibRibRibRsbRebLibLcb
LobRebLoRsbLibRebRsRsmbRgbsbRsbLhb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bLebLsbRobRibRgbLcbLobLsbRsbRobLgbRsbLobLcbLcbReRsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLsLsLsLsmmmbLsRsbLsbLibRsbLsbLsbLsbLsbLobLsLgLsbLsbRgRsmbRgRsmbLob
LsbLsbLgbRcbRsbRsbLsRsbLcbLsRsbLsLsmbLsbLsbRsbLsbLsbLcbRsbRsbRsbLibLgb
LibLibLobRsbLsbRhbLgLsbRibRgbRsbLsbRibRsbRsRsmbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bRsLsbRibLsbsbsbLebLcbRhbRgbRibRgbRiRsmbLsbRgbRgLsbsbRibRibRiLjbRiRsmb
RsbLhbRjbLibLsbLgbLsbLibLibLiLsbLsbLsbLsbRcbLgbRsRsmbRsbRcbLgRsbLhbLeb
RgbRsbLhbLsbLsbLgbLgRsbLgbLsbLibRgLsbLibLsbLgbRibLhbRibRcbRcbLsbLgbRib
RibLsbRgbRibRgbLjbLsbRsbLibRebRsRsmbRgbLjbRhLsbLibRibRgbRibRgbRgbLsRsb
LibLgbLobRobLjbRcbLibLcbLibRcbLjbLoLsmbRsbRgbLiLsRsbLgbLgbLiLsbRsbLibL
sbLsbLgbRgbLgbLgbRgLsbLgLsbLsbLibLsbLgbLsbLgbLsbLibLcbLiRsLsbRjbLgbLiL
sbRsbLibRsbLibLiLsRsbLsbsbLgbRsbLsbRsbLgRsbLsbLgLsbLeRsbLibLibRibRiLsb
LiLsbLsbRcbLibLsRsbLsRgbRgbRiLsbRgbRjbLsbLibLiRsbRibLgbLsbLsbLibLsbLib
LhbRobLobLcRsbRsRhbLsbRsbRibRibLjbRhbRcLsbLgLsbLibRsbLebLsbRibLibLjbLi
bRgbLiLsbRjbLibRsLsbLsbRcbLiRsbLsRsbLgbLsbLibRjbLibLsbLibLsbLibRsbLibL
sbLiLsbLsbLsbLgbRsbLiLsbLsbLgbLgbLsbLgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsRsmbLsLsmbLsLsLsLsLsLsLsmmmmmmbLgLsbLsbLsbLsbLsbRsbLsLsmbsbLsbsbL
sbLsLsRsmbLsbLsLsmbsbRsLsbLgbRsbsbLsbLgbLsbsbLsbRsRsLsmbLsbLsLsLsmmbRs
LsLsmbLsLsLsLsLsmmmmbLsbLsRsbLeRsbRobRcbRgRsmbRsbRgRsmbsbLsbRcRsmbRsbs
bLiLsbLobLibLhbLibRsbLsbLsLgbLgbLsLsmbLsLgbsbLsbRsLsbRsbsbRsLsLsmbLsbL
sbRsbLsLsmbLsLsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bsbLoRebLiLsbRsbRobRoLsbLobRobLibRobRgbLcbRgbLibLibLgLsbLobRibLgbRgbRs
bLcRsbLibLiLsbRjbLibLsbLgbLgLgbLgbLgbLsbLibLsbLibLgbLgbLgLsbLgbLgbRsbL
iRsbRgbLobRobsbsbsbsbsbLsbsbRsbRsbLsbLsbsbsbRsbLsbRsbRsbsbLsbsbRobRgbL
sLsRsmbLsRsbLsbsbsbsbsbLgbRsbLiRsbLjbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bLsbRsbRibLeRgbRoLsLsLimbRsbLhbLsbRebRjbRebRsbRgbRibRsbRjbRoLgLsRsbRjb
LhLgbReRsmbRsRsmbLebRgbLobLibRgbRsRiRsmbRhbRsRgbRebRsbLcbRebRsLsbLsLib
LsbRgbLsbRibRsbLgbLebLibLcbRgbLsbLjbLsbLsbLsLsmbLiRsbRhbLebRsbLgbRobRg
RgbRgbRsbLebRsRsmbLebLgbRibLibLgbRgbRsbLeRsbRsRhbRgRsmbRibRjRebLiLsbLs
RsbLsbLsbLgbLgbRcbRibRsbLebRebRgbRgbRibLsbLcbRiRsmbLsbRgbLgLsLsmbRsbRi
bLcLsmbLsRibLebLgbRjbRibLebRsbRobRsLsbLsLsLsLgmmbRsbRsbLsbLsbRsbLhbLsR
jRgRsmbRsbsbRsbRsbLebLcbRsRebLibLeLhLsbRebLebRjbLjbLjbLgLsbLsLsLgmbLsL
gRsbLsbLgbRgRsRsRsmmmbRcRgbRgbLcbLibRgbRsbRgbLibRebRibLiLgbLgbRgbLsbLj
bLgbLsbLsbRjbRcbRiRsmbRhbRebRsbRsLgLsbLsLsLsRsRemmbRibLgbLibRiRsmbReRi
bRibLsLsmbRgbRgbRsLgbLibRsbLsbLsbLgbLsbLeLsLsLsmmbRsbLgbRgbLibRgbRobRo
bRgbRgbLsRjbRcbRcRgbLcLgbRebRgbRsReRsmbRsbRsbRsReRgRgbRsbRhbLebLsLsmbL
ebRsbLsbLgbRibLgbRgbRsbRobRsbLebRjbLiLsbLsbRgRgbRgRsmbLsbLsbRsRsmbRibL
gbLsbRebRgbRsbRgbRsbLjbLcbLsbLjbLebLsbLgbRibLsbLgbLiLebRgbRsbRsbRiRsmb
LebLsbLeRgbLgbRsbRsbLsbRsbRsRsLsLsLsmmmbLebRgbLibLeLsLsmbLgbLsbLsbLsbL
sLsLeLgmbLgbRsbLebLgbLebRebRsbRsbRgbLeLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bRsLsLsmbLgRsbLsRibLsRsbLsbLoRsRsRsmmbRgRsmbRhLsbLebRsLiLsbRjbLsLsmbLj
bLsbRsbLsbRobRsbRsbLsRsbLebRobLebLgbRsbRibRgbLgbRiRsmbLebLoLiLsbLsbLjb
LsbLsbLgbLobLiRsbRgbRsbLgbLgLsbLsbRsbRgbLcbRsRsRsmmbRgbRgLsbLsbRgLsbRj
bLsRsbRgbRsbRsLsRsbRsbRsRsmbRsbRgLsbRgbRsbRsbLsbRgbRibRsRsmbRsLsbRsRsR
smmbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLiLsbLsbRobLsRcbRsbLsLsmbLgRsRibRsRsRsRsmmmbRjbRsbRgbRsbsbRsbLjbRe
bRsbRgbRsbLsbRjbRobRebRcbLebLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRjbLobLebLobLsbLgbLhLgbRgbLsbLsbRebLsbsbRibLsbLgbLsbLsRsbLgbLsLsmb
LgbLsLsmbLsbLsLsmbLsbRcbLibLsLsmbLgbLsLsLsmmbRsLsbLsbLsbLsLsLsmmbLsLsm
bRebRsbsbLsLsLsmmbLsbLsbLsbLsLsmbLsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bLoLsLsmmbLeRsRsmbRsLsbLgbRsbLcbRgbLgRsLsbRibRoLsbLcRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bLgbRsbLeLsLgbLebLgbRgbLgLjbLsbLeLsbLiLibLhLsbLsbLjbLjRsbLsLsmbRsRsmbR
sbRsbLsbLebRjbLjbLobRsbLsbRsbLebRibLobLobRgbRsRsRsmmbRsRsmbLcbRjbLsbLe
bRsbRobRsLsbRsbLobRgbLebLhbRgRgbRjLsbLjbLebRebLcLsmbLibRibRgbLsbLcbLjb
RebLsbLiLsbRsbRsbLhbRsbRsbLeRsbLsbRjbRebRebLsbRsbLoLsmbRjbLsbRobRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 25; Drug: Control Apo 0.5 然
bRhbRsbLibLgbLsbLsbLcbLsLgbLsbLgbLsLsmbLjbLjbLsbLcLsmbLsbLjbLibLibLgbL
ibLsbLgbLgbLgbLsbLibLsLsmbLgbLsbLgbLsLsmbLgLsbLsbLgbLibLsLsmbLgbLsLsmb
LgbLsbLsbRgbRjbRibRgbLjbLcRsbRsbRsLsbRcbRcbRsbLsbRsbLcbLjRsbLsbLsLibLg
bLsbLoRsbRsbRgbLsLsmbLsLsmbLibRibRgbLjbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 26; Drug: Control Apo 0.5 然
bRcbLibLobLcRsbLibLiRsbRibLibLsLsmbLgbLjbLcbLibLsbsbLobLsLsmbLcbRjbLoR
sRsmbRsbLsbLcRsbLhbLsRsbLgbLsbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 27; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 28; Drug: Control Apo 0.5 然
bRsbLgRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 29; Drug: Control Apo 0.5 然
bLiLsbRibRibLcbRgbRcLsbRcbLcbRgLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 30; Drug: Control Apo 0.5 然
bLibLcbLobLoRsbRibRibLibLsbRcLsbLobRsbRsLsbRibRsbRibRcbRgbLsRsbRibRjbR
gbRgbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bLgbLibRsbRsbLsbLgLsbLsbLiRsbsbLsbLiLsbLsRsbLgbRibLsbLsbLgLsbLsbLsbLsL
smbLgbLgbLsLsLsmmbLsLsLsmmbLiRsRsRsmmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLeLsbLsbLobLsLsmbLiLsRsbLgLsbLsbRsbRcRsRsmmbLcbLobLibLgbRsLsLsmbLgbLo
bLiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRsRsmbRsbRsRsmbRsbRsbRhbRibLsLsmbRcRsmbLsbReRsLsmbRsRsmbRibRsbRsbR
oRsmbLsbRgbLsbRsRsmbRgbRsbsbRsbRgbRsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bLjbRcRsmbRsbLgbRcRsmbLibLcRsbRcbLcbRibRibRcbRcbRobRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bLsbRgbRgbRgbRhbRibRiRsLsmbRgbRsbLsRsRsmbRsbRobLsbLsbRoLsRsbRgbRhbRibR
gRsmbRsbRsbLjbRcbLsbLibRsRsmbLibRsbLibLgbLoRsbLsbLgbLibLob

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bRgRsmbLgbRiLsbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bLgbLgbLgbLsbRsbRsbRsRsmbLsRsbRsbRsbRsRsmbLsbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bRgRsmbRgbRsRsmbRsbRsRsmbLsRsRsmbRsbLsbRgbLibRobRgbLsbRibLgbRgbRibRhbR
gb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bLgbRoRsmbsbRsRsmbsbRsRsmbLhbLjRsbRoRsLsLsmmbLsbLjLsmbLgLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bLsbRsbRsLsbLsRsbRsbRsRsmbLsbRsbLsbRsRsmbRsbLsbRsbRsbLsbLsRsbLsbRsbRsb
RsbsbsbLsbRsbRsbRsbLsbRgbLsbRsbLsbsbRsRsmbRsbRsbLsbLsbRsbsbRsbRsbLsbRs
bRsbRsbLsbRsbRsbRsbRsbLsRsbRsRsmbLsLsmbsbRsbLsRsbLsbRsbRsbLsbLsRsRsmbR
sbLsbRobRsRibLobRsbRsbsbLsbRsRsmbLsRsbsbRsbRsbRsRsmbRsbRsbRsbLsLsmbRgb
RsbRsbRsbRsbRsRsmbsbRsLsRsbRsbRsbRsbRsbLsbLsRsbLsLsmbRsbRsbRsbRsbRsbRg
RsmbRsbRsbRsbRsbRsRsmbRsbLsRsbRsbRgRsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLsbLgbLsLsRsmbLcbLsbLsbLsLsmbLiLsbLgbLsbRsLsbLsbRsLsbRsbRsLsbLsRsb
sbRsLsbRsbLsLsmbsbsbsbLsbsbLsLgbLsbLsbLsLsLsmmbLgbLgbLsLsmbLgLgbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsmbsbRsbLobLobRoRsmbLibsbsbsbsbsbsbsbsbRsRsRsmmbRsRsmbRsRsmbRjbRcb
LibRsbRobRhbRibRsbRgbRsbRhbLcbRoRsmbsbRsbLsbRebRsbLsbRibRcRsmbLjbsbRsL
sLsLsRsmmbRgbsbRsRiRsmbLsbRiLsbRibLobLobLsbsbRsbRobLsRsbRsbRsRsLsmbRsb
RsbsbLgbRsbRoRsLsmbRsLsbLgbLobRibRobLibRjbRsRobLgLsbsbRoLsRsbLsbRsbLgb
LsbLsLsmbLgbLgRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bsbRgbRgbLjbRjbLjbRsbRsRsmbRobLsbRsRgbRjbLgbRsRsRimbLebRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bRgbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsbRsRiLsbRsLsbRsbRsbRgbLebRgbRsbRsbsbR
sbRsRgRsRsmmbRgbRsRsmbRsRsmbLsRsRgRsmbRgRgbLsRsbsbRsbLsLgbLjbRobLebRsb
LsbsbRsbRsbRsRsmbsbLsRsbRgRgbRgbRibRjRsmbRsbLsbsbLsLsmbLgbRsbRsbLjbLhb
LgbRsLsbLsbLebRsLhbLsbRsbLsbRgbLebRgbLebsbsbsbsbRsLsLsRsmbLsbRgbRebLob
LsRgLsRsRsmbRsRsRsRgRsRsmmmmbRsbLsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bLsRsbLsbLsbLsbRgbLgLsbLsbLsbRsLsbRsbLgbLsLsmbLsLsmbRsbLgLsbLgRsLsbRob
LsbLsbLsbLgbLsbRsLsbLgLsbLsLsmbRsRsmbLsRsbLsbLsbRsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bRsbLsbLebRsbRsRsmbRibRgRsmbLjbReRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLsLsmbLsLsLsLgLsmmbLiRsbRsbRsbLsbRibRobLsLsmbRsLsLgbLobLeRsRsmbRgbRsR
sRgmbRsRibRsbRsbRobLobRebLebRebLobRgRsmbRsRsmbRsbRsbLibLgbRgbLgbRebReb
LiLsLsLsmmbLgbLeRsbLsbLsLibRsbRsbLgRobRsLgbLibLiLgLsRsLsbLgLsbLgbLsbRs
LgLsbLgbRgLsbLgbLsLsLsmmbLsLsLsmmbRgbLiLsbRjbLsbRsbLsLsLsmmbLjLsmbRibL
gRsbRgRsmbRsRsmbRsbLsbRsbLebLibLsLsmbLibLcLsmbRsRsmbRsbRgRgbRgbRgRsmbR
gRsmbRgbRibRsbLgbLsLsLgmbLgbLsLsLsmmbLeLsLsmbLiLgLsbLgLsbLsLsLsmmbLibL
sbLsbLgbLgLsLgbLcbLoLgbLsbLsbLsbsbsbRsbLsbLsLsmbLeLibLsbRsRsRsLsmmbRsb
RsRsLsmbRebLgbRgRsmbLsRsbLjbRebRcbRobRgRsmbRgbRsLsLibRsbLgbLiLsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124248; End: 124748;
Recording: 6-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bLeLgLsbLgRsLsbLcLobLobLgbLsbLgLsbLsbRcbLsRsRsmbRsLsbRsRsmbRhbLsbLsbLg
bLsbLsLsLgmbRsbRsbRgbLgLgbLsbLsbLcbRsLsRsLsbLgbLsLgbLsbLsbLsLsLsmmbLiL
sRsbLgLsbLsbRsbLsLsmbLsLsLgmbLsbLgbRoLsRsRsmbLsbLsRebReLobLcbRsbLsbLsb
LsLsLsmmbLsbRobLsLsLsmmbLgbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 1; Drug: Control Apo 0.5 然
bLjbRjRsmbRgbRobRhbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 2; Drug: Control Apo 0.5 然
bLibRsbLsRsbLoLsmbRibRgbRcbRsbRhbRibRsbRjbRibRsbLcbRjbRhbLjLsmbLcbRcbR
oLsLsmbLeLsLsLsmmbLgbLsLsmbLsRsbLsLsmbLsbLgbLgbLgbLgbLgbLobLcbLibLcbLh
LsbLibLibLibLibLgbLgbLcbLibLibLibLibLsbRcbRhbRgbRgbRobRhbLsbRsbRsRsmbR
sbLgbRcbRibLgbLibLjbLgbLgbRebRibRgbLsbLgRsbRsbLcLsmbLibLhbRgbRgbRgbRgb
RibRgbRsbRcbRhbRibRsLgbLibLibRgbLcRsbRgbRgbRebLgbRcbLsbLgbLsbRsbLsbLjb
LibLgbRjbRcbRjRsmbLjbRobLcbLcbLsbLcbLibRcbLgbLsbRsbRjRibRgRsmbRsRsmbRs
RsmbRsRsmbRgbLjbLgbLgLsbRsRsmbLgbLcbRibRibRgbRgbRgLsbRgbRsRsmbRgbRgbRg
bLsbRsbRgbLcbLsbRsLsbRibRgRsmbRebRibLsbLgbLgbLcbLcbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 3; Drug: Control Apo 0.5 然
bRgbLgbLcbRsbRibRibLgbLsLsmbLgbLgbRgbRsRsmbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 4; Drug: Control Apo 0.5 然
bRjbRcRsmbRoRsRsmmbRibRsbRgbLgbLsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 5; Drug: Control Apo 0.5 然
bRebRibLsRsbsbRsRsmbLcRsbRsRgLsbLsbLibLsLsmbRiLoLsmbLcLsmbsbLoLsmbRsbR
sb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 6; Drug: Control Apo 0.5 然
bRcbRobLibRibRsbRsLsbRjbLjbLsbLobRsbRgRsmbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bRibLcbRsbLgbLibRibRobRcLsLsmbRobRiRsmbRsbRcbLobRcbLjbRcbRcbRibRibLcbR
jbLibLsbRobRcbRgbRiRsmbLobLcbRibRsbRjbRcLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bRiRsmbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bRsRsmbsbLsLsRsmbRiLsbLjbLibLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bLibLib

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bRsbLsRsbLsbLsRsbLsbLsbLiRsbRebRsbRebLjbRobLibRebLibRcbLebRcbRebLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bRhbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bRsbsbLgbLgbLgLsbLibLibRobRhLsbRcbRhLsbLsbRibRobLcLsRsmbLiRsbRcbRgbLob
LobLobRhbLobLcbReRsmbLhbLobRibLoRsbLhLsbLiLsbLsbLibLsbLoRsbRebLobLibLj
bRsLsbLgRsbLibRobLobRibLobRgbLobRoRsmbsbsbRsbLsbLsbRsLsbRsRsmbLsRsLsbL
iRsbLsbLibsbLibLsbLjbLsbLiRsbLsbLobsbLobRsLsbLebLob

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bLibLgbRcLsbLjbLjbReLsbLibRgLoLsmbLebLgbLobRhbRibLibLhbLhRsbRjbRobLhb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsbRhbLcbLsbLsbLibLsbRsRsmbRsbLhbLsLsRsmbLibRsbRsbRsbLiRsbRsbLsbRs
LsbLsbRsRsmbLsLsmbLgbLsbLobRgbRgbRibRsRsmbRsbRsbRsbLsbRsbRsbRgbRsbRsRs
mbRsRsmbRgLsbRsbRsbRsbRsRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bLobLsbRibRibRjbLiLsbLjbLsRsRsmbRsbLgbLibRsbLibRgbLgbLobLgbLcbLgRsbRcb
RibLjbLoRsRsmbLjbLjLgbRsbRgRsmbLiRsbLsbLibLgbRobRebRsbLibLibLgbLgbLgbL
sRsbLgbLiLsbLhbLgbRsLsbLhbRsbLgLsbLgbLsbLibLibLgbLibLibLibRsbRsbLibRsb
RsbLgLsbLibRgbLcbLgbLiLsbLibLgbLibLsbRgbLhLsbLibLhbLibRcbRibRsbRsbRsbs
bRsRsmbLcbsbRsLgLsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bsbLsbLsLgbLsbLsLsmbRsLsbLsLsLsLsRsmmmbLsLsmbLsbLsbLsLsLsmmbLsLsmbLsbL
gbRsLsbsbLsbLgLsbLcbLhbLiLsbLsbLsLsmbLsbLsbsbLsbLsLsLsmmbLsbLsbsbLsbLs
bLsLsmbLsLsmbLsbRsbLsbLsbLsbLsbLsLsmbLgbLsLsmbLsLsLsLsmmmbLsRsbsbLibLs
LsLsmmbLsbsbLgLsLsmbLsLsmbLsLsLsmmbLsLsmbLoLsmbLcLsmbLgLsLsmbLgbLsbRcb
RiLsRsbsbRsbsbLsbRgbLsRgbLsbLsbLsRsbRsLsbLgbRgLsRsbLsLgLsLsmbRsLsbLsLs
mbLsbLsLsmbRsLsbLsbLsbLsLsmbLsbLsbRsbLsLsmbLsbRsLsLsmbLsLsLsmmbLsLsmbL
oLsmbLsbRsbRsRgRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bLibLsbLebRcbRsRsmbRibRgbRsbLsbRcbRibRsbLsbRsbRibRebRebRibLeLsbLsbLsRj
bLsLgbRibLgbLibLsbRibRgbRibRjbRsRgLsRibRebLsLgbRhLsLsLgLsmbLsLsRsmbLgb
LibLsbLgbRibLsbRsbLgLgLsbLsRsbRsbLgRsbLgRsbLgbLgbRcLsbRebRsbRobLoRsLsb
LgbRsbLcbLibLebLsRibLjbLjbRobLsbRsRgbRsbRsbRgRsmbRsbLsRsbRgbRebRhbLebL
sRibLiLsbLgbLsbLgbLcbRibLhbLgLsbRsbReRgRgbRhbRsRgLsbRsbRsRsRiRsmmbLobR
sRsmbsbsbsbsbsbsbLsbRsbLsLsmbsbsbLsRsbLebRgbLibRsbLibLsbLibLsRebRsbReb
RoLsbLsbRsbRjRsRjmbLgRsbRebLsbLcbRjbRjbLsbLsbRsbLsbsbsbsbsbRjbLsbLsbLs
bsbLsbRsLsbLsbLgbLebLibRgRgbLsbRebLjbRsbRgbRebRgRsmbLsbRcbRebRsbLsLsLe
RsmbsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bRibLsbLsbRobRsbRsbLsbLibRhRsmbRebRobLcbRgbLgRsbLsLsLsmmbLjbLebRibRsRs
RsRsRsmmmmbLcbLgbLsbRebLsbLobLsRsLsbRebLoRsbRgLsRsLsLsLsRsmmbRsRsmbLeb
LebLibLibLeLsbRibLsbLsLgLsbRsbLsLsLsmmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bRebRebRsbRsRsmbLgbLsLsmbRsbLsbRsLsLsmbLsLsmbLsLsLsmmbLsbRebLebLsLsLsm
mbLsbLgRsLsbLsLsmbsbsbLsbRsbsbsbLsbLsLsRsLsmbsbsbsbRsbLsLsmbLsLsmbsbLs
bLsbRobLobRobRjbRsRsmbRsbLsRsbRsbRsbLgLsbRsbRobRsbLgbRsbRsbRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bLsLsmbLsLsLsmmbLgbLsbLsbLsbLgbLsLsRsmbLsLsLsmmbLgLsbLsbRsLsRsbLeLsRsb
RcRsmbRsLsbRgRsRsmmbLsbLgLsbLgbLibLsLsmbLgLsbLgRsRsmbRsbLsbRsLsbRgbRsb
RsRsmbRsbLsbRsbRsbRsLcRsRsmbLjbRobLjbLgRcRsmbsbLgRsbLsLsmbLsLsmbsbLgbL
sbLsbLgbLsLsRsmbLsLsmbRsLsbLsbLsLsLsmmbRsRsmbLsLsLsmmbLcbsbLsbLibRjbLg
bRjbRsbLsbRebRhbRcbLgbRsbLsbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bLgRjbLsbLgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbRebLobLjbRjbLobLibLjbRsbLsbRjbLsbRjbRjbRsbLsbLoReRsRsmmbRsbRsbR
eRsmbRsbRsbLsLsRsmbLsbRsRsmbLjbRjbRgbLsbLsbRebLgbRsbLgbLgbLjbLgLsbLsLs
LsmmbLgbLsbRgLsbLsbLsbRsbLjbLjbLobRibLjbRgbReRsRsmmbRsRjbRsbLebRsbRibR
hbRjbRgbLsbLgbLgbLibRgLsbLjbRsbLibRgbRsbRgLsbLjbRjbRsbRgLjbLsbRsRsmbRi
RibLsbRsbRsbLsbRsbLhbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 25; Drug: Control Apo 0.5 然
bRjbRgbLobLjbLjbLgbRsLibLgbLgbLsbLibLgbLoRsRsmbLgbLgbLcbLsbLjbLsbRhLsb
RsbLsbLibLiRsbLsLsmbRsLsbLsbRobLgLsbLibLgbLsLsmbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 26; Drug: Control Apo 0.5 然
bLobLobLoRsbLcRsbLcbLcRsbLsLsmbLibRsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 27; Drug: Control Apo 0.5 然
bLobLobRsbLebLobRsbLibRobRobRebRsbLcbRobLobLobRsbLsbLobLsbLobLobLcbLcb
LobLcbRobRebLobLebRsbLobLebRobLobRobRibLobLobRebLobLsbRebRobLobLobLobL
ibRgbRhbRebRcbLobRobLgbRobRebLcbRgbRjbLobLcbRobRebRcbLibRcbRobRobRobLe
bRobRgbLobRebLebRibRgbLcbRobRgbRebLobRobLibRebLobRcbLibLcbRebRibLobReb
LobRebRcbLebLobLebLgbRebRebRgbRgbLobLgbRgbRcbLibRgbLibLobRcbRgbRobRobR
cbRsbRibLobRibLjbRebLobLcbRebRebRobRibRobLcbRobLobRjbRhbLcbRobRobRebLe
bRgbLobRobLsbRebRebRsbRobRobRobLgbRcbLcbRobRobLcbRobRgbLebRobLebRobRob
LebRcbRgbRebRebRobRobLobRebLebLebLcbRobLebRobLebLebLcbLobRobLibRobRgbL
obRibRsbRgbRgbLsbLcbRobRobLobLebLobRhbRcbRobLcbLobRibRobLcbRcbRibLhbRo
bLcbLcbLgbLhbRebLcbRobRcbRebLobLhbLobRebLcbRsbRebRobRobRobLsbLobRibLeb
LgbLjbRebLobRibLhbLebRobLebLobLcbLobRcbRibRobRebRobRebRcbLebLgbLebLebR
ebRobRebRsbRobRobRebLobRcbRebRobRobLobRebRibRebLcbLobRhbRobRcbLobRgbRs
bRebRibRebRobRcbRebLebRgbLebRobRibRgbRebRhbLibRebRhbRobLebRhbLobRobReb
RobRebLebRsbRgbRibRhbRgbLobRobLebRibRebRobRgbLebLebLobLobRobRcbRobLcbR
obRcbLgbRobLebLobLgbRobRobRibRobRobRebLobLgbLcbRobRibRgbLebLcbLobLobRe
bLcbRobRobLobRobRebRgbLibLebRobLobLebLobLhbRgbLobRcbRcbLobLobRobLobLcb
LobLobLgbLobRgbLibLobRsbLcbRibRibRobRcbRcbRobRibRgbLobLebLgbRcbRobRhbR
gbLcbLsbLcbLobLebLebLibRebRcbRgbRobRcbLcbLibLobRobRobLobRcbRebLobRobRg
bLobLobLcbRibRobLobRobLobRhbLgbLobLebRobRebLebLobRebRobLebRobRobLobLcb
RobRgbLobLobRobRobLebLobRcbLobRcbRobRobLobLcbRobRobLobRebLobRibRcbLobR
cbLgbLsbLebRobLsbLgbLhbLsbRcbRebLebLobLobLgbLobLcbLobRobLcbLobRebLebLo
bLebRobLobLcbLcbRcbLebLcbRobLcbRebRobLobRobRobLcbRhbRobLsbRobLgbLsbLeb
RcbRsbRobLobLobRebRebRobLebRobRcbRobLobRcbRobRobLobLebLibLebRobRsbLibR
cbRobLebLobLobLobLgbLobLebLobRobLgbRsbRgbLibLebLebLcbLgbRgbRobLebLobRo
bLebLcbLobLobRebRebRibLebLebRcbLcbRobRebRgbRobRsbLobRobRobRobLgbRgbLeb
RsbRgbLobLobLcbLcbRcbLcbRebLobLebLsbLgbLcbLhbRcbLibRcbLibLcbLhbLjbRcbR
ibRcbLobLsbLobLebRebRobLebRcbLsbLcbRebRobRebRebRobLgbRobRsbRcbLobRcbRs
bRobLebLebRcbRgbRcbLibRobRobRobLebRebLobLsbLsbLebRobRobLebRobRcbRibRib
LebLobRebRobLibRebLcbLobLcbRibLcbLobLobRobLobLebLobRobRcbRobLebRcbRibL
ibLobRcbRebLobRobRcbRobRebRobLcbRcbRebLcbRcbRobRobRsbLcbLgbRsbLobLcbLe
bLobLebRsbLobRibLebRobRobRebRobRebLobLibLebRebRhbRobLcbLibLobRebRsbLeb
LcbRhbRobLcbRebRgbRobRobRcbLibRgbRgbRebLibLcbLcbRibRebLcbLobRobRobRhbL
cbRebRgbRebLcbLobLebLobLobLobRcbRebRobRebLgbLcbRgbLebRhbLobRebLebLcbLc
bRobRobRhbRsbLebLcbLebLobLebLcbRsbLebLgbRebLibLobRcbRcbLcbRebLobLcbLob
LobRcbRobLhbLebRebRebRobLcbLobRgbLobRhbRcbRebRcbLibLebLibRobRcbRsbLgbL
ebLcbRobRobLcbRobLobLebRebLobLsbLcbRobRobRebLobLcbLhbLibLobRibRebLibLc
bRobRobRcbRebRobLcbRibRebRcbLebRebRebRcbRobRcbLcbRobRobLgbRgbLobLebLib
LobLebLebLcbRgbLcbLobLibRcbRobLobRgbLibRobLobRebLebRobRsbRcbRcbLebLcbL
gbRobLobLgbRebRcbRobLsbRcbRgbLgbLsbLobRobLobRgbLcbLebRhbRgbLhbRcbRgbLc
bRobRgbLcbRobRobLcbLcbLobLobRcbRobRobLjbLobRobLobRobRibLobLsbLobRebLeb
LibRebRgbLobRobLebRobRobRcbLebRcbRobLobLobRhbRobRcbLcbLobLcbLibRebLibR
gbRobRobRsbRobRcbLcbRhbRibLibLebRobRibRobLebLcbRobRibRebRebLobRib

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 28; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 29; Drug: Control Apo 0.5 然
bRcbLcbLgLsbLibLgLsbLibLibRcbRgbRsbRgbRiRsmbRgbRjbReLcbsbLsLsmbLsbLgLs
bLsbLsbLiLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 30; Drug: Control Apo 0.5 然
bRiRsmbLgbRgbLibRjbRgRsmbLibRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bLsRsbLsbLgRsbLgLsbLiLsbRgbLsbLsLsmbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLsbLibLibLgLsbLsbRobLcbLibLsbLiLsbLsbRsbLhRsbRsbRsbsbRsbLjbLgbRobLhLs
bLsLsmbLgLsbLcbLcbLhbLgbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRsbLsbLibRsbLsbRiRsmbRgbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bLjLsmbRibRsRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bLibLsbLcbsbLsbRsbLiRsbRobLgbLgbLgLcbRgbRobRoRsmbRgbLsbLgbRcbLibLiRsbL
hbLibRibLebLgbLeRsbLjbRsbRgbLibRiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bRibLobsbRgbLibRibRsbRsbRibRsbRobRib

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bLibLhbRsbRgbLgbRgbRgbLcbRsbLsbLgLsbRgRsmbLsbLobLgbLsbLgbRgbLibLobLsbL
gbLibLsbLgbLsRsbLsbLgLsbLgbLibLoLsmbRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bRsbsbsbLsbLsbRobLgbLsLsmbRgbRjbLobRgbRsbsbRsbRibRsbRgbRsbRsbRsRsmbLsR
sbLobLsRsbRgbRiRsmbRsbRsbRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bRebLgbLhbRobLibLjLsmbLibRsRsmbRcbLsLsmbRibLibRjRgRsmbLgLsbLibRibLgbLs
bLibRsbLsbsbRgRsmbLgbRibLgLsbRjbRcbLsLsmbRibLsLsmbRobLgbsbLgbLgLsbLgLs
bReLsbRibLgbRibRsbRgbLjLsmbRhbLsbLsLsmbRgRsmbRgRsmbLebLsLsLsLsmmmbLsLs
LsmmbLgbLsLsmbRobRibLsbRiRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbRsbRsbLsRsbLsbRsbRgbRcbRsbLgbLibLsbRebLgbLsbRsbRsbRsbRobRgbRcbs
bRsbLsRgbRsRsmbRsbLsbRsbRsbLgbRsbRsbLobRibRoRsmbLsbLibRsbRsbLibRsbRsbL
sbRsbRsbLsbRsbRsLsbRsRsRsmmbRsbRsRsmbRsbRsRsmbRgbLsRsbRsbLsbLsLsmbRsRs
mbRsRsmbRsbRsbRsbLsbLsbRoRsmbRhRsmbRiRsmbRibRobRiRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bLgLsRibRsbRsbLsLsmbRgLgLsLsmbLsbLsbRsbLsbLsbLeLsLsmbRsRsmbRobRibLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bRsbLsbLsbsbLsbRsbsbLsRsbLsLsmbRsbLiLsbRsbsbLsbLsLsmbLsbLgbsbLsLsLsmmb
LsbLsLsRsmbsbsbLsbLgbsbRgLsbLsbLoRsbRibLgLgbRgRhbRgbRobLiLsbLsLsmbLsLg
LsbRgRsmbLgbLsLsmbLibsbsbLsbsbLsbRsbsbLsbRsbRsLsbLsbsbLsbRsLsbLgbRsbLg
bRsbLsbLsbRsbRsbLsbLsbLsbRsbLsbLsbLsbRsbRgbLobLobLoRsbRgRsmbRoLsbsbsbs
bsbLsbsbsbLsLsRsmbsbRsRsmbsbRsbLiRsLsbRsRibRobLiRsbRoLsbLsbRsbLcbLiLsL
smbLibRcbRcbRibLgbRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bRsRsmbRsbRsRsLsmbRoLsbRgbLsbRsbRsbRjbLebRsbLiRsRsmbRgRsmbLsRsbRobRgRs
mbsbRsbRgbRgRsRsRgmmbLeRoLsbRjbRsbsbRgRsmbLsbRsRgbRsbRgbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bRjbsbRsbLsbRibRebRebRsbRsLsbsbRsRsmbRsbLgbLsbLibLgbLsbsbLsbLsbLsbLibR
sbRgbRsRgbLsRsbRsbRsbRgbLgbLsbLsbLsbLsLsLsLgmmbLsLsLsLsLsmmmmbLibLsbsb
LsbLsLsmbLgLsLsmbLsbLgbLgbLsLsLsmmbRsbsbRsbLsLsLsmmbLgLsbLsLgLsLgLsLsL
gmbLsLgLiLsbLibRsbLgRebLsLsmbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bLibLsbRsLsbRsbRsbLsLibLgbRsbLsbRsbLsLsmbRsbRsbLgbRsRsmbRsbRsbRsbRsbLs
RsbLgbRsbLsbLsbLsbLsLsmbLgRsbRsbLsbLsbRsbLsbLsbLsRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLgbLsbLgbRhbLsbsbsbsbsbsbsbRsbRsbLsbLsbLsLsLsRsRsRsmmmmbsbLsbLhb

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLgbRsbLsLgbLcbLgbLsbRsbRsLsLsRsRsmmbRsLsbRgbRsRsLsmbRsbRsRgRsmbRgR
sRsmmbLobLgbLgbLibLsLcLsRsLsmbLsbLgbLgbLgbRsbLsLsmbLiLsbLsbLiRsbRiLiLs
LsmbLsLsLsLsmmmbLsbLebLebLibRgbLgbRibLobRgbRibLhLgRsbLsLsmbRsRsLsmbRjR
smbRgbLibRsbLhbLgbRsLsbRsbRsbLoRsbRibRiRsmbLsbRibRebLiRsbRsRsmbLhbRcbR
gbLsLgbLsLsRcmbsbsbLibLgbRsbLebLgLsbLgLsbLsbLsLsLgmbLibLsbLobLibLsLgbR
sLsbLsbLiLsbLsbLibLsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 124750; End: 125250;
Recording: 7-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bRsLsLsmbLgbLobLsbLsbRibLsRsLsbLibLgbLgLjbLiRsbRsLsLsmbLsLsLsLsLsmmmmb
LsbLsbLeLsLsmbLgbLobLgLsbLsLgLgbLsbLsbLiLsbLgbRsLsLsLsLsRsmmmbLibRebRi
bLsbRobLobLsbLsbLsLsLsLsLeLgmmmbLebLsbLibLsbRsbLgbRsbRsbLobRcbLsLsmbLi
bLsLsLsmmbLsbLsbLsbRgbLobLgbLibLibRsbLgbLcLsmbRgbRsRsmbRsRsmbLsRsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 1; Drug: Control Apo 0.5 然
bLsbRgbRhbLoRsbRsbRsbLibLobLcLsmbLoRsRsmbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 2; Drug: Control Apo 0.5 然
bLibLibRsbRcbLhbLoLsRgmbRibLsbLgbLibLibLcbRiRsLsmbRgLsbRgbLibLobRgbLcb
sbLgbRibRgbRgRsmbRgbRiRgbRsbLsbRsbRsRsmbRsbLsbRjbRobRhbRhRsmbRhbLsbRgb
RsbRgbRgLsbLgbLibRjLsbRgbLcbLibLcRsbLcbRibRsbRibRibRgbRiRsmbRsbRgbLsLj
bLcbLcbLcbLhbLibLibLgbLgLsbLcRsbRibLcbLcbRiLsbRgbRsbLcbLiRsbLgbLsbRsLs
bLibRjbRibLjbLgbLibLsRsLsbLcbLgbLhbLgbLgbLgbLsLjbLgbRjbLcbLcbLobRsbLhb
LgbLibLibLiLsbRiLsbLibLobRibRibLsbLgbRsbLsbRgbRgbRsbRcbRcbRcbRhbRcbLgb
RsbRsRsmbLsbLsbLgbLsbLjbLgbLhbRibRibRibRgRsmbRsbRsRsmbRgbRsbRcRsmbRcbL
ibRsbRgbLgbLibLgbLcbLhbLgbLgbRsbLibLcbRgRsmbLcbLiLsbLiRsbLgbLgbLgbLibL
cLsmbRibRibLgbRjbRibRcbRhbLgbRsbLjbLibLgbRibRsbLhbLibLgbRsbRgRsmbRibRg
bRcbRcbLjLsmbRgbRgbLjbLhLsbRgbLobRgbLibLhbLgbLsbRsbLgbLhbRjbRobLgbLjLs
mbLcbRgbLobRsbLcbLgbRsbLsbLgbLebRjbLcbRgbRsbLibLgbLsbLjLsLsmmbRgbRsbLs
bLcRsbLibRgbRsbLgbRsbLgLsbLibLibRsbLsLhbLhbLibRsbRibRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 3; Drug: Control Apo 0.5 然
bRsbLsLsLsmmbRgbRgRsRsmmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 4; Drug: Control Apo 0.5 然
bLsLsmbLsbRebRibRhbRgbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 5; Drug: Control Apo 0.5 然
bLoLsLsmmbLeLsLsLsLsmmmbLsLsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 6; Drug: Control Apo 0.5 然
bRjbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bRhbRoLsbRobRcbLhbLobRibLibRsbRgRsmbRibRibLcLsmbRiRsmbRoRsmbRhbLibRhbL
sbLiLsbRibRsbRibRibLhbRibRibLgbRibLsbRgbRgbRsbRgRibRibRsRsmbRsbRgbRgbL
jbRcbLjbRibLjLgbRcbRobRobRsbRibRjRsmbLjLsmbRcbLibLcLhbRoLsbRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bLgbRsRsmbLgbLsbLsbRjbLsbRsbRsbRsbRsbRgbRcbRsbLsbRsbRsbRsbLsbLoLsmbRcb
RhLsbsbLsbLsLsmbLobLsbRjbRebRsbLsbLsLsmbLgLsbLgbLgLsbRsRsmbRsLsbLibRsb
LoLsmbLsbLsRsbLsbLibLoRsRsmbRgRsLsmbRsbRiLsbLsbRsRsmbRsbRsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bLhbsbRsRsmbRgbRibLoRsbRsRgbRoLsbRibRhbRsbLiLsbLgbLiRsbLobLibLebLgbLib
LobLibLsbRcbLsbLgbRgbRgbRsRsmbRibRsRsmbRsbRgbLibLcbRobRcbRiLsbLibRsbRj
bsbRsbLiRsbRsbRoRsmbRcbLsbLsbRsbLsRsbLjbLsbRibRgbRibRsbLsbLgbLgbLsRsbR
sbLgLsbLibLobLgbRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bLsbRsbLsbLsLsmbRsbRsbRsbLsRsbsbLsbLsbsbLsLsmbLsbRsbsbLsLsmbsbLsbRsbLs
bLsRsbLsbLsbRsbLsbRsbsbRsbsbRsbsbRsRsmbRsLsbsbRsbLsbRsLsbLsbRsbRsbRsbs
bRsbLsbLsbLsbLsbLsbsbRsbRsRsmbRsbLsbRsbLsbRsbRsbRsbLsLsmbRsbRsbLsbRsbL
sbLsRsbRsbLsbLsbLsbRsbRsbRsbRsbRsRsmbLsbsbLsbsbLsbRsRsmbLsbRsbLsbRsbLs
bLsbLsbRsbLsbRsbRsbRsbRsbsbLsRsbLsbLsbsbsbsbLsbLsbLsbLsbRsbLsbLsbLsbLs
bLsbLsLsmbRsRsmbRsbRsbLsRsbRsbRsbLsRsbRsbRsbRsLsRsbLsRsbRsbLsbRsbLsbRs
LsbLsbLsbLsbRgbRcbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bRcRsRsmmbRebLeRgbLsRoRsmbLsbLiRsLsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bRobLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bsbLsRsbLgRsLsbLcbLiLsbLiLsbLobLgbLobRobRsbRibRibRebRobRhRsmbRebLibLib
LibLjbRsLsbRobRsRsmbRibLibRgbRsbRiRsmbLjbRibLobLsbRobRhbLhbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bRoLsbLgbLibRgbLobRobLobLcbLobRoRsRsmmbLobRsbRcLsbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsmbRsbRsRsmbRsbRsbLsRsbRsbRsRsmbLibLsbRebRgbLsLsmbLsbRsbRsbRsLsbLs
bLsLsmbLsbLgbLsbLsbLsbLsbRsLsbRsLsbLsLsLsmmbLsLgLsbLibRgbLsbLobRgbRgbR
sLsbLsbRsLsbLsLsmbLsbLiRsbRsbRsLsbLsbLsbLsLsmbLgbRsbLsbsbRsbLsbsbsbsbL
iLsbLibRsbRobRsbRsbRoRsmbRsbLobRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bRgbLgbLsbLsbLhbLsLibRobLgbRibRsbRgbLjbLjbLiRsbRsbLiLsRsbRibLjbLjbRgRs
mbRgbRibLgbRgbLgbRhbRgbLsbRjbRsLsbRjbRgbRsbRsbRibRibRgbRjbRsbRibLsbLsb
RiRsmbRgbLsbRebLgLsbLsLsmbRjRsRsmmbLsbRiRsLsmbLgbRibRsbRgbLgbRgbLcbLcb
LgbRjbLcbRjbLgbLgbRsbRcbRgbRgbRebLobLjbRibRgbRsbLibRibRsbRjbRsbLcbRobR
obLgbLiRsbRgbLiLsbRsbLiRsbLsbLibLsbLgLsbLsbRgbLobLcbRjbRgbLsLsmbRiRsLs
RsmbLsLsmbRiLsbRiRsmbRgbRjbLgbRgbRsbRgbRibLsbRjbRcbLgbRgbLgLsbLgbRgbRg
bRgRsmbLsbRibLgbRgRsmbRibLgbRiRsmbRsLsbRgbRgbRgbLsbRibLsbRgbRgbLgbRibR
gbRsRgbLsbRjbRibLjbRiRsmbRsLsRsbRgbRibRgbLsbRgLsbRgbRsRsRsmmbRsbRgbRjb
LcbRcbRobLgbRebLsbRibRsbRgbLgbRibLjbLgbLibRjbLgbLcbReRsRsmmbLebRiRsmbR
sRsmbRcbRiRsmbRibLcbRhRsmbLgbRibRiRsmbRibRibRgbRgRsmbLsbRgbRsRsmbRgLsb
Lsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bRiRsmbLsbLsbLsbLibLibLsbLgLsLsmbLsLsmbLgLsLsmbLsLsLsLsmmmbLsbLsLsmbLs
RsbLsLsmbLsbLeLsLsLsmmbLoLsmbLsLsmbLsbLsbLgLsbLgbLsLgbLsLsmbRsRsLsmbLs
LsmbLsbLsLsmbLsbLsLsmbLsbRsbLsLgRsbLsLsmbLsLsmbLsbLsLsmbRsLsbRsbLsbLsb
LsbsbLsbLsRsbLgbLebRcbRcRsRsmmbLoLsmbLsbLiLsbLsLgbLgLsLsmbLsbLsLgRsRsm
bLgbLsLsmbLgbLgLsbLsLsmbLsbLsLsmbLsLsmbLsbLsLsmbsbLsbLsLsmbLhbLcLsmbRs
bLsRsbsbRsRsmbLsbLsbRsbRsbRsRsmbRsbRsbLsbRgRsmbLebRgRsLsmbLsLsmbLiLsLs
RsmbLsbLsbLsbLsRsbLsLsmbRsLsbLsbLsLsLsmmbRsbLsRsLsbLsLsLsmmbsbLsLsmbsb
LsLsLsmmbLsLsLsLsmmmbLgLsLsmbLsLsRsmbLsLsLsmmbLgbLiLsbLsLsmbLsbsbLsbLs
LsLsmmbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bLebLobLoRsbLhRsbLobLhbRsbLsLsRsLsLsmmbLsbRiLsbLobLhbLsbRhbLcbRsbLsRsb
LgbLjbRsbLcbLoLsmbRibLobLobRgbLsLsmbLsbLsbRobLhbLibLibRsbLibLgbLibLgbR
sbLibLibLsLsmbLgbLsbLibLsbLcbLiRsLsbRebLjbLcbRsbLibsbLobRibLhbLibLsbLi
bRsbLgbLgbRsbLgbLibRsbLiLsbLgLsbLgbLgbLgbLgLsbLsbLobRobRgbLibLgbLgbLgb
LgbLgbRgbLhbLgbLsbLgbLsbLsbLsbRsbLgbLgbLiRsbRsbRobLoLsmbLgbLsbLjbRiLsb
LsbRsbRgbLobLcbLsbLgbLsbLiLsbsbLgbLgbLgLsbLgbLgbLibRsbLhLsbRgbLgbLibLi
bLsbLsbLsbRsbLsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bLebReRsmbsbRibRebRgbRebRcbRsbLjbLjbLgLibsbLsbsbLgbLibRjbLebLjbRobLjbL
cRsRsmbRgbLibRsbLcbLsRsbLiLsbRsbLsRsbRsRsRsmmbRsLsbRjbLsbLobRjbRsbLcLg
LgLsbLgRgbRsRsmbLsbLsbRoRsRsmmbLsbRsbLjbLgbRoLsbRsbRobRsbLgbRiRsmbRgbR
cbLsRgbLcLsmbLebLgbLebLgbRibRsbLjbRjbRoLgbLgbLsbsbLcbRgbRgbRcbRsbRgRsm
bRibRibRgbRsbRgbRgbRgRgRsRsmmbRibLibLsbRgbLsLsLeLsmbLsRsbLgbRgbRsRgbLe
bLgbRcbLsbRibLoLsmbLsLsLsLgmmbRibLibLcbRibLcbLibLgbRobLsLsLsLsLgmmmbLs
bLsbLibRsbRebLobRsRsRsmmbsbRibsbRiLsbRsbRsRgbRsRiRjbLgbLibLsbLibRgbRgL
sRsbRsRsRgmbRsbRsbRebRibRsRsmbRibRoLsbRjbReRsmbRobRiLsbReRsmbRibLsbRiR
smbRgRsmbRsbRhRsmbRsbReRgbLibLobLibRebLjbLebRgRsmbRgbRsbLobRebRebLsbLs
Lsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRebLcbLsbRjbRjbLhbLsbRgLibLiRsbLsbRgbRcbRebLobRiLibLsLsmbRsLsRsbLg
bRebRsbLsbLibLobRgRsmbLsbRhLsbRjbRsRsRgRsmmbLjbRibRgbRjbLebRgbLjRebLgb
LgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bLsbRsbRsRsRsmmbRsRsRsmmbRsRsRsmmbRgbLsRsbRebRebRoRsmbLsRsRsmbRsLsRsRs
mbRgbRobRebLhbLsRsRsRsmmbRsbLgbLsLsLsLsLsmmmmbLgbLsbLsLsmbRsLsbLgLsbRs
LsbLjLsmbLsRebRebRsLsRsLsbLsLsmbLgLsbRgbLsLsmbRgbLjLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRgbRsbLsRsbRiLsLsmbLibLsbLsbLgbLsbRebLjbLsbRsRsmbLsLsLsmmbLsLsLsmmbRs
LsbLgbLsbLsbLgbLsbRsbRsbLsbRsRsmbLsRsbRsbRsbLjbRsbRgbRsLsLgbRsLsbLgbRs
bLsLsRgmbRebRgLsbLsbLgbLjbRsbRsLsLsRsmbLgbRoLsbRsbRsRsmbLsbRsbRebRiLsR
sbLsbLgbLsLsLsLsmmmbRsLsbLgbLsLsLsmmbLgRsbLsLsmbRebLsbLgbLcbRibRsbRsRs
mbRebRebLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bLsbRgbLsRsbRgbLsLsLsmmbLoRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bLebLgbLsRsbRsbRjbLjbRibLsRsbLjbRsbRobRebRcbLsLsmbsbLgbRibRsbRsbRcLsRs
bRsRsmbLsbRgbRsbLibRsRsmbLsRsbRobLobRgbLgbRgbLsbLibRgbLgbRhbReRsmbLsbR
gbRibRsbLgbLgbRsbRobRgbLsRsbLibLjbRsbLsbRgbLobRsRgRgRsmbRsbRibRgRiRsmb
LsbLsbRgRsmbRjbLsbRjbLsbRsbRebReLgLsLgLgbRsbLsLsmbRcbRibLsbRhbRjbsbRsR
smbRibLsbLgbLibRiRsmbLsRsbLgLgbReRsmbRgbLgbLebLcbLiLsbLsbLjbLebLsLjbLj
bLgRsLgbLsbLsbsbLsbLibLiLsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 25; Drug: Control Apo 0.5 然
bRcbLsRsbLsbLsbLsbLjbLgbLgLsbLgbLsbLcbLgbLgbLgbLibLgbLobLsbLobLgbLhbLg
bLgbLsbRgbRgbRsbLjbLsbLibLibLsbLgbLgbLsbLsbLibLsbLjbRcbLsbLgbLgbLsbRib
LobLsbLiLsbLgbLgbLgbLgbLgLsbLsLsLsmmbLgbLibLsLsLsmmbRsLsbLgLsbLsbLsLgb
LsbLibLsbLgbLgLsbLibLsbLsbLibLsbLsbLsbLjbLsbLgbLgbLsbLibLjbLgbLsbLibLs
bLjbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 26; Drug: Control Apo 0.5 然
bLjRsbLgbLobLibRcbRoRsmbLsbLcbLibLgbLsbRsbLoRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 27; Drug: Control Apo 0.5 然
bRebRebLgbLobRobRsbLebLcbRebLebRcbLobLobRebRebRibLcbRobLcbRobRobLibRib
RgbLobRobRibRcbLgbRobLebLobRgbLcbLebLobRcbRobRobRobLcbLobLcbRobLobRobL
obRcbLgbRgbRobRobLibRcbLebRobLobRebRobLsbLobRhbRobLgbLobRobRhbLebRcbRs
bLobRcbLcbLcbRcbRobLobRobRebRebLcbLcbLebLobLcbRobLobRebRobLobLcbRobLeb
RobRebLebLgbRebRcbLebLobLebRobRcbLibLobLhbRcbLcbLobLebRgbLobRobLobRobL
hbRebRebRobLobRebRobRobLobLobLobLobLgbLobLcbRebLobRobRebRgbRobRobRgbLg
bLibRobLobRobRhbRebLebLebLcbLsbRobRcbRebLobLobLgbLsbLebLgbLibLebLebRhb
LebRgbLobLobRcbLebLgbLibRgbRobLobLcbRobLobRcbRibLobLsbLebRcbRibRobRebR
ibRibRcbRobRhbRcbRobRcbLcbRcbLsbRobLobLobLcbRobRebRcbRobRebRobRebRebLe
bRcbRobLcbLobLebLcbRibLobLobLcbLcbRobLobLobLobRobRhbLcbRobLobRsbRobRob
LobLebLobRobLobLobRcbRobLsbLcbRobRobLebRobRobRhbLgbRsbRibRebRebRcbRobR
ebRobRobRebRgbRcbRobRobLcbLgbRebRebRcbLobLobRebRebLgbRebRobLjbLibRobLo
bLebRcbRebRcbLibLebLobRebLobRobLgbRcbRcbLobLobRobRobLobLebLebLobLgbRcb
LgbRobLibRgbLcbLcbRcbRobLobLobLcbRebLobLebLjbRibRibRcbRobLcbLgbLobLhbR
ebRobRcbLobRebLobLcbRebRobRobRobLibLebRobRobLobRebRebRobRebRobLobRgbLi
bRobRgbLebRebRobLcbRobRebRobRebLibLobLcbRebRobRgbLobLsbLcbRcbRobLhbLeb
LebLobRobLsbLobRobRibLobRobLobLobLebRebRibRebLobLcbLebLcbRebLibRebRobL
ibLobLibRsbLgbRobRobRgbRcbLobLsbRcbLebLgbLobLobLobLobLobRebLobLobLobLi
bLobLebRgbLgbLgbLobLobRobLobRcbRebRobRobLgbLcbRgbLcbRobLebRobRebRebLsb
LcbRhbLobLobLobRobLgbRobRcbLobLobRgbRobRebRebLgbRcbRobRcbRobLgbLibRebR
obLcbRobRobLcbRcbRobLcbLebLebLobLcbLebLobRibRsbLobLebLobRgbLebRcbRcbLo
bRibRcbRebLobRcbRobLcbLibRobLebRobRobRobLhbRsbLebLebLsbLcbRobRobLcbLob
RobLobLgbLibRebRobRobLobLobLobLobLcbLcbLibRobRcbRhbRebRebRgbLebRebRibR
obLobRobLebLcbRibRebLebLhbRebRobRobRcbLhbLobLebLcbRobRobLobLobRibLsbRe
bRgbRgbLcbRgbLebRobLibLebLobRebRobRobRobRobLobLobRobLcbLebLibRebLgbRob
RebRobRsbRhbRobLobRobLsbLcbLebLgbRibLobLsbLcbRobLcbLebRebLebLhbRgbRobR
ebLcbRobLibLebLebRobLobLobLebRobRobRobLobRebRibRobLobRebLebRobRcbLcbRe
bLcbRhbLsbRobRebLobRebRebRebLcbLcbLebRobLcbRobRibRebRobLobRebLobRebLcb
LobRobLobRebRobLcbLobRobLcbRobLobRobRibRcbLebLobLobRcbRobLobRebLebRobL
obRibLcbLcbRebLgbRebRebLobRebRebRobLcbRibLebLgbRcbLobRobRobLobRcbRcbRo
bLcbRobRgbLsbLobRcbRebRebLcbLobLobRobLebLcbLebLcbLebLibRibLobRgbRebRob
RcbRobLsbRhbLgbRebLobLsbLobRcbRgbLobLebLcbLibLebLobLebRobRobLobLebRebR
cbRsbLgbLcbLobRobLobRcbRcbLibLibRcbLobLgbLcbRsbRobRsbLebLcbRobRibRebLe
bLobLebLobLibRcbLobLibLgbLobRebLgbRebLobRebLobRgbLobRcbRobLobRobRgbRob
RcbLhbLobLcbLobRobLcbRebLgbRebRobRobRobRebLobLebLobLsbLobRcbRsbRobLibL
ebLcbLobLobRobLebRebLobLebLobRobRobRebRobRobRebRobLobRibRibLcbRebRgbRc
bLobLsbRobRobLobLibLobLsbLgbLebLebRebRobRebLobRhbRobLibLobLebRobLebRcb
LebLobLebRcbRcbRobLebRobLcbRibLebLebRebLobRebRebRcbLcbLgbRobLebLsbLobR
gbRgbLobLobRebRebRobLebLhbLgbRcbRgbLobRibLsbLcbRebRibRebRebRobLobRibLs
bRobLebLebLcbRobLobRibRobRebRebLobLebLibRsbLebLcbLobLcbRobRebLsbRobLeb
RcbRobRebLobRcbRibRobRcbRjbRobRobRcbRebLobRobRibRebRobRcbLobRobRibRobL
ebRebLcbLcbRcbRebRobLobLebLob

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 28; Drug: Control Apo 0.5 然
bLsbRgbLsRsLsbLsLsmbRjbLebLsbLobRebLobLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 29; Drug: Control Apo 0.5 然
bLhb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 30; Drug: Control Apo 0.5 然
bLoLsmbRobLcbRjRsmbRcbLsLsmbRsbLjbLhbRhbRhbRibRgRsmbRjbRsRsmbRjbRjbRhR
smbLjbRoRsmbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bLsLsmbRibLsbLsbLcRsbLgLsbLgLsLsLsmmbLsbLgbLsbLgLsRsbRsRsmbLeRsbLsbLsb
LsbLsbRsRsmbLsbRibLsbLgbLcbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bsbsbLobRcbRsbLsRsbLsbLsLsLgmbLgbLibLsbLsbLgbRsbLgbLsbLsbRsbLgbLsbLsLs
mbLgbLgbLcbRsbRgbLibLcbRsbLiLsbLsLsmbLsbLsbLsbRsRsmbLgLsbRsRsmbLsbLibR
sbLsbRsbLgLsbLsbLiLsbLsbRsbLgbLsLsmbRsbsbLsLsmbLibRsbLsbLjbLsbRsbLsLsm
bLsLsmbRsbLibLcbRgRsmbRgRsmbRgbsbRsbLcLsmbLiLsbRjbLsbLgbLibLsbLhbLgbLc
b

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRsbRsbRsRsmbRgbRgbRsbRibRsbRibRibRgRsmbRsbRibRsbRibRibRibLsbRibRgb
RgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bLsbRjbLsbsbsbRsbsbsbLsbsbsbsbsbsbsbsbLsbsbsbsbLsbLsbsbsbsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bLgbLgbLibLcbRjbRjbLgRsbRiRsmbLsbRgRsmbRsbRsbRsbRibRgbLgbLsbLiRhbRsbRj
RsmbRcbRsbLsbLsbRoRsmbRgRsmbRgRsmbLsLsLsmmbLsRsbRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bLsRgbRsbLgRsbRsbRobRsbRibRcbLoLsmbRoRsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bLgbRsbLgbRsbLgLsLsmbLsbLsLsmbLsLsmbLcbLsbRsRsmbLjbLibLebLcLsRsmbRsbLs
bRsbLsbRsbRgbLsbRgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bLcLsmbLsLsLsmmbRibLsbLebLsbLsLobLobLsbRgRsmbLibLsbRgbRsbRsRsmbRsbLgbR
eRsmbLgbRgLsRsbRsbRsLsRsRsmbLsLsmbRsRsmbRsbRsRsRsmmbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bRibRsbRgbLibLjbRjRgbLgbRjbRjRsmbLgLsbLibLibLibLsbLgbLibRjbRsbLibLibRc
bLiLsbLibRobLibRcbRgbRibLgbRgRsmbRoLsLsLiRsmbLgbLibLsbLgbRobRobLibRcbR
gbLibRhRsmbLibLsLibRibRgbLibLibRsbLsbLgbRibLiLsbLsbLgbRjbLibLibLgbLsRs
bRgbLsLibRsbLgbLsbLgbLgbLhbRcbLibLiRsbRgbLgLsLsLsmmbLsbRobLjbLoRsbRjRj
RsmbRhbLiLsbLibRsbLibRcbRgRsmbLcbLsbRcbRgbRoRsmbLjbLobRibLgbRjbRobLibR
obRibRibLjbLsbRgbLibRcbRobLibRobLjLsmbRjRsmbLibLibRibRibRsRsmbRsbRsbLs
bRgbRgbLgbRsbRibLsLsLsmmbRgbRgRsmbLsbRsbRibLiRsbRgRsmbRhbRibRcRsmbRgbR
ob

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bLobLebLsbRsbRcbLibRcbRsRsRsmmbRsbRsbsbRsRsmbRsbRibRsbRsbRgRsRsmmbLsbL
sbLsbRsRgbLsbRsbRsbRsLsbLsRsbLsbRsbRsbRsbRsbRsbRsbRsbRsbsbRsbLgbRsRsmb
RsbLsRsbRgbRsbRgbRsRsmbLsbLsbsbLobLcbLibLibLsLsmbLgbRoRsmbLsbRsRsmbLsb
LiLsbLsbRsbLsRsbLsbRsbRsbRsbRsbsbsbLsbsbLsbLsRsbRsbLsbLsRsbRgbLsbLsbRs
LsbLsbRsbRsbRsbRsbLsRsbRsbLsRsbRsRsmbRsLsbLsbLsbsbRsbLsbLsbRsRsRsmmbLs
bLsRsbRsLsbRsbLsbRsbRsRsmbRgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bRsLsbRoLsbLsbLobLcRsbRiLgbLsbLobRsLsLsLsmmbRsRsmbLsbsbsbLgLsbLsLsmbLs
LsmbLgbRsbLsbRsbLsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsmbRobsbLibRgbRsbLobLsbRsLsLsmbLibLgbsbLsbLsbRsbLsbRgbRgbLsbsbRgbL
sbLgRsbLibRsbLgbLiRsbLsbRiRsRsmmbRsbRsbRjbsbsbRsbsbRsbRsbRsbsbRsRgbRsb
RsbRsbRgbLsbLsbsbsbRgRsmbLsbRsbLsbLsbLsLsmbRebRobRgbRcRsmbLjbRcRsmbRsb
sbRsbLsbRsbsbsbRgbLsbLsbsbLsbRsbRgbRsRsmbRgLsbRsRsmbRsbRgbRsRsmbRiRsmb
RiRsmbsbRsRsmbLgbRoLsbRibLobLgLsbRibLcbRgbLibLibLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bLgbLeLsbRsRhbRsLsbRibRsbRebLgbLsRsRsmbLobLobRsLsbRgbLgbLobRcLsbRgLsRs
LsbLhbRsbRsLgbLjbRibLjbLebLsbLebRobLibRgbRsbRsRsRsmmbRsbLsRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bLgLsbLgbRsbLgbLsLgbLsLsLsRsmmbLgbLsbLsbLibLgbRoRhRsmbRgbLsbsbsbsbRsbL
sRsbRsbRsRgbsbRsbRsbLobsbLebLobRsbLsbLsbLsbRsbLsbLsLsmbLsbLsbLsbRsbRjb
RsbRgbRgbLgbLsRsRsmbRsRsLsmbRsLsbRsbRobLgRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbLsbLsbRsLsbLsbLsRsbRsbLobLsLsmbLsbLgbLsbLgRsRsmbLsLsmbLsbLsLsmb
LsLsLsmmbLgbLiRgLjbLsLsmbLgbLsbLgbRgbRobLobLsRsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bRgbRsLsRsRsmbRsbRsLobLibRobLsbLebLsRsbLsbLsLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLibRcRhbRsRsmbsbRgRsRsmmbLgbRoLsbLcLsmbRsRsRembLsRsRsmbLhLsbLsLsLgmbL
sLsLsLsmmmbLgbLobLgbLgbLgbLgbLsbLsLsLsLsLgmmmbRsLgbLgbLgbLgLsbLsbLeLiL
sbRsRsmbLobRgbRsbLgbLgbLsbRsLiLgLsLsLsmmbLebLsbLjLsmbLsbLsLebLebRebRsb
LgbLgbLgbRsbLsLsmbLobLsbLsbRjbLgRsbRsbsbRsbsbLsbRsbsbsbLebLsLsmbLsLsmb
LsbLgbLebRsbRsRsmbLibRobRebRgLsbRjbRsRsmbRiRsmbRgbRsbRibRibRsRsmbRsLsb
LsbLgbLobLjbRobLsRsLsbRgbRsbRgbRsRhRgLsbRgbLgbRiRsLsmbRsRsLsmbLgLgbRgb
sbRgRgbRgRsmbRibRebLobLgbLsbLgLsLsmbLibRsbLiLibRsLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125252; End: 125752;
Recording: 8-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bRjbRebLsbLiLibLjLsmbLsLsLsLgLsmmbRoRsmbLsbLibRjbRgbLobLjbRsbLibLjbRcb
LjbLcbLgLsbLsbLsbLgbRsbsbRhbRgbLobLsbLsRsbLjbRsbLibLebLgbLjLgbRebLsbRg
bLgLsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 1; Drug: Control Apo 0.5 然
bLhbLgbLobRgbRsbRsRsmbRgbLobLobLsRsbRsbLobLiRsbRsbLsbLobRsbRsbLobRsbRi
bLsbLsbRcbRsbRsbRiLsbLgbLhRsRsmbRiLsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 2; Drug: Control Apo 0.5 然
bRibRgbRsbRgbRibRgbRgRsmbRsbRsbRsbLjLsmbRcbLcbRgbRcbRobRibRsbRjbRobsbR
obRobReRsmbRibRgbRsbLsRsbRgbRsbLsbRgbRsbRsbRsRsmbRibLsLsmbRgbRcbRhbRhR
smbRcbLgbRcbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 3; Drug: Control Apo 0.5 然
bRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 4; Drug: Control Apo 0.5 然
bRsbRsbLsbRgbLgbLsbLsbRibLgRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 5; Drug: Control Apo 0.5 然
bRsbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 6; Drug: Control Apo 0.5 然
bRobRsbLsbLgLsbLsbRsbRhbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bRhbLibRibLobRiRsmbLiLsbRibLibRobLcLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bLsbLsbLsLsmbLsbLsbLobRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRsRsmbRsRsmbRibRsRsmbRsbRsbRgbRgRsRsmmbRsbRsbRgbRsRsmbRsbRgRsmbRsb
RsbRgbRsRsRsmmbRgbRobRgbLsRsbLibLhRsbRhRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bRsbLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bRgRgRsRsmmbLibLibLebLobLibLsbLiRgbLeRsbLibLgbsbRcRsmbLiRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bRibLibRgbLcRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bRsRgbLsbLgRsbRibsbsbRsbLsbsbsbsbRsbLhbLjbLsbLjbRsRsmbLibLgbLgbLsbLsbL
gbLgbLgbLgbLiRsbRibLebLhbLibsbLibLgbLgLsbLgbLgLsbLgLsbLiLsbLsbLibRib

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bLgbLiRsbRcbRcbRcbRobRibRgbRebRsbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bLsbRsbRcbRsRsmbRiRsmbRgbRsRsmbRsbRsbRgRsmbRsRsRsmmbRiRsmbRsbRsLsbRsbL
gbRgbRebLsbLsbRsbRsRsmbRsbRsbRsRsmbReRsmbRsbRsbRsRsRsmmbRobRsbRsbRgbRs
RsmbLsbLcbLibRsbRsRsmbLsbRsbLobRsbLsbRsRsmbRsbRsbLcRsbLibLcbLobLsbRsLs
bLcbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bRibLsbRiRsmbRsbLsbRibLgbRgbRgbLsbRibLsbRibLsbRgbRsbRgbLsbRibLgRsbLobL
ibRcLsbLsbLgbLsbLsbLibRsbRsbRgRsmbRsbRiLsbLgbRibRgRsmbLsbRibLgbRgbRibR
sbRibLsbRibRsbRgLsbRibLgbRiLsbRgbRgbRsbRibLsbRibLgLsbRibRgRsmbRgbRgbRg
bRgRsmbLgbRibRsbRgbRgbRgbLsbRibLibRibRibRgbRsbRgbRsbRibLgLsbRgRsmbRibR
ibLgbRgbRibRgbLsbRiRsmbRgbRgbRiLsbLsbRibRsbRibRgbRsbLsRsbRibLsbRgbLsbR
ibRiRsmbLebsbLsbRsbRibLsbRgbRgbRibRgbLgbRibRsbRiRsmbRsbRgbLgbLsbLcbLgb
LgbLgbLgbRgbRjbRcbLibRhRsmbRibLobLobRgRsmbRgbLjbRiLsbLgbRsRibRsbRibRgb
RgLsbLgbRsbRhLsbLgbRibRgbRgbRibLsLsmbRgbRibRsRsmbRibRgbRgbRcbRgbRgbLsb
LiLsbLcRsbRgbLibRhbRcRsmbRgbLgbRibRgbRgbRgbRsRsRsmmbRhbLebRibRibLgbRcb
LgbRhbLibRibLsbRibRiRsmbLgbRsRsmbRiRsmbLgbRsbRiRsRsmmbRgbRsbRgRsmbLcbR
ibRgbLgbRiRsmbLgLsbRibLsLsmbRibLibRhbLoRsbRibRsbRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bsbLsLsmbLsbRsLsbRsLsLsmbLsLsLsmmbsbRsbLsLsLsmmbLsbLsLsmbsbLsLsmbLsbLg
bLsbRsLsLsmbLsLsRsmbLsbLsbRsLsbLsLsmbsbRsbLsbRsbLsLsLsLsmmmbLsLsmbLsbL
sLsmbLsRsbLgbLsLsLsLsLsmmmmbLsLsmbLsbLsbsbLgbLsbRsLsbLsbLsbLsLsRsmbLsL
smbsbLsbLsLsmbLsbLsLsmbLsbLsbRsLsbLgbLgLsLsmbLgbLhLsRsLsbLiRsbLgLsbLib
LhbLsbLsbLsbLiLsLsRsmbLsbsbLsbLsLsLsmmbLsbLsbLsLsmbLsbLsbLsLsLsmmbLsbL
sLsmbLsLsmbLsbLsbLsLsmbLsbLsbLsbLsbLsbLsbLsLsmbLsLsmbLgbLgbRsLsLsLsmmb
sbLsLsLsmmbLsLsmbRsLsRsbRsLsRsLsbLsbLgbLsbLsbLsbLsbRsbsbLsLsmbsbLsRsbL
sbLsbLsLsmbLgLsbLgLsbLsbLgbLgbLgbsbLsLsmbsbLsbLsbsbLsbLsRsbLsLsmbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bRgLsbLsbLiLsbLibRgbLibLibRsbLibLgRsbLsbLibLsRsbLiLsLsmbLsbLgbLsLgbLiL
sbLgbLgLsbLsLsmbLgbRsLsbLgbLsbLsLsRsmbRibRoLsbLhLsbRgbRobRjbLiLsbLiLsb
RsbLibRsbLibRsbLibLgbLgbLgbLsLsmbLgbLgLsLsmbLsbLsbRebRebLsbLebLebRibLi
bRobRobLgbLcLsmbLgbRgRsmbLhbLibRsbLobRsbLgbLibLsbLgLsbLgbLhRsbRgbLgbRo
bRsbLibLcbLsbRsbLibRgRsmbLhbRgbLgbLibLgbLibLsbLgbLgbLibRgbRgbRiLsbRiLs
bLjbRiRsmbLobRoLsRsbLjbRgbLobLcbRgbLhbLsbLebLobRgbRgbLgbRgbLjbLobRibLe
bsbLsRsbRjbRsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bRibLebRebLsbRsLibLhbRobRsbLgbLcbRsbRibRebLcLsmbLsRibRgbRsbLgbLsLsmbLi
bRobRibRsRsmbRgbRibRjLgLsbLgbLibLebRsRibReRsmbLibRjbRebLsbLibLgLsbLibR
gbRjRgbLjLsmbLibRgbLsbLsbsbRsbsbsbLcbRgbLibRibLebLsbRsbRsRsmbRebRibLob
LgbLgbRebLebLcbRgbLsbRgbRsbRsbRgbLibRjbLebLcbLeRsbRgRsmbRgbRsbLsbLobRi
RsmbLibRcRsmbLebLgbRiRsRiRsmmbRsRibLjbRibLjbLobRsRsmbRhLoLsmbLsbLebRgb
RsRoRsmbLgLsbsbLebRjbLeLsbRjbRebLgbLiLgbLsbRgRsLsLsmmbLjbLsbRsbLsbLsbR
sbLsbLsbLsbLgbLeRsRsmbsbLjbRsbRsRsmbRibLgbRibRsbLcbRsbLsbLhbLjbRibLib

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bRjbRjbRgbLgbRebRgRsmbLhbLibRsbRibLgbLebLsbRjRsmbLgRsbLobsbRibRsbLiRsb
RibLsRgbLgbLobLsbLjbLsbLsbRcRebLjbRebLebLsbLebLsbRsbLjbLjbRibLobLobLib
Rib

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bLgLsbLgbLsbLcbRjbRsLsLsLsmmbLsLsmbLsbLgbLsLsRsmbRsbRsRsmbRjbRsbLibLsb
LsRsbLsbLgbLsbRgLsLgbLgbRjLsbLsLgRsbLgbRsbLsbLsbsbLsbRsbLgbRsLsbRsbLsb
RobRsbRsbRsbLsbRsbRsbRsbRsbLobRsRsmbLeLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bLsLsLsmmbRsbLcLsmbLebLgLsbLsLsmbLgbsbsbRsLsbRibLcbRsbRebRibRsLsbLgbLs
LsmbLsbLsbRgLsbLsRsbRsbRsbLsbLsRsRsmbLeRsRsmbRebRcbRsbRjbLobRgbRsbLcbR
ibsbRsbRsbRjbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bRgbLsbLgbLsbRsbLcbRsbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLhRsbRsbRgbRsLjbsbRibRhRsmbLsbRebLsbLjbLgLsLsLcmbLjbLsbRsbRsbRibRg
RsmbLsbRsbLgbLgbRibRsbLoLsLsRgLsmmbLjbLjbRsbLcbLebRjbRibRsbRjbLsbLebRe
RsmbRsbLsRsbLsbRgbRebLsbLjbLsbRiLsbLcbRibRibRjbLsbRsbLcbLobLgbRsbLcbRs
bRsbReRgRsmbLjbRgbLibLgbRebRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 25; Drug: Control Apo 0.5 然
bRibLsRsbLsbLsbLcbLgLsbLsLsmbLgbLgbLjbLgbRibLsLsmbLsLsmbLhbRcbRsLsbLib
LsbRhbRsbLhbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 26; Drug: Control Apo 0.5 然
bLsbsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 27; Drug: Control Apo 0.5 然
bLsbLsbRsRsmbRsLsbLsbsbsbsbsbLsbsbsbLsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsb
sbsbsbsbLsbsbsbsbsbsbsbLsbRsbsbRsbLsRsbsbsbLsLsmbsbsbsbRsbRsbLsRsbsbLs
bLsbsbsbLsLsmbRsRsmbsbsbsbsbLsbRsLsbsbRsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 28; Drug: Control Apo 0.5 然
bRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 29; Drug: Control Apo 0.5 然
bRgbRcbLhbLsbLibRgbRoLsbLsbLjbRcRsmbLsbLcLsmbRjbRcbRobLibsbRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 30; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bRsLsbLsLsmbLsLsLsRsmmbLsbLgbLsLsRsmbLgRsbLsbLgbLsbLibLgbLjLgLsbLsLsmb
LsbLsbLsLsmbLsbLibLgLsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLcbRgbRgbLsLsLsmmbRibRsbRoLsbRcbRobLcLsmbLhbLobLgbLsRsLsbLsbLsbLgbLsb
LgbLsbLibRsRsmbRsLsbRhbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bRcbLoRsbLcbRibLjbRgbRsbLgbLhbRgRsmbLobRjRsRimbRsLsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bRgbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRhbLsbLjbLiLsbRsbRsLoRsRsLsmbRgbRibLsbLsbRsRsmbRsRgbRgRsmbLsbRgRsm
bRhbLsbRsRsmbRsbRgbRsbRsLsbRibRgbRsbLgbLcLsmbLgbRgRsmbRsbRsbLgbRgbLgbL
sbLsbsbRgRsmbLsbLsbLsLob

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bLsbRsRsmbLsRsbLsbRsbLsLsmbLsbRsbRsRsmbLsLsLsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bReRsLoLsLsmmmbRsRsmbsbsbLsLsLsmmbLsbRibLsLgbReLsbReRgLsbRebRgbRebLjbL
jbRsbReb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bRobRobLsLsLsLsmmmbRhbLibRgbLsbLibLibRsbRjbRiRsmbLjbLhbRobRcbLhbRobRhb
LgLsbRebRsbLsLsmbLsbLsLgbLgLsbRobRcbLhbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bRgbRsbRsRsmbRsbRsbRsbLsbLsRsbRsbRsbRsbRsbLsRsbLsbLsbRsRsmbRsbLsLsmbRs
bRsbRsRsmbRsbRsbRsbsbLsRsbRsRsmbLsbLsbRsRsmbRsRsmbLsbRsRsmbRsLsbLsbRsb
RsRsmbLsLsmbRsbRsbLsRsbRsbLsbLsLsmbRsbRsbRsLsbRsbRsbRsbLsLsmbLsRsbRsbs
bRsbRsbRsbRsbLsLsmbLsbRsbLsbRsbRsRsmbRsRsmbRsbRsbLsRsbRsRsmbLsbRsbRsbR
sbRsRsmbRsbRsbRsbLsbRsbLsbsbRgbRsRsmbLsbLsbLsbRsbRsRsmbRsRsRsmmbRsbRsb
sbLsbLsbRsbRsbRsLsbRibRibRcRsmbLsbRobRsbRibRhbRibLsbLobRsbLsbLsbLsbRsR
smbLsbLsbLibRiRsLsmbRgbRgbRsbLsbLsbRgbRcRsmbRibRsRsmbLsbLsbRsbRsbRsbRh
bRsRsRsmmbLsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsLsLsmmmbLgLsbLgbLiLsbLsLgbRibRiLsbsbRsbsbsbsbsbLgLsLsmbLgbLsbLebR
gbLibLebLebRsbLeRsbsbRsbLsRsbsbRsbLsbsbsbsbLsbLsRsbRsbLsbRsLsbRsbRcbLs
bLsbLibLjbLcLsmbRibRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLsbsbLgbLsbRsRsmbRsRsmbLsbRsLsbRsRsmbsbRsbRsbLsbLsbLsbsbRgRsRsLsmm
bLibsbRcbRsRsmbsbsbsbLsbRoLsbLsLgLsbRebLoRsbRsRsmbLsbLgbLgbsbLsbLsbLsL
smbRsbsbLibRsRsmbLsLgbsbsbLsLsmbLsRsbRsbsbsbsbRsbRsbRgbLgbLjbLsbLsbRsb
RobRgbLsLsmbLibLsbLsbLsbLsbLsbLsbLsLsmbLgbRgbLcbRibLibLobRsbLsRibLsLsm
bRsbLsLsmbLsbLsbLsRsbRsbRsRsRsmmbLsbsbsbsbRsRsmbLsbLsbLsbsbLsbLsbsbRsb
sbRsbLsbLsbRgLsbLsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bLgbLebLibRiRsmbRgbRjbRjRsRsmmbLsbRgbLgLsbLsLsLsLsLsmmmmbRiLsLsmbLjRgb
LcbLobRsLsbRiRsmbRgbRsRsRsRsRsRsmmmmmbRebRsbLsbLsbRsbRiRsmbRsbRjbLebLo
bRobLeRsRsmbRsbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bRsLsLsLsmmbLgLsLgbsbRsLsbLsbLsbLobLsLgbLgbLgLgbLsbRsbLgbRsbRsbLsbLsbR
sbRsbLsbLgbRgbLsbRsLsbLsLsmbLsbLsbLsbLsRsbLsLsmbLsLsmbLgbRcbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bRsRsmbRsbRsbRobRsLjbRsbRsbLsbLsRsRjRsmbLsbRsbLsbLsbLsbLsbRsbLsbLsbRgb
RsbLsbLgLsRjbRjbLcbRsRsRsRsmmmbRsRsmbRsbRsbRsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbLgLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLgbRibLcbLibLsLsmbLsLgLsbLhLsLsLgmbLgbLiRobLsLsmbLsbRibRsLjbRobRgLsbL
gbLsbRgbRgbRsbRsbRsbRebRsbLsbRgbRsbLhbRsbRgRsmbRgbRhRsRsRsmmmbLsbLsbRo
RsmbsbsbRibRiRgRsmbRsRsRsRsRsmmmmbRgbLsbLjbRsbLsLsLimbLgRebLsLsmbLgbRs
bRhbLobLcbRsbRgbRsbRgRgRgbRcbRsLsbRibLgbRibRgbLsRsbLiRsLsbLsbLibLiLsLs
RsmbLsbLsbLsLsmbRsbsbRsbLsbRsbLibLgbRsLsbRsbRsLsbRgbLgLsLsLsmmbRsbsbLs
bRsRsmbLhbRsbLsbLgbLgbLebRsbLsbRsRgbReRsmbRsLsbLibLebLiLsbLsRsRsmbReRs
mbRsbRhbLcbRsbRibRsbLsbLsLsLsRsRsmmmbLsRsbRsbsbRsbsbLsLsLsmmbsbLgbRsbL
sRgbsbRgbRsLsbRsRsmbLsLsmbRebLcLsLsmmbsbRsbLsLsRsmbRsbRiLsbRsbLsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 125754; End: 130254;
Recording: 9-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLibLsbRjbLcbLgLgLsbLsLsLsmmbLibLhLsbRobLsbsbLsLsmbRsRsmbLsbLsbLeLs
bLobLsLsmbLobRgRsmbLsRsbLsLsmbLcLgbLsLsmbLeLgbReRsmbLiLsLsmbLgbLsRsbRj
bRsbLcbLibLgLgLiLgbLjbLgbLoLsmbLibLsbLsbLgRsbRsLsLsmbLsbLsLsLgmbRobLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 1; Drug: Control Apo 0.5 然
bRcbLibLsbRsbLsbRgbRsRsmbRsbRgLsbRsRsmbLcRsbLhbLobRgLsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 2; Drug: Control Apo 0.5 然
bRcbLcbRibRgbRcbRiLsRsbRsbRibRibLjbLcbRobRsRibRgRsRsmmbRsRsmbRgbRsbRsb
LsbRgbLibLsbLgRsbRsbRsRsmbLgbLibLcbLibLibRgbRibRsbRsRsmbRcbRibRgbRgbRh
bRsRsmbLhbRgbRebRsbLgbLcbLobLgbLsbRibRibRsbRibRsbRgRsmbLsRsbRgbLjbLgbL
sRsbLibLgbLcbLibLiLsbLcbLibLobLgbRsbLjbLibLibLibLcbRsbLibRibRiLsbRsbLs
bRcbRibRibRsbRsbLgbLgbLgLsbRsbLgbsbLcbLgbLibLgbRgbLgbRsbRgbRiRsmbLjbLj
bLjLsmbLgbLgbLsbLsbRsbLgbLgbRsRsmbLsRsbLgLsbLgbLgbLjbLiRsbLibRgbRsbRsb
LobLcbRibRgbRgbLgbRgbRsbRibRgRsmbRsbRsbRhRsmbLgbRobRibRgbRgRsmbLcbRgbR
hbRhLsbLsbLgbRhbLsbRcbRibRgbRsbLsRsbRsbLgbLcbLibLibRsbLibLibRibRibRsRs
mbRsbRcLsbLgLsbLibLsbRibRgRsmbLsbRgbRsRsmbRsLsbRgbsbLsLsmbRsbRgbRsbRgb
RsbRsbLsRibsbLsbRgbRsRsmbsbRgbRibRcbRcbLcbRgbRcbRhbRsbRibLcbLhb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 3; Drug: Control Apo 0.5 然
bRsbRsbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 4; Drug: Control Apo 0.5 然
bsbLsLsRsmbLsLsmbLgbLgbLgbRjRsmbRcbLsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 5; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 6; Drug: Control Apo 0.5 然
bRsbRoLsLsLsmmbRsbLibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bLebRobLiRsbRobRcbLibRobLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bRgbRsRsmbRsbRsbRsRsmbLsLsmbRsbRsbRgbRsbRibLsLsRsmbLgLsRsbLhbLsbLsLsRs
mb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bLsbLsLsmbLsbLsbLjRsbRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bLjbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bLebLcbLebLgbLibLobLcLsmbRgbRhRsmbLhbLhRsbLhRsbRjbLgLebRsbRsLsbLiRsbLe
LsbLhbLgbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bLjbRobLcRsRsmbLiRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bRgbLhRsbRgbLcbLibLiRsbLgLsbLsbLgbLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bLhbRcbRibLobRebRobRhbRebLsbLobLibRebRebLcbRebLobRcbLobLobRcbRebLebLob
RebLobLebLsbRobLcbLcbLibLobRgbRebLsbRebLobRgbLsbLobRobLobLobLebRebLobL
cbRobRobLhbRobLsbRgbRobLcbLobLebLcbRcbRebLgbLjbRobLcbLebRobRcbLjbLibLo
bLobLgbLebLcbLobRebRebRcbRebLobRebLobRibLobRobRcbLobLobLcbLobLebRobReb
LebLsbRebLobLcbLobRobRebLobRobRsbRobRebRjbLibLobRobRobLobLibRibLobLibL
ibLobRgbRebLobRebRebRebRobLibLobLebLcbRobLibLobRebLjbRgbLebRebLebRhbLo
bRobLibLjbRobLebRsbRobRobRebLobRobLobLcbLebRibRcbRobLobRobRcbLgbRcbRob
RgbRobRobRobLebRobLobRobLobLobLobLhbLgbRobRgbLobRgbRhbLibRobRgbRcbLibL
obLobRcbLcbRobLibRobRebRobRobRebLebLebLobLobRobRobRebLobLcbLebRcbLsbRe
bLobLgbLobLobLebRcbLobRobLcbRibRcbLcbRebLgbRobRebRobRebRibRebLobLgbLeb
RobLhbLjbLjbRebRebRebLsbLgbLobRibRgbLobRhbLobLobRibLcbLcbRebRibRibRcbL
ebLcbRgbLobLcbRebRjbRibRobRcbLobRobLgbLgbRebRebRobLobRebLcbLebLebRobLi
bRobLobRsbRebRibRebRebRsbLcbLebRcbLobRjbRsbRobRgbRobLibLibLcbRobLobLeb
LobRjbRibRebRcbRobRebLobRobLobRibRebLobLobRibLsbLcbLobLobLibLgbLebRibR
obRcbRibRobLobRcbRobLsbRebLibLgbLobRgbRjbLcbLobLibRobRobRcbLobLcbRebRi
bRcbRobLobLobLobLobRobRsbRebRobRgbRobLgbRsbLsbRobRobRobRobLebLibLebLob
RhbRhbRobRcbLobRebRobRobRobRobLobRobRobLobLsbLobLobLobLobRcbRebLebLsbR
ebRebLebLobLcbLobRobRobLgbLgbRobRobRebRobLgbLobRcbLcbLebLcbLibLobLobLo
bLobRobRebLcbLcbLobRobRcbLebLobLobRobLgbRcbLobLobLobRibLebRebLcbRobLob
RcbLobLobLobRobRgbRebRcbRibLobRobLebLobRcbRobRibLobRebRcbLobRobLobLgbL
ebRgbRibLobRibLgbRebRobRobRibLobLobRobLhbRebRgbRibRobLgbLobLebLebLobLg
bRgbRobRobLgbLebRobLobRcbLobLcbRobRobRgbLcbLcbLobLobRibRibLebLebLebLcb
RebLobRobLobLobLobLobRebRobLibLcbLgbRobLcbLcbLibLibLcbLobLebLcbLobRobR
obLgbLobLsbRsbLebLcbLcbLcbLobRobRobLebRgbLobRcbLgbRobRobRcbRobLebRobLc
bLobLibLgbLcbLcbLcbRebRhbRobRgbLcbRsbLgbLobRobRebLcbLcbLcbLobLebLcbRob
RebRgbRebRgbLobRobRebRibLobRobRebRobLcbRobLobLebLobRibLobLobRobLobRebL
obLobLibLobRcbRebRcbLobRobRjbLobRjbLobLobLobRjbRebRobLobRjbRcbLcbLebLe
bLjbLcbLsbRobRobLobRcbRsbRebLsbLjbLjbRebLcbLobRebLjbRcbRobRebLebLobLob
LobLsbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bLsbsbsbLsLsmbLibLsbLsbLgbLsbLsbLsbLsbLsbLsbLhbReRsmbRgbRsRsmbRsbRsRsm
bRsbsbRgbRsbRsbRsbRsRsmbRsbRgRsmbRgbLsbRsRsLsmbRsbRsbRsRsmbLsbRsbRsbRs
bLsRsbRsbRsbRsRsRsLsmmbLsbLsbLsLsmbsbsbRsbsbsbRsbLsRsRsmbLsbRiRsmbLcbR
hbLsbLebLibLgbLcLsmbLibRebLgbLsbRsbLsbLsbLsbLsbLsLsmbLgLsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbsbsbsbRsLsbRsbsbsbRsbsbsbRibRgRsmbRsbLsLsmbRebLebRjbLgRsbRibLoL
smbRsbLsbRsbLeRsbLgLsLsmbRobRsbRsbRibRsRsmbRsbRibLjbLcbLsbLgbLiRsbRgbR
sbLibLsbLiRsbRibLibRjbLgbLobLebLibLgRsbLsLsmbLgbLibLcLsLsLsmmmbRgbRsbL
gbLjbLebLsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsmbLsbLsLsmbLsLgLsLsmbLiLsLsmbLoRsbLibRcbRsbsbRsRsmbRsRsmbRsbRsRsm
bRsRsmbLsbsbRsbLsRsbRsLsbRsRsmbLsbLsRsRsRsmmbLsLsmbRsRsmbRsbLsbLsRsbRs
bRgbRsbRsbRsRsmbLsRsbRsLsLsRsmbRsbsbRsbLsLsmbsbRsbRsbRsbRsRsmbLsRsRsmb
RsbLsRsbLsbRsbLsRsbRsRsmbLsbLsLsmbLsbRsbLsRsbRsRsmbLsLsmbRsbRsRsmbRsbL
sbLsLsmbReLsLsmbRsLsLsRsmbLsbLsbLsLsLsLsmmmbLsLsmbLsbRsbLsbRsbLsLsmbLs
LsmbLgbLsLsLsRsmmbLsLsmbLsLsLsmmbLgbLsLsmbLsbLsLsmbLibRgbRobRsRiRsmbRi
RsRsmmbLsbRsRsmbLsbLsbRsbRsbRsbRsRsRsmmbRsbRsRsmbRsRsLsmbRsRsmbRsbRsRs
mbRsbRsbRsbRsRsmbRsLsbLsRsRsmbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bLsbRsbLsbLsbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bRoLsbRsbRgbRsRsmbRsRsmbLsbLsbsbRjbRibLebRsbRsbRebLsRsbLobLiLsLgbRhbRh
LsbsbLibRgbRibLhbRcbLsbRsbLgbLcLsLsLsmmmbLsLsmbLgbLobRibRjbRibLsbsbLgL
sbRobRsbLsbRjbRgbRgbRibLsbLgLsbsbRsRsmbRcbLsRsRsLjmbRgbLjbLebRoRsmbRiR
smbLsLsLsRcmmbRibLgbRibLebRcbRobRsbLjLgLsbLgbRjbLibRebLebLebRgLsLgbLiL
gRsbLebsbLibLebLsbLsRcbRjbLsbRgbLsbRgbLiLsbLsbLsRsbLsLjbLjbLgbRsLsbLgb
LsLsmbLiLsbRgbRiRsmbRibLobLibRjbLsbRibLgLsbLebLsbLobRibRgbRgbRobRoRsmb
LebLibLcbRebLcbRobRoRhRiRsRsmmbRsbLgbLcbLsbRsbLsRsbRsbRiRjbLibRsbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bRsbLgbLibLsbRobsbLsbLsbRgbLeLsbLsLsmbRgbRsbRgbLibLgLsbRcbLebRgbLjLcbR
jbRjbRjbRgbLsLsmbRsLsbRobRebRsRsmbLsRsRsmbLsbLiRgbLibRsbLebLebRgRsmbLs
RsbRgbRsRsmbRgbRsbRjbLebLibLob

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLsbRsRsmbRjbLgbRgbsbLsbLsLsmbRcbRgbRibRsbLsRsbRsLsbRsbRsbRsbRsbRsb
LgLsRsRsmbRsbLsbRsbLgbRsbLeRsbRsbsbRgbRjbRsbRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRsbLsbLsLsmbLsbLsRsbLsbLiLsbRsRsmbRsbLsbLibLgbLcLoRsbRgbRsbRcbRsLsbRj
LsbRsbLsRcRsRgmbRcLsbLsbLgbsbLgbLsbLsbLsLsLsmmbRcRsLsmbRgRsmbLsbLebLcL
sLsRsmmbRsbsbLsLsRsmbRsbLsbRsbLobLcbRibLsLsmbLebLsbLsbLgbRsbLebRjbLsLs
mbRsbRsbRjbLsLsmbLsLsmbLgLsbLeRsbRgbRibRebLsbRgbLgbRsbLgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bRobLjbsbsbRsbLsbLsbLjbLjbLsbLsbsbLibRsbRsLsbLgbRebRcbLeRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bLsLsmbRsbLsbRgbLebRsbLibRebLgbLebLgbLebRgbRgbRgbLsbReRsmbRgRsRsmmbRiL
sbLsbLsRsbRibLibRibRsbRsbRsbLjRsbRsbRsbRsbLiRsbLsRsbLsbRiLjbRoRsmbLgbL
cbLsbRebRgbLebRobRsLsbLsLsmbLcLsmbLsbLgRsbLgbRiRgbRsRsmbRebRjbRsbLgbRs
bRgbRibRsbLiRsRsmbLoRsbRgbRgbRiRsRsLsmmbLiRsbRgLsLgbLsbLgLsbLsRsbRsLsb
LsbRibLjbRsbRiRsmbRsbRsbRjbLgbRibLsbRsbRobRsLsbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 25; Drug: Control Apo 0.5 然
bRhbLgbRiRsmbLsbLcbLiLsbLibRsbLoRsbLsbLsLsmbLgbLcbLgbLsbLgbLsbLsLsmbLh
RsbLsbLcbLgbRgRsmbLsbRjbRsRsmbLjbLjbLsbLobLsLsmbRsbLsbLgLsbLibLgbLibLs
bRibLgbLgbLgbRsbRsbLibLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 26; Drug: Control Apo 0.5 然
bLjbLsbRgbLgbRgbRsbRsbRgRsmbRsbLsLsmbRibLcRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 27; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 28; Drug: Control Apo 0.5 然
bRsbLjbLibRhbRsbLoLsmbRsRsmbLcRsbLebReb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 29; Drug: Control Apo 0.5 然
bRiRsmbRcRsmbRobRsbRgbRibRsbRibRjbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 30; Drug: Control Apo 0.5 然
bLhbRcbRgbLobRibRsbRibLib

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bRgRsmbRgRsmbRibRsbRibLgbsbLsbLjbLcbLhbLsLsLsmmbRibLgLsbLgLsbLsbLsbReR
smbRsbLsbLsLsmbLoLsmbRsLsbRhbRsLsbRsRsmbLsRsbRsbRsbLsLsmbLsbLgbRsbRsbL
sbLgLsLsmbLsbLgbLsbLsLsmbLgbRsbLoLsLsRsmmbRsbRsbRgbRsbsbRibLsbRsbRibLs
bRobLsbRsbLsbLsbLsbRsbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLjbLgbLcLsmbRiRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bRobRsbRibLsbLhbRsRsmbRibLsLsmbLibLsbRsbsbLibLsLsmbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bsbRgbRsbsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bLiLsbRibRgbRibRgbLobLibRsbLgbLsbLsbLgbLsbLsbLsbLsbLgbRsbRibRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bRibRsRsmbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRgLsbLsLsmbLsbRsbRsRsmbRsRsmbRsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bRgbRibLsRsbRcbLibLsRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bRoRsLsmbsbRsbLsbLgbRoRsmbLobLsLgLsbLobRoRsmbLsLsLsmmbLsLsmbRebLiLsbRo
bLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsbRsbRsbRsbRsbRsLsbLsbLsbRsbRsbLsLsmbLsbLsbLsbRsbRsbsbReRsmbLebLo
bRgbRgbRsRsmbLsRsbRsbRsbLsbRsbRsRsmbRsLsbLsbLsRsbRsbRsbLsRsbRgbLsbRsbL
sbRsbRsbRsbRsbLsbRsRsmbsbLsbsbRsbRsbLsRsbLsbRsbRsRsmbRsbRsbRibLsRsbLsb
RoRsmbRsbRoRsmbRibRsbRsRsmbLgbRsbRgbRsbRsbRsbLsbRsbRsbLsRsbLsbLsRsbRsb
LsbLsRsbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bLsbsbsbRsbLsbLsbLsbRsbRsbRsbsbsbRsRsmbsbsbRsbLsRsbRsbLsLsmbLsbsbRsbLs
bLsbLsbsbsbsbsbLsRsbsbRsLsLsmbRsbRsbsbRsbRsLsbLsbRsbsbsbsbsbRsbsbsbsbL
sbLsbLsbRsbsbsbLsRsRsLsmbLsbsbRsbRsRsmbLsbsbsbLsbLgbLsbLgbLjbLoLsmbLsb
Lsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bLgRsbRsRsmbLobLobRsbRebLsRsbRibRsbLsbLobLcbLsLsmbsbLsbsbsbsbRsbRibLsR
sbRsbRsbLgbRsRsmbRgbLsbLjbLgbRjbLobLibRjRiRsmbRiRsmbLjbsbsbsbLsLsmbRsR
smbsbRsRsmbLsRsbsbRsbRhLsbLgbRsbLibsbsbLsLsmbRsbLsRsbLsbLsRsbLsbsbsbsb
sbLsbsbsbsbsbLsbLibRsbRobRobRgRsmbLgbLibLgbLsbsbLgbRsRsmbLgLsbsbsbsbLs
bsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsRsmbRsbRobLsbReRsmbLibRebRoLsLsmbLsbLgbRgRsLsmbLeRsRsmbRibRsbRsb
LsbLhbLsbRsRsmbRsRsmbRsbLsbLcbsbRsbLsbRsbLjLsmbRgLsLsRsmbRsbRobLebRgbL
eRsbRgbRsRgbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bsbLgLsLsmbRgbLsRsLsbLsLsLgLsLgmbLsLsLsmmbsbLsLsLsmmbLgbLsbLsbLsbLsbLs
bLgbRsbLgLsbRsLsbLsLsRsLsmbLsbsbLsLsmbLcbLjbLsbRgRsmbsbRsbRsRsRsRsmmmb
RsbRsbRgbLsRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRjbLsbLgbRsbRsbRgLsbLsbLsbRsLsbRsbRsbRobLsbLsbLsbRsbLsbLgRsLsbRjbL
iRsRgRjbRibRsbRsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bRibRgbRsbRsbLsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bRsRsmbRsbRibRibRsRsmbLsRsbRgbRgRsRsmmbRsbRgbLsbRiRsmbsbRsRsmbRibLsbRh
RgRsmbRgbsbRebRcbRsLsbLgbLibRsbsbLgbLsLsRsmbLibLgLsbLsLsmbRgbRsbLsLsmb
LsbLebRsbRsRsmbRiRsmbLsbRsRsmbRsbRsRsRgRsmmbLgbLsRsbRiRsRsmmbRsbLsbReb
LsbRsbRgbRsbLsbRsbRsbLsbRgbRiRsRsmmbRsbLsRsbRsbRgRsmbLjbRsRgbRiRsmbRgL
sbRsbRsRsmbRobLhbLsbRsLsbLibLgbLsbsbLibLsLsmbLsLsmbLsbRsLsbLgLgLsLgbLg
bRsbLobRsbLiLgLsbLsLsmbLsbLgbLebLgLgbLgLsbLgbLsRsRsmbLgbLsbRcbRcbLobLe
LsbRsRsmbRsRsRsmmbRsRsRsmmbLsbRsRsRsmmbRsbRibLgbRsbLsbRgRsmbRsRsmbLsRs
bRgbRhbLsbLsLiLsbRsLsbLsLsmbLsbLsLsmbLsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130255; End: 130755;
Recording: 10-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bLsLsLsmmbLsLsmbLsbRhbRcbLiLsbRgLsLsmbRcbLoLsmbRjbLsbLgbLsbLgbLibRibLi
bLcbsbRsLsbRsRsmbLsbLgbLgLgbLiLsLsmbLsLsLsmmbRsbLgLsbLsbRgbLiLsbLsLcLs
mbLgLsbRsLsLsmbLsRsLsbLebsbLebLgbLsbRsbLgbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 1; Drug: Control Apo 0.5 然
bLhbLoRsbRoRsmbRibLsRsbRobRsbLoLsmbRsbRobRsbRsbLsbLobRgbRgbRsRsmbRsbRe
RsRsmmbLsbLsbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 2; Drug: Control Apo 0.5 然
bLcbRebRiRsmbLsbRgbRgbRsbRsbRsbRsbRgRsmbRsbRsbRsbRhbLsbRibRsRsmbRsbRsL
sbRsbRibLcbRhbLhbRcbRsbLibLcbRsRsmbRjbRibRibRsRsmbRgbLgbRsbRsbRsbRsbRh
bLibRobRjbRcRsmbRsbLgbLsbRsbRcbRsbRcRsmbRsbLibLgbLibLcLsLsmmbLgbLibLgb
LhbLibRjbLgbLibLobLibLgbRsbRsbLiLsbLjbRjbLcbRgbLibLgbLhbLjLsmbRhbRsRsm
bLibRobRcbRhbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 3; Drug: Control Apo 0.5 然
bRobRebRgLsLsRsLsmbReLsRsLsbLsbLsbLebRobLobRsbRsbLsbLsbLsRsRobRsbRoRsm
bLsbLsRsbRsLsbLobRoRsmbLobRsbRsbRsbRsbLsbRobRebRobRebRsbRcbLsbRobRsbLs
bRsbRobLsbLibLobRsbRcbRcbRsbLebLsbRoLsbLsRobLebLibRibLebRsLsRsbLsbRsbR
obRsbLsRsRebLsRsbLsRsbRoLsLsmbLsbLobLeRsbLsbLobLsbRebRobRebLsbRsbReLsb
LsbRebRsRsmbRobRsbLsbRsbLebRjbLsbRobLsbLebRsbRsLsbRsbRobLebRgbLobLsReb
LsbRobRoLsbRsbRobRsbRsbLebRcbLsbRebLobRebRsLsRsbLebRoRsmbRsbLebRobRsbR
sLsbRjRsmbRsbLebRsbsbReRsRsmmbRobRobLobRsRobRobRsbLsbLebRobRsbRsbRsbLs
bLobLsRobLsbRsbRebLsbRsRsmbRsbLgbRsbRsbRobRsbReLsbRsbLsLobLobRsbRcbRsb
RgbLcbLsLsmbLsbRsbRsbRsbLsbRsbLsbRsbLobLsbRsbRsbRsbLsbLsLsmbRsbLsbRsRs
mbLsbLsbLsbRsbLsbLsbLsbLsbRsbRsbRsbRsRsmbLsbRsbLsRsLsbLsbLsbLsbRsbRsLs
bRsbLsbRsbLsbLsbRsLsRsRobRsRsmbLsRsbLsbLsbLsbRsLsbLsbRsbRsbRsbLsbRsbLs
bRsbRsbLsbRsbLsRsLsbRsbLsRsbLsbLsbRsbRsLsbRsbLsbLsbRsbLsbRsbLsbLsbLsbL
sbRsRsmbRsbLsbRsRsRsmmbRsLsRsbLsbLsbLsbRsbRsbRsbRsbRsbLsbRsbLgbRsbRsbL
sbRsbLsbRsbRsbRsLsLsmbLsRsRsmbRsbLsbLsRsbLsbLsbLsbLsbRsbRsbLsbLsbRsbRs
RsmbRsRsmbRsRobRsbLsbRsbRsbLsbRsbLsbRobRsbRsRsmbRsbLoRsLsbRsbRsbRsbRsb
LsbRsLobRsbLsbRsbRsbRsbRsbRsRsmbRsbRsbLsbRsbRsRsmbRsbLsbRsbLsbLsbLsbRs
bRsbRsbLsbRsbRsbLsbRsbLsbLobLsRsRsmbLsbRsRsmbLsLsmbRsbRsLsbRsLsbRsbLsb
RsLsbsbLsbRsbLsbRsbRsbLsLsmbRsbRsbRsbRsbRsbRsbRobRsLsbLsbRsbLsbRsbLsbR
sbLsbRsbRsbLsbLsbRsLsbRgbLsbRsbLsbRsbRsbLsbLsbRsbRsbLsbLsRsRsmbRsbRsbR
sbLsLsmbLsbLsbRsRsmbLsRsbRsbRsLsbRsRsmbLsbLsbRsbLsbRsbLsRsLsRsbLsbLsLs
RsRsmmbLsbRsbRsLsbLsbLsRsbLsbRsbRobRsbRsbLsbLsLsmbLsbRsbRsRsmbRsbRsbRs
LsbLsbLsRsbRsbRsbLsbLsbRsbLsbLsbRsbLsRobLsbRsbRsbLsbLsbRsbLsRsbLsbLsbL
sbRsLebLob

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 4; Drug: Control Apo 0.5 然
bRsRsRsmmbLgbLsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 5; Drug: Control Apo 0.5 然
bRibLgLsbLiLsbLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 6; Drug: Control Apo 0.5 然
bLsbRgRsmbLsbLibRibLhbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bLjLsLsmmbRcbRhbRobRobLiLsbRibLgbRibLiLsLsmbRibRibRibRiRoRsmbRsbLgbReb
RcbRibRhbRibLgLsbRsbRibLhbLoLsmbRjbRhbRibRibRgbRcbRibRhbLoLsmbLsLibRjb
RobLcbLhbRjbRoRsLsmbRcbRhbRibRsbRiRsmbLsbLjbRcRsmbLcbLcbRibRhbRhbRgbRc
bRoLsRsbRsbRsRoRsmbLgLsbRibRibRgbRsbRgbRibRgbLsbRsbRsbRsbRgbRsbRibLcbR
hbRsbLgRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bLgRsbLgbRcbRsRsmbLsLsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bLcbRgbRsbLgbLjbLsbLgbRgbRcLsbLobReRsmbLobLiRsbRgbRsbLgbLjLsmbRobLsRsb
RsbRsRobRibRsbLibLsbRsbRsbLibLibLgbRgbRsRsmbLobRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bRib

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bLgbRsLgbLgbLiLsbRibLsbRsbRebLgbRsbLgRsbLebLibRgbLhbLsRsbLiRsbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bLeLsbsbsbsbsbLsbRsLsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bLsRsbRsbRsLsLsmbRsRsLsLsRsLsLsLsmmmmbRsbsbsbsbLsbRsbRsbLsbLsbRsbLcRsb
RsbRgLsbRibLibLoLsmbLoRsLsbLobLobLobLob

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bLebRibRebRebRcbRebRobLobLebRsbRsbRobRebLobRobRobLobLcbRobRobRibLcbLsb
LebLebRsbRobLebLebRebLibLobLobLobRebRhbLebLcbRobRcbLsbRcbRebLobLcbRhbL
ebRobRgbRcbRcbRsbLebLcbRcbRcbLobLcbRebLcbLebRcbLibLibRebRcbRobLgbLobLe
bRibLebLobRjbLebLobLobLibRobRebLebLobRgbLobLcbLcbLibLcbRobLobLcbRsbRob
LobRobLsbRobLebRgbRsbRobLcbLgbLobLsbRobRgbLebRebRcbRebRgbLobRebLgbLobR
hbRebLobLobRsbRebLebLcbRobLibLhbRgbRobLebRobLcbRgbLcbLcbLibLgbRcbLobLo
bLcbRobLgbLibLibLebRebRhbLgbLcbLobRgbLebLobLobRobRobRobRobLobLebLcbLhb
LsbRobLobRebRebLebLobLebLcbRebRsbRobLebRgbLobRgbRobLobLobLobLibRobLebR
jbRebRobLcbRebLebRobLebLebLobRebRsbLebLsbRebLcbRobRobRcbRcbRobRobLobRc
bRcbRcbRebLebLhbLcbRebLebLcbLibLobLebRebRobLebLibLobRcbLcbRebLebRsbRib
LsbRobLebRebLobLebLobLobLobRobRibLibLebLcbRibLcbRobLobRgbLobLobRcbRebR
ebRcbLibLibLibLobLebRobLobRsbLhbRobRcbLebRebLobLebRobLobRobLcbLsbRobRe
bRebRebLobLebLgbRobRsbLgbLobLobLobRobRobLobRgbRcbLibRobLobLgbRcbRebRcb
RcbLebLgbRobRgbRobRgbLibRobRcbRobLgbRobRgbLcbLobRobLcbRibLcbRobRibLebL
obLcbLcbRobLobRobRcbRobRebLibRobLibRebRobRobRobLcbRcbRsbLobLebRobRcbRe
bRobRobLhbLobRebLobLobRobLebLgbRibLsbRebRcbRebLobRibLsbRobRobRebLcbReb
RobLobLobRcbRobRsbLcbLebRobLhbLcbLibRcbRobLobRobLobLobLgbRobRobLibLobR
ebLcbLobRobRebLibLobLobRcbLobLcbLebRcbLcbRcbLebRebRobRcbLgbRcbRcbLebRo
bLobLobRobRsbRebRobRobRgbLgbRobRgbLobLobLobRobLebRebRobRobRobRebRebLib
LebRobLsbLobRebLobLgbLobLobLsbRobRsbLobRobLobRsbRebLobLobLcbRobRcbRhbR
obRebLcbRsbLebRcbRcbRibLcbRobRcbLobLebLobLgbLobLobLebRgbRgbRgbLobLobLc
bRobRobRgbLjbRebRcbLcbLebRebRobLsbLebLebLcbRebRobRobRcbRgbRebRcbLhbLob
LsbRibLebRgbRebRsbLebRibLebRebLibLgbRobRebLobLcbLcbLibRobLjbRcbRibRibR
obLebRobRobRcbLobRsbRcbLobRcbLgbLobRcbLobLobRebLobRobLobRibLobLhbRobRo
bLebRobLobRobRobRobLobRsbLibRebRcbLobLobLobLcbRebLebLobRcbLibRgbLobRob
RgbRcbLobLobRobLebRhbRibLebRobRibRsbLebLobLebLibLobRobRobLobRobRgbRgbR
obRobRebLobLebRobRobLjbLobRcbRjbLebLobLebLcbRebLobRobLebRobRebRebRibLo
bLobLobLgbRhbRobLcbRobLebLobLcbRebLibLgbRibLsbRobLgbRobRibLhbLsbLebLcb
RibLcbRgbLobRgbLgbRcbRebLcbRhbRobRobRobRobLobRobRcbLhbRibLebLobLcbRobR
obRibRobLebRcbLgbLobRcbRibRobRibLcbLcbRobLobLibLibLobLcbLebLcbRobRcbLc
bRgbRobRcbLobRibLobRebLhbLebLebLgbLcbLebRebLobLcbLobLobLebRobRobLsbRgb
LcbRobLcbRsbLebLcbRobLobLobLgbRcbLobRobLobRobLobLebRibRobRobRebRobRobL
obLcbRobRcbLobRgbRebLcbLcbRebRibRgbRebLobLebLebLebLebLebLsbLobRebRebLc
bRobLgbRibRobLobLobLcbRobLobLobLjbLobLobLebLcbRcbLobRcbRobRcbLobLobRob
RgbRebRibRibRebLobLebLobRebLgbLebRibRobLebLobLobLebRebRobRobRobLibLsbR
cbLobRobLobLebLcbRibLebRobLsbRobLebRobRgbLobRcbLcbLebLgbLcbLsbLcbRebRe
bRhbLibLobRsbLgbRobRcbRobRcbRobLgbLebLebLobRobRobLgbRobRcbRcbLobLcbLgb
LebRobRobLebLsbRobRebLobLobLebLhbLebLobRgbLsbRobRobLobRobLebRcbLcbLcbL
obLobLcbRobLibRebRibRobRebLobRcbLobRibLgbLebLcbLhbRcbRebRobRobRebRebRg
bLobLebRobLobLobRibLobLcbRgbLebLebLibRibRobLobLobLhbRcbLobRobLobRcbLcb
LobLibRobLgbLobRobLcbRibLobRebRibRsbRobRhbRibRgbLebLgbLjbLobRcbRibLcbR
obRcbRgbRebRgbLebRebRebRcbLgbLgbRobRibRebRebRebRobRobLibLcbLebLobLobRe
bRobRcbRcbRcbLebRobRibLobRcbLobRgbLobRobRebLebLcbLobLgbLcbLgbLobRhbLcb
LgbLobLibLobLobRibRobRcbRsbLcbLcbRcbLebLobLobRebRcbRebLebRobLgbRcbLobL
ebLsbRobRcbRebLhbLcbRobRsbLebRobRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bRgbLibLsbLgbLibLobLgbLgbRsbLgLsbLcbLsLsmbRsRsmbLsbLsLsmbLgbLibRsbRgbR
sbLsbLibLibLibRsbRsRsmbRsRsmbRsbLebRsbLsbRcbRgbRsbRsRsmbRsbsbRsbLsLsmb
RsbRsRgbRsbRsbRsbRsbRsRsmbRsRsmbLebLibLobRsbRgbRsbLobLsbLsbLgbLsbLsbLs
LsmbLhLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bLjRsbLcLsmbsbLsbLsbLsbLgbRibLjbRjbReRsmbLsLsmbRibLibLgbLobLsbLgbRhbLg
bRcbLibRiLsbLsbRibRibRsbLsbRhbLgbRobLibRgbRiRsmbLgbRobRsRsmbRgbRsRgbRg
bRebsbLsbRiLsbRiLsbLsbLsbRgbRibRiLsbRgLsbRibRibLjbRebRibRjbRjbRibRcbLg
bLgbRhbLjbLobLiLebLgbLibLsRibRgbRgLsbRiLsbLgbRcbRobRsLsbLjLgbRibRibRib

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbRsRsmbRsRsmbRsLsbRsbRsRsRsLsmmbRsbRsRsmbRsbRsbLsbRgbLjbRsRsmbRs
bLsRsRsmbRsRsRsRsRsmmmmbRgRsmbLgRsbLsbLsbLgLsLsLgRsmbLsLsRsmbLsLgLsLsm
bLeRsbRebLgLsbLsLsmbLsLibLsRsbLsbLsbLsLsmbLsLsLsmmbLgLsbLgbLsbLgLsbRsb
LsbLsRsbLsRsbLsLsmbLsLsmbRsLsbLsLsmbLsbLsLsmbLsLsLsmmbLgbLgLsLsmbLgLsb
LsLsmbLsbsbLsLsmbLsbLsLsmbLsLsLsmmbLsLsmbLsLsmbLgbLsLsmbLsbLsLsmbLsRsb
LsbLsLsLsmmbLsbLsbLsLsLsLsLsmmmmbLsLsmbLsbLsbLgLsLsmbLiLsbsbsbsbLgbLsb
sbLsbLsbLsLsLsRsmmbLsbLsbLsbLsbsbRsLsLsmbLsbRsbLsbLsRsbLibLiLsbLcbLgLs
bLhbLsLsmbsbLsLgLsbLsRsbLsLsLsmmbRsbLsRsbLsLsLsmmbLgbLsLsLsLsmmmbLgbLg
bLsLsLsLsmmmbLsLsmbLsbRsLsbLsLsmbLsLsmbLgbLsbRsRsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bRobLobLiLsbLgbLibLgbLebLibLibLgbLgbLsbLibLgbLgbLgLsbLibLcbRibLibLgbLi
bLibsbRsbsbLsbsbsbsbLgbLgLsbLibRsbLibLhb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRgbRiRsmbRsbRgbRhbLeLgLgbRsbLibRibRsLsRsRsmbRsRsRsmmbRgbRsbRsbsbRj
bRgbLibRobRsRsmbRibRhbRsbRebLebLebRoRsmbLcbRebRobRsRgbRebLebRsRgRsLsmb
LgLsbRebRoLsbLibLsbLsLjbLsbLsbRsbLobLobRgbRsbLsbRcbRhbLebRibRobRsbLcbL
hbRsRgbLjbLsbLjbRebRhLsbRiLsbLjbLobRibLiRsbLobRgbRgbRgbRgbRgbLcbLiLibR
sRgbLgbLsbRsLsbRcbRhbRjbLibRsbRhbRjbLoRgbRibRebLsbLsRsbsbRgRsmbRsbRsbR
gbRgbRsLsbLebLibRsbRsLsbRsRsRsmmbRgRsmbRsLsRsbRsbLjbRsRsmbLsLgbLsbRoRs
mbRsbLhbRcbLsbLsLsLsmmbLgLsbRgRiRsRsRsmmmbRsRsmbRsRsLsRsmbRsbRsRgbLebR
gLsbLsbLsbLoRsRgRsRsmmbRsRsmbRsbRsbRgbRsRjbLsLsmbsbsbLsbLsLsmbLgbRobLs
LsRsmbLsbRebLebLjbLsLgbLgbLcbRibLjbLcLsmbLsbLeRsbLhbLibRebReRsmbLcbLcb
LgbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bLhbLsbRiLibLsbRgRsmbLebLeRsbRgbLiRsbLgRsbLcbRcRsmbLsbRhbLgbLobLgbLibL
gbRhRgbLsbRsbRiRsmbLgLsbLgbLibLgbLiLsbRgbReRsmbRgbRsbRibRebRgbRsbRsbRs
bsbLsRsbLobRgbLebLoLgRgbLebRjbLibRobLebLobLgLsbLgLsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bRhbLgbRgRsLsmbLgbLsRsbRsRsmbRsbLsRsbLgRsbLsbLsbLsRsbLsbLsRsbLsRsbLgbR
sbRsbRsbLsbLsbRsbRsbRsLsLsmbLsbLsRgbsbLsLsmbLsbLgRsbRgbRsbLsLsmbLgbLsb
LsbRsbLsRsLsbRsLsLsmbLcbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bReLsbLoRsRsLsLsLsmmmbRsbsbLsbLcbRjbRgbRibRgbLsLsmbLgLsbLsbLsLebLsLsmb
RjbLsLsmbLsLsmbRsLsbRsbLsbLjLsmbLgLsbLsbLgLsLsmbLgbLobRebRcbLibLgbLsbL
sbLcbLsbLsbLibRgRsmbLgbLsLsmbLsbLgbLobRsbRgbRebLgbLgbRcbLsbLgbLibLsbRs
bRsLsLsmbsbRobLsbLsRsRsmbLcLsmbLoRsbRebLjbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bLebRjbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bLsLsmbLsbLcbRsbLeLibRgbLjbRgbRgbLebLgbLibLebRsbRjbLjLsmbRjbRgRibRsbLs
RsbRobLeRsbRsbLsbLsLsmbRgbLebLgbRgRgbRsRsmbRgbsbReRsRsmmbLjLiRsbRsRsmb
RcbRsRsmbRsLsbLsbsbsbsbLgbRcRsmbRcRiRsmbRsbsbLgRsbRgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 25; Drug: Control Apo 0.5 然
bRobLjbLibRjbRobRsRgLsbRibLsbRibRgbRgRsmbLsbLgbRjbLsbRsbRsbLgbRgbLsbRg
bRsbRsbRgbLsbLsbLsbRibLjbLjbLibLsLsmbRjRsmbLsbRsLcbLsbLhbLibLhbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 26; Drug: Control Apo 0.5 然
bsbLgbsbLsbLgbLgbLcbLiRsbLsbLhbLcbLiRsbLobLobLoRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 27; Drug: Control Apo 0.5 然
bRsLob

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 28; Drug: Control Apo 0.5 然
bLeLsbLgLsbRsbRjb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 29; Drug: Control Apo 0.5 然
bLjbLsbLgbRibLsbRgbRcLsbLhRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 30; Drug: Control Apo 0.5 然
bsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bRgLsbRgbLsbRibRgRsmbRgbRsbLgRhLsbRsbRebLsRsbLsLjbsbLobLsbLsbLgbLibLsb
Lgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLibRcRsmbLhLsbLebLhbLcbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bLsbRsbRsbRoRsmbLobLobRsRgbLsLsRsmbLsLsmbLiLsbLsbRgbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bLobRgbRcbLsLsmbLjbLobRiRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRiRsRsmmbLsbLobLobLsbRibRsbLiRsbLsRgbsbLsbLsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bLeRsbRobRiRsmbRebRsbLobLsLsmbRcbRsbRcRsmbRobRsbRsbRjbRcRsmbRsbRsbLibR
sbRcbLsbRsbRobLhbLgRsbLsbLsLsmbRcbLibLob

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bRgbRsbLsbRsbRsbLsbRsLsbsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bLsLgbLgLsbLsbLsLhbRiRsmbLgLsbLsbLsLsLsmmbLgbLgbLsRsbsbRgbRsRsmbLsRobR
sbLgbLibLgbLibLibLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bLgLsbLgbLibLgbRhbLibLsLsmbRjbRobLjLgLsbLobLjbLsLsmbRibLibLsLsmbRhbLob
LsLsLsmmbLsLsLsmmbLoRsbLjLgbRhbLgbLiLsRsLsbRoRsmbLjbRjbRgbRgbRgbLsbLsL
sLsmmbRibRgbLsbRiLsbRiRsmbRsRsmbRgbRgbRsbRiRsmbLgRsbRsbRgbRgbRsRsmbRgb
LsbLgbRgbLobRebRobLcbLcbLibRibRsbLsLsmbRebRoRsmbLsLsmbRobLsbLsLsLsmmbR
obLjLsmbRibRsbLhbRobRobRsbRsRsmbLjLsmbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbRsbLsbLsbRsbRsbLsbRsRsmbRsbRsbLsbRsbRsRsmbRsbLsbLsbsbRsbRsbRsbL
sLsmbLsbRsbLsRsbRsbRsbRsbRsbRsbRsbLsRsbsbRsbLsbRsLsRsRsmbLsbLsbRsbLsbR
sbRgRsmbLsRsbRsbRsbLsbRsbRsbRsbLsbRsRsmbLsbRsbRsRsmbRsbLsLsmbRsbRsRsmb
LsbRsbLsbRsRsmbRsbRsbRsbRsbLsbRsbRsLsbRsLsbRsbLsRsbLsRsbLsRsRsmbRsRsmb
RsbRsbLsbRsbLsbRsbRsRsmbLsLsmbLsRsbRsRsmbLsbRsbLsbLsbRsbLsbRsbRsbRsbRs
bLsRsLsbLsbRsRsmbRsbLsbLsbRsbsbRsRsmbRsbLsRsbRgbLsbRsbRsbRgRsmbRibRsbR
obRsbLobLsRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bLhLsLsmbRcRsmbRhbRgRsmbRgbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bLgbLgLsbsbsbLsbLsbRsbLsLsmbsbLcbRibRsbRhLsbLsLgbRgRsmbLobLibRsLobRgbL
gbLcbLibRhbLsbLsbRobLsLsmbLibLibLsLsmbLgbRsbRsbsbLgbLsRsbLgLsbsbLgbLsR
sbsbLsbsbsbsbsbsbRsbRsbsbsbsbsbsbLsbsbLsbRsRsmbLsRsbsbRsbLgbLgbLsbsbLg
bLgRsbLgbLgbLsbRgbsbLsbLsLsLsmmbLsbsbLsbLsbsbRgbRsbRebLjbRibRsbsbRobLg
bLcRsbsbLhRsbRsRsmbsbsbLgbRsLsLsmbLgRsbRsbLobRhRsmbRsbsbsbRsbsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bLibRjbRsbRgRsmbRgbRsbRsbRsbRgbRsbRiRebLgbRgbLsbRebRobLsbLsbLsbRsbLsbR
sLsbLsbLjbLsLsmbRsbLiRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbRsRsmbRgbRsRsmbRgLsbRsbLsRsRgbRsbRgbRcRsLsmbLsbLsbLsLobRoLsbsbR
sRsmbRsRsmbRsbLsbLsbLgbLsbLsbLsbLsbRsbLgbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bRsLsbLsRsbLsbRsbRsLsbRsRsmbRsbLgRsbRsbRsbLgLsbLsbLsbLsRjLsbRsLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbLsbRgbLobLgbsbLcbRgLgbLsRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bRsLgRsbLgbRsbLibLgbLsbsbLgbLgLsbLsLsLgLsmbRsbLsbLsbLsbLgbLsbLsLsLsLsm
mmbLsLsmbLibLsbRsbLsbLgLgRsbRsLsbLibRsRsmbLgLsLsLgLjmbLsbLiLsbLsbLgRsb
RsLsbLsbLgbLsbLsbLiLsbRsbRsbRobRcbRgbRsRsRgRsmmbRsbRsbReLibRobLgLsLibR
sbLsbLsbLebRcLsbLsbLsbLgbRsbLsRsbLsbLiLsbRsbRebRsbRebRgbsbRsbRibRjbsbR
gRsmbRibRsbRsbRsbRsbRgRgbLsRsbRgbRgbRsbRsbLsRsbRsRsmbRsbLsbsbRgRsmbRgb
RsbsbRsRsmbRsbRsLsbRgRibLsbRgbRgRgRsmbRsbRibRsbRibRsbRibRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 130757; End: 131257;
Recording: 11-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bsbLsLsLsmmbRebLebLobLsbRsLsLgbLgbLgbsbLsbLsbLgbRsbLebLcbLoRsRsmbLsLsm
bLsbLsLsmbLsLsLsLsLgmmmbLsLsmbLeLsLsLsLsmmmbRobRgbsbRsbLjbLiLgbLsbRsRs
LsmbLgbLsRsbLgbRcLebLgbLsLsLsmmbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 1; Drug: Control Apo 0.5 然
bRibRoRsmbRoRsmbLgbRsbLobRgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 2; Drug: Control Apo 0.5 然
bLcbRjbRobRsbRgLsbRsRsmbRcbRobLobLsRsbRsbRobLobLobRobRoRsmbRcbRibRgbRo
bRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 3; Drug: Control Apo 0.5 然
bLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 4; Drug: Control Apo 0.5 然
bRsRsRsRsLsmmmbLsLsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 5; Drug: Control Apo 0.5 然
bLsbRsLsLsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 6; Drug: Control Apo 0.5 然
bRgbRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRsbLibRcbRibLsRobRobRhbRibLibRibRibRhbLhbRcbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bRibLsbRibRsbRcbRsRsmbLsLjbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bLjbLoLsRsRsmmbRibRsbLsRibRsbRgbRsbRsbRsbRsbRsbRgRsmbRsRsmbRgbRgbRgbRs
bRgbRsbRsRsmbRsbRgRsmbRsRsmbRsbRsbRgLsbRsbRsbRsRsLsmbLsbRsRibRibLiRsbR
sbRsbRoRsRsmmbLibRgRsmbRsLoRsRsmbRgRsmbLgbLsbLgbLhRsbRibRsbRsbLsbRsbLj
bLgbLgbLibLibRibRsbRsbRgRsmbLsbLgRsbRhbRjbRcbLcbLsbRsbLsbLsbLoRsbRgbRs
bRsRsmbRsbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
bsbRsbsbLsLsmbLsLsmbLsbLsbLsbLsbRsbRsbRsbLsbLsLsmbsbRsbLsbRsbRsbLsbLsb
RsbLsbLsbsbLsLsmbLsRsbLsbRsbRsbRsbLsRsbLsbLsRsbsbsbsbRsbsbLsbRsLsbsbRs
bRsbLsbRsRsmbRsbsbsbRsbRsbRsLsbLsbsbRsbRsbRsLsbRsbLsbLsbRsLsRsbRsbRsbL
sbRsRsmbRsbsbRsbRsbRsbsbLsbLsbLsbRsbRsbLsbLsLsmbLsbLsbRsbRsbLsbLsRsbsb
LsbRsbRsbLsbsbLsbRsbLsbLsbRsbsbRsRsRsmmbLsRsbLsbLsbLsbRsbLsbLsbRsbRsbR
sLsbRsbRsbLgbsbLsbsbRsbRsbRsbRsbRsbLsbLsbLsbsbLsbRsbLsbRsLsbLsbRsbRsbL
sbLsbRsbLsbRsbsbRsLsbsbRsRsmbLsbRsbLsbLsbRsRsmbRsbLsbRsbsbRsbRsbsbRsbR
sbRsbRsbLsbRsbRsbLsbsbsbLsbRsbLsLsmbLsbLsLsmbRsLsbRsRsmbsbLsRsbRsRsmbL
sRsbLsbRsRsmbRsLsbRsbLsbRsRsmbLsRjbRjbRsbRsbLsbRsbRsbRjbRsbLsLsmbRsbRs
LsbLsbLsbRsbLsbLsbRsRsmbLsbRsbLsbsbsbLsRsbLsbLsbRsLsbLsLsmbRsRsmbLsbRs
bRsbRsbRebRsLsbLsbRsLsRsbRsbLsbsbLjbRsLsbRsRsmbLsbLsbLsLsLsmmbRsbLsbLs
LgbLsbRsbRsbRsbLsbRsbsbRsbLsbLsbRsbLsbLsLsmbLsbRebLsbLsRsbRibLebRebRob
LsbRebLebLsbRebRsbLebLebRcbLcbLsbLobLsbRcbRobRobLsbRcbLebRobLebRsbRobL
ebLebRsbLobRsbRsbRsbLgbRsbLobLsbRebLebRobLebRebRobLsbLcbLsbRobLobRobLs
bRobLsbLebLsbRobRsbLobRebRobRobRebRsbLgbRebRobLebRobRobRebLsbRobLobLob
LobRobLjbRobRsbLebRjbRsbLebLsbLgbLsbLebLsbRobLsbRsbLsbLjbLobLobLsbLjbL
gbLsbLebRsbRebLsbLsbRobRobRebLsbRsbLcbRsbRgbRobRsbRobLsbRsbRobRobRsbLs
bLcbLcLsmbLobRebLjbLsbLsbLebRsbLgbRobLgbRsbRobLgbRebRebLebLsbLsbRobRjb
LcbRebRsbLsbLcRsbRsbLgbRobRobLsbLjbLebRsbRsLgbRebLsbRobLobLobRebRobRjb
RsbRobRgbRsbLsbLsbRobRebLhbLobRsbRibLebLjbLsbLcbLjbLobLsbLebLebRobRebR
obRgbRsbLsbRjbRobLgbLgbRsbRebRsbRcbLobRebLebRebLjbRobLcbLsbLobRsbLobRe
bLsbRebLsbRebRsbRebLebLebRobLibRsbLobRgbLebRebRobLebLobLobRjbLcbLobLeb
LjbRjbLobLebLgbLobRobLebRsbLebRebRebLobRobLebLsbLebLobRsbLsbLsbRsbRsbL
sRsRsmbLsRsbRsbLsRsLebRsLsbLjbRsbLsLsRsmbLsbsbRsLsRsbRsLsRsRsLsRsmbRsR
obRgbLsbLsbLsLjbLobRsLsLsmbLsbLsbLsbLsbLgbRgLsbLsbRsLjbRsbRsRsLsmbLobR
gLsbRsLgbLsbRgRsmbLsRsRsLsRsLombRgbRjbLsRobRgbRsbRsbLsRsLsbLsLsmbRsbRs
bLsRsbRsbLsRsbRebLsRsLjbRsbLsLsRsmbRsbLsbRsLsbRsbLgRsLsRsbLsbLsbLgbLsL
sLsRsmmbRsbRgLsbRsbLsRsbLsRsbRsbLsLgbLgbRsbLsbRsbRsLsLsRsmbLsRoLsLsRsL
smbLsbRsRsLombRsRsLsLsLsmmmbRsbRsbRsLsRsLsbLsRsbRsRsLsmbRgLsbRsLgbRsbL
sLsmbRgbRobRgbLjbRsLsbRgLsRsbRsbRsbRsRsmbRoRsmbRsLebRob

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bRgbRcbLcLsLsmmbLsbLiLsbRgbLgLsbLebLhbRsLsbRsbRsRsLsmbLsRsLsbLsbLsbRsb
RsbRsbRsbRsLsbLsbRsbRhbRebsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bRjLgRsbLsbRibRsLsbRgbLoLsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bRibRiRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bLsLsmbRsbRsbLsLsLsmmbRsbRjbRsbRsbRsbRgbRoLsbRsbRgRsmbRsbRsbRsbRsbRsRg
RsmbLsbsbsbRsRsRsmmbRibLsLsmbLsbRebRobRsbRsbRgRsmbRsLsbRsbLsbLsbRsRsmb
RsbRsbRsbRsbRsbRobRsRsmbRsRsmbRsRsmbRgbRsbRibLsRsbRsbRsbRsbRsbsbRsbLsb
LjbRsbRsbLgbsbRsbLebLsbLgRsbRjbRoLsbRsbLsbRsbLcLsmbRsbRsRsmbRsRgbRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bRgbsbsbRsRsRsmmbRsbLsbsbRsbsbsbRgbLgbRgbRsLsRsbLsLsmbRgbRsRsRsmmbRsbR
gbRjRgbRgRsmbLgLsbLgbRjbRsbRibRgbRgbLgbRgbLibRgRsmbLebLsbLobRgLsbRsbRe
bsbRjbRsRgRsmbLebRgRsmbLsRsbRgbLsRsbRibRsRsmbRsRsLsRsmbRgLsbLgbRjbRibR
sRgRsmbsbLgbLsbLsbLsbRsbRsbLsLsmbLgbLsRsbLsbRsbsbLsbLcbLjLgbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bsbLsLsLsmmbLgLsLsmbLsbRsLsbLsbLsLsLsLsLsmmmmbLgRsbLgbLsbLsLsmbLsLsLsL
sRsmmmbLgLsbRoRsmbRsRsmbLsbRsRsmbRsbRsRsmbRsbRsRsRsRsmmmbRsRsmbRsbRsbR
sLsbRsRsmbRsRsmbRsRsmbRsbRsbRgbRsRsmbRsbRsbRsbReLsbRsLsLsmbLhLsbsbLobL
cLsLgLsRsmbLsLsmbLsbLsbLsLgbLsbLsbLsbLsbLsbLsbLgLsbLsbRsLsbLsbLsbLsbRg
RsmbRgbRcbRoRsRsmmbRgbLobLgLsLgbLsbLsLsmbLsbLsLsmbLsbLsbRsLsLsmbLsbLsL
sRsmbLsbLsbLsLsmbLsLsmbLsbLsbLsbLsbLgbLsbLgLsRsbLsbLsLsLsmmbLgbLsLsmbL
sLsLsRsmmbLgLsbRsbLsbLgbsbLgbLsbRsLgbLsLsmbLsRsbLsLsLsmmbLsbLsbLsbLsbR
sLsRsbLgbLgbLgRsbLgLsLsmbLsLsmbRsbLsbLsLsmbLsbLsbLsbLgbRsLsLsmbRsLsLsm
bLsLsmbLsbLsLsmbLsLsLsmmbLgbLsbLsRsbLsbLsLsLsmmbLgbLgLsLsmbLiLsbsbLsLs
Lsmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bLebLibLobLibRgbLcbRgbLcbLibLcbLcbLcbRsbLoLsmbRibLgbsbsbsbsbsbsbsbsbsb
sbsbsbLsbRhbLobLibLcbLiRsbRgbLcbLibLebRcbLcLsmbRgbsbsbsbsbsbLsbRgbLibL
ibLiLsbRsbLibLiLsbLibLgbLibRebLibRjbLibRgbRgbsbLibLjb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bLsbRsbsbsbLgbLsbLgLsbLjbLhbRsbRebRgbLsbRsbRjLobLeLsRsbRcbRgbRjbLsbLib
RobRebLgLsbLsbLsLebRibRsbRsbRsbsbLibLcbRsbLibRgbRibLebLsbLgLsbLcbLsLsm
bLcbRebRsbLgLsLsmbLsbRgbRgbLcLsmbLgbLcLsmbRcbRsRsmbRcRgbLcbLobLsbLsbRe
bLcbLjbLibRgLsbRibLsLgLsLsmbLgLsbLsRsbLibRhbLebRoLsbRibLjbRoLsLsmbLjbL
sbLjbLsbLcbLobLiLsbLgbLobRgRsmbRgbLsRsbRsbLsRsbLgLsbRjbRgbRsbLjbLebLeb
LcbRgbLcRsLoRsRsmbRgbLgRgbRjbRhbLjbRobLoRsbLgbLgbLsbLcbRsbRcbRsRsRsmmb
RgbLjbRibLgbRjRgbRgbRgbRsbLeb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bRjRsmbRobRjbRjbRgbLjbLsbLhbLsbLgLsbRibRobLobLoRsbRjbRobLgLjbRgbRsbRgb
LobLobLsbsbsbRobLsLobsbRsbLobLebRjbRobLobLebLjbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bLgbRsbsbsbLgbRsbLsbRsbsbLsbRjbLgbLsbLsbLsbLgRsbLsLsmbRsbRsbLsLsmbLgbL
sbLebLgbLgbRsbLsbLsbLebRebRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRcbLsLsmbLsbLsbLgLsRsbLgLsbLsbLsRebRgbLsRsbRcbRsbLsbRsbRhbLgLsbLgbRgb
LcbLiRsbRobRsbsbRsRsmbRsbRsbRcLsbRgLsbLgbRibLcLsmbLeRsbLcbRebLsbLcbsbs
bLsbLgbRsbsbsbLsbLsbRsbLibRgbLgbLjbRsbLjbLsbReLsbRsLsbRebRsbRsRsmbRsLs
RsbRjbsbLgLsbLobLsbLsRsbLcRsLsRsbRsLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLsbRjbRsbLsbLsbLibsbsbLsbRgbLgbRcRibLsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bRobLsbRiRsmbRjbRgLsLsmbLjbRjbLsbLsbLsbRsbRjbLobLsLsLcmbRobLsbRjbRebRj
bsbLsbLsLsLsmmbLsbRsbRjbRsbRgbRgbLsbRgbRjbLjbRjbLgRgbRebLjbsbsbLobRjbR
sbLsbRsbLsRobRobLebLobLsbLjbLsbRsbLsRsbRcbRibLcbLgRsbRcRgbLsLsmbRcbLsb
Rsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 25; Drug: Control Apo 0.5 然
bLjbLjbLcLsmbLcLsmbLobRsbRgbRsLsbRsbRsbRibLsbRcbLsbLibRgbRibLcbLiLsbLs
bRsbRsbLibLsbLgLsbLibLsbLebRgbRsLsbLsLsmbLsbLjLsmbLibLsLsmbLsbRsbLjbLi
bLhbLsbLsbLgbLibLibLsbLsbRibLsRsbLgRsbLsbLgbLsbLgbLsbLgbLgbLgbLgbLsLsm
bLsLsmbLgLsRsbLgLsbLgbLsLsLsmmbLsLsLsmmbLgRsRsmbRsLibRsbLibLsbLsbLsbLi
bLgLsbLjbLsbLjbLsbLjbLgbsbsbsbLcbLsbLsbLibLsLsmbLgbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 26; Drug: Control Apo 0.5 然
bRiRsmbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 27; Drug: Control Apo 0.5 然
bLsbRobRobLobRobLcbLobLcbRobRsbRcbLobLebRgbRcbLebLobLobRcbLhbRebLebLcb
RsbRibRgbLebLcbLhbRebLebLobLobLobRobRobRcbLobRgbRobRobLgbRobRebRobRobL
gbRcbRebLebLcbRobLcbRobLebRobRcbLcbLebRebRebLebLobLobRgbLgbRgbRebLhbRi
bLobLcbLcbRobRsbLcbRebLobLobLobLebRebLebLobLobRobLebLebRebRebRobLebLeb
LobRebLhbRebLobLibLebRobLgbLebRobRobRhbLobLhbRobLsbLebRobLobLobRcbRgbR
ibLobLobLobRhbRgbRebRebLebLgbLcbLebLebRcbLebRobRobRobLobRobRobLobRobRe
bLsbLebRobLobRgbRobRcbLobRobLcbRebLebLibLhbLobRobLibLsbRgbRobLebLebLob
RobLcbRgbRobRebLobLebRobRcbRebLebRibLebRgbLobLibRobRcbLobRibLibRobRcbL
obRcbLebRsbLebLcbLebLibLcbLgbRobLebLcbRcbLobRobLobLcbRobRcbLgbRebRobLo
bLgbRebRcbRibLcbRebLcbRobLobRsbLobRebRobRebRobRcbRebRibRebLobLebRobRib
RobRebLobLcbRobRebLobLobLobRobRcbRibRcbLobRebLobRebRobLobRcbRibRobRebR
obLebLgbLobRobLibRcbLobLebLebLobRibRgbLhbRgbRhbRobRobLobRebLcbRobRgbRc
bLebLibRebRebRgbLobLebLhbLebRobLobRgbRobRcbLobLebRobRcbRobLibLcbLobRob
RobLebRebLcbRobRcbLebRobLobLobRebLsbLgbLebLobLcbRebRobLobRibRsbLobLobL
cbRobRobLobLobLebLibLobRobRobRobLebLgbRobRobRobRcbRebLobLebRobRibRobRc
bLobLobRcbLobRobRcbLobLibRobLibRgbRebRobRcbRobLobLebRsbRobRobLcbLcbRob
LebLcbRobLobRsbRhbRobRobRobLebRobRobLebRobLobRobLobLcbRobLobRobLcbLobL
ibLobLobLobRobRobRobLcbLebLebLgbLobLgbRobRibLobLcbLobRcbLcbLebLebRcbRs
bRobRcbRcbLhbRobRcbLobLebRibLgbLobLobRebLobLobRobRibLcbRobLsbRebLebLob
RcbRcbRgbLebRobLobLcbRgbRobRebLobLebLgbRobLgbRobRcbRobLcbLobLobLobRobL
obLobRobLebRobLibLobLgbRebLobRebRobLobLobLobLobLobRcbRobRobLobRibRebRg
bRobRobLebRebLcbRobRobLebRibLebRhbLebRobRcbRobLobLobRebLobRgbRebRobRob
RebLebLebLobRobRibLhbLebRhbRcbRhbRcbRibRgbLobRcbLobRcbLebRobRebLcbLobL
obLcbRobRobLibLebLebLjbLobLobLobLobLebLebLobRcbLebLobRcbLgbLgbLebLobLg
bLobRobLsbRobRobLobLobLgbRobRcbRsbRsbRobRobLcbRibRgbLcbRebRobRebLebReb
RsbRebRebRhbLobRgbRobLcbLobLebLobLcbLcbRobRobLobLibLibRebLobRebLebRobL
obLebRobLobRobLobLsbLobRcbRobLobRebRobLobLgbLebLhbRibRebLcbRhbRcbRcbRo
bLobLobLebLibLsbRcbLobRebLobRobLobRcbLhbLebLebRobRgbLgbLobLibRibLobLhb
RcbLcbLcbLebLobLobLgbLgbLobLebRibLcbLebRgbRibLhbLobLobRobRobRibLcbRgbL
obRobRcbLebRobLcbLsbLebRobLebLebLibRebLobRobRcbLgbLgbLebLebLobRobRobLc
bLobLebLcbLobRebRibRebRobRcbLebRibLobLobLobLsbLibRobLibLsbRcbLcbRibLeb
LibLebLcbRebRebRsbLebRebRobLobLobLcbLobLobRebRebRcbRsbRibRgbRobLobLgbL
cbRobRcbRobRobLobRebLgbRobRobRebRebRobLobRobLobRobLcbLibLobLobLobLcbLo
bLgbRebLgbLebRcbRebLcbRobLobLebRcbRcbLobLgbRebRcbRebLgbLobRobLcbLibLeb
LobRobRcbLibRobLgbLcbRobLhbLcbRobRsbRobRebRhbRcbRcbRcbRebRcbLebLsbLebR
cbRobRgbRibLobRobRcbRhbLhbRibLibRhbLhbLobRobLgbLobRibLibRebLobLgbRobRo
bRebRcbLobRobRcbLsbLhbLcbLebLcbRcbLebLobRobLobRebRgbRcbRhbRobRobLobLob
RibRgbRobRobLobLcbRebLobLcbRobLobLhbRobRobRobLebLebRgbRcbRsbLibRcbRobL
obRcbRsbLobLobRibLebRcbLobRcbRobRobLobLobRgbRgbLobLobLsbLcbLobLobRobLo
bLobRebRibLcbRibRobLibLobRcbRgbLobLcbLobLsbLebRhbLhbLebLobRibRobRobLob
LcbLcbRobRcbRobRebRobRcbLebRebRibLcbLhbLebLcbRibRobRibRebRobRgbLcbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbRsbLhbRsLsbLsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 29; Drug: Control Apo 0.5 然
bRcbRsRsmbLoRsbRsLsbLsbLobLibLsbRgbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 30; Drug: Control Apo 0.5 然
bRcLsbLsbRjbLibRgbRgbRgbRjbLhbRjbRcbRibRsbRhbRgbLhbLsbRibLsbRsbRcbLsLs
mbLsbLsbLgbRhbsbRsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bLjLgbLgLsLsmbLibLsbRibLsRsbLsbLsbLobRsbLgbRgbLsbLsbRsbsbLsRsbLsbLsLsm
bsbLsbLsLsmbLsbLgRsbLsbLgbLgbLgbLsbLsbLsbLsbLgLsbRsLsbLsbsbLsbLsbRsbLs
Lsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLcbLobLgLsbLsbsbsbsbsbsbsbLsLsmbRsbLsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bLoLsLsmmbRibRgbRgbRgbRsbRgbRgbRgbRgbRgbRsbRgbRsRsmbRgbRgbRgbRsbRgbLsb
LsbRgbRcRsRsmmbRsbLgbRibLgbRcbRsLsbRibRibLgbRsbRgbRsbRibRibRsRsmbRsbRs
bRgbRsbRgbRgbLgbRsRsmbRoLsbRsbLsbRsbRgbLgbRsbRcbLsbRibRsbRhbRgbRibRsbR
obLiLsbRgbRibRibRsbRsbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bLgbLgbRobLibLcLsmbRgbLsRsbLibRsbLgbLsbLsbLsbLgbRobRibRcRsmbLsbLgbRsbL
cbRgbLibLgbRsbRgbLibRibLibLsbLgLsbRsLsbLibRsRsmbsbRjbLibLgbLiRsbRgbLsb
LgbLobRiRsmbLhbRgbLibRibsbLibLcbLiLsbLcbRcbLgbRiRsmbRibRsbRsbRcLsLsLsm
mbLsbLgbLsbsbRiRsmbRcbLgbLsbLsbLebLibRsbRjbLibLibRsRsmbLibLobRiRsmbRcb
RcbLsbLsbLgbLjbLibRsLsbLibRgbRsbLhbRjbRibLjbLibLsbLsLsmbLibLsbRsLsbLsb
RsbRsbLgbLgbLjRsbRsbRgbLibLgbLibRibRsbRjbLsbRcLsbLjbLobRibLibLibRgbLiL
sbLsbLgbLgbLobRsRsmbRgbRcbLgbLsbLgbRibRhbLsbRsbLjbLibLibLsbLsLsmbLgbRg
bLsbLgLsbLgbLsbLsbLsLsmbRsbLgbRsbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bRoLsbLsRsbRhbRsbsbLsbLsRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bRobRsbLibLibLsRsbLsbLsLsmbRgbRoLsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbsbRsbRgbLsbsbLsbLgbRsbRsbLgbLoRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bLsbLibRjbRsbRsbRgbLobLeLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bRcbLsbLgbLgbLsLsLsmmbLgbRobLgLsbLgLsbLhbRcRsmbLsLsLsmmbLiLsbLibLsbRoR
smbLobLobRobRsbRsbLsLsmbLibLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbRsLsbLsbLsbRsLsRsbRsbRsbLsbRsbRsRsRsmmbRsbRsLsbLsbLsbRsbRsbRsbR
sRsmbRsbRsRsmbLsbRsbRsbRsbRsbRsbRibRgbRibLsbRcRsmbRcbLsbLsbRebLebLsbLg
bRsRsmbLsRsbRsbRsbRsRsmbLsRsbRsbLsRsbLsbLsbRsbLjbLcbLibRibLoLsmbRsRsRs
mmbRsbRsRsRsmmbRsbRsbLsRsRsmbRsRsmbLsRsbRsbLsRsbRsbLsbRsbRsRsmbRsbRsbL
sbsbRsbRsbRsbRsbRsLsbsbsbLsbRsbRsbRsbsbRsRsLsmbRsbLsbLsbLsRsbRsRsmbRsb
RsbRsRsRsmmbLsRsbLsbRsbRsbLsRsbLsRsbRsRsmbRsRsmbRsbRgbLsbRsbsbRsbRsRsm
bRsbLsRsbRsRsmbRsRsmbRsbLsRsbRsbRsbRgRsmbRsbRsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bsbLgbLsbLsbRsLsbRsbLobLoRsbRebsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bsbLsbsbLsbLsbLsRsbLsbRsRsmbLsLsmbLgRsbLsbRcbRobRsRsmbLcLsmbLsbRobLoRs
bLsRsbLsbsbLibLgbsbRsbLsLsmbLsLsmbLsLsmbLgbsbLsbLsbsbLsbLsbLsbLsbRgbLs
bRsLsLsmbLiRsRsmbRibRiRsmbRgbLgbRsbRsbLsbLsbsbsbLsbRsbsbRgRsmbLsbRibLs
bRcRsLsmbLibLsbRobRsbLsRsbLsbLsbRsbLibRsRsmbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLgbRgbsbLsbRsbRsbLjbLjbRsbLoLsLsmmbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLsbRsbRsbRsLsbLsbLsLsmbLsbLsbLsRsbLsbLsbLjbLsbRsbRsbRsbLsLsmbRsbLs
RsbLsLsmbRsbRsbLsbLsLsmbLsLsLsmmbLsbRsRsmbRsRebLobLsLgLsLgRsbLsbRsbLsb
LsbLsbRsbLsbRib

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bRgbRsRsmbLsRsbRsbLebRobRsbLgLgbLsbLsbLsbRsbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bRibRoLsbRsbRsbRgRsmbLobLibLobLibLobLibRebRcbLsLsmbRjbRebRgRgbRsbRsRhb
LhbRsbRsbsbLcRobLobRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLsRsRsmbRhbLjbRsbRsbRsLgbLsRsbRsbRsRsmbRsRsmbLsbRgbRsLsbRsbRsbLsRsbRs
bRsRsmbRsRsmbRgRsmbRibsbsbRgbRsbLsLsmbRsRsRsmmbRsbRsbRgbRsbLsbLsbRsbRg
RsRsmmbRsbRibRgbRsbsbRgbRibRgRsmbRsLcbRsRsmbsbsbRsbLsbRsbRebRsbRgRsmbR
sRsmbRgbRsbRsbsbRgbLgRsbRsbRgRsRsmmbRsRgbRgRsRgRsmmbRgbRibLsbRobRgbLsb
RsbRsbLsbRgbLsbLsRsbRgbRgbRgRsRsmmbRgRsmbRsbRibRsRsmbRibLobLhbLsbLsLgb
sbLgbLgLsLsmbLsLsmbLsbLsLsmbLsbsbLgbLgbRsbLgbLsbLsbsbRsRsmbLsbLgLsLsRs
mbRsbLsLgLsbLibLgRsbRsbLsbLsLsmbLsLsmbRsRsmbRsbRsLsbRsRsmbRsbRgbRiRsRs
mmbsbRiRsLsmbRsbRgbRgbLsRsRsmbRgRsmbRsbRsbRsRsmbRgbRsbRgRsmbLebRsbRsRs
mbRibLsbRsRsLombLgbRsbLsbRgbRibRsbRsRsmbRsRsmbRsRgRsmbRgbRgbRsRjbLcbLs
LsmbLsbLgLsbRsRsmbRsLsRsbLsbLibLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131259; End: 131759;
Recording: 12-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbLebLsbsbRgLsbLebLibLibRebLsbRjbRiRsmbLsLgbLsbLgbRsbRibLsbLsbLcb
RsRsLsmbLsLsmbLiLgbRcbLobLebLsLsLsLsmmmbRhbRobsbRsRsmbRsLgRsbLsRsbLsLs
LsLsmmmbLiLsbLgbLgLiLsbsbRsRsmbLsLsmbRsRsmbLsLsmbLsLsLsmmbRsRibLgRsbLi
LsbRsLsbLsRsLsbRibLsbsbLsLsLsLsLsLsmmmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 1; Drug: Control Apo 0.5 然
bLobLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 2; Drug: Control Apo 0.5 然
bRcbLobRsbRjbRcbRcbRiRsmbLcRsbRgRsmbRcbRibLjbLoRsbRobRcbRebRibRibRibLs
bRgbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 3; Drug: Control Apo 0.5 然
bsbRsRsmbLoRsbLobLebRsRsmbRsbRobRsLsRhLsbRsRsmbLobLsbLsbLgbLsbLsbLsbLc
bRsRsmbRgbsbRobLsbLgbLsbLsRsbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 4; Drug: Control Apo 0.5 然
bsbsbsbsbsbsbsbsbRibLgbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsLsLsLsmmmbsbsbRhb
RcbRjbLcbLibRsbLsbRsbRjbRhbRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 5; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 6; Drug: Control Apo 0.5 然
bLsbRsRsmbsbsbsbsbLsbLgbRjbLibLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 7; Drug: PCAP814 1 然 Apo 0.5 然
bRsRsRsmmbRcbLcbsbLsbRibRsbLobRhb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 8; Drug: PCAP814 1 然 Apo 0.5 然
bRsbRsRsLsmbRgbRsbRsbRsbRsRsmbLsbRcbLsbLibLsbRsRsRsmmbRsbLsRsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 9; Drug: PCAP814 1 然 Apo 0.5 然
bLjbRobLibLgbRsRsmbLsbLobsbsbsbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 10; Drug: PCAP814 1 然 Apo 0.5 然
b

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 11; Drug: PCAP814 1 然 Apo 0.5 然
bLcbRgbLjRebRsRcbRsbRsbRobRobLjbLsRsLsbLcbLeRsbLibLiRsbLibLibsbLgRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 12; Drug: PCAP814 1 然 Apo 0.5 然
bsbsbsbLsbLobsbsbsbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 13; Drug: PCAP814 3 然 Apo 0.5 然
bRebRgbRibLsLsmbRobRcbRibsbLsbsbsbLsbRsbsbLsbRsbsbRsbsbLsbRjbsbRsbLsbL
sLsmbLsLsmbRsRsmbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 14; Drug: PCAP814 3 然 Apo 0.5 然
bLsRibRgbRobsbsbRcbRibRgbRsRsmbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbLiLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 15; Drug: PCAP814 3 然 Apo 0.5 然
bRsbRsbRsbRsRsmbRsbRsbRsRsmbRjbRsbLsbLsLsmbLibRsbRsbsbsbLsbLsbLhbLcbRs
bRsRsmbRsbRgbLhbLsbLsLsmbLsbLgbLsbLsbLsbLsbRsbsbLsLsmbsbLobLibRsbLsbLg
LsbLsbLsbLsbLsbLgbRsbLgbLgbRsbLibLsbRsbsbRsbLcLsmbRsbRsbLsbLjbRiRsmbRh
bsbLgbLcbLcbRsbLsbLsbRsbRgbRoRsmbRoRsmbRjbRsRsmbRsbRsbsbRsRsmbRsbRsRsR
smmbRsbRsbRsbRsbRsLsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 16; Drug: PCAP814 3 然 Apo 0.5 然
bLgbLjLgbRiRsmbsbRibLsbLcbLibRsbRoRsmbRgRsmbRgbLoRsbLsbRgbsbRsbsbLcbRg
bRgbLebRcbLgLsLsmbLsbLsbRoRsmbLoRsbLgbRsbLgbLcbLgbLgbLibLsLsmbLibLgbLs
bLibLsbLibLsbLsbLibLsbLgLsbLsbLibRgRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 17; Drug: PCAP814 3 然 Apo 0.5 然
bLsLgbLsbLsLgbLsRsLsRsbLsbsbLsbLsbLsLsLsmmbLsLgbRsbLsbLgbsbLsLsLsLsmmm
bsbsbRsLsbsbLgbRsLsbLsbsbLsRsbLsbLsLsmbLsLsmbLgbLgbLgbLsLsmbLgLsbLgbLs
bLsbLsRsLsbLgLsLsRsmbLsLsmbsbLsLsmbLsLsmbLsbLsLsLsmmbLsbLgbRsbLsLsRsmb
LsLsLsmmbLsbLsLsLsRsmmbRsLsbLsbLsbRsLsbRsLsLsmbLsLsmbLsbRsbLsbLsbLsbLs
bLsbLsbRsLsLsmbLsbLcLsmbLebLiLsbLsbLsbLsbsbLsbLsLsmbsbLsLsmbsbLsRsbLsR
sbLsbLsbLsRsRsmbRsbLsLsmbLsLsmbRsLsbLsbLsbLsLsmbLsLsLsmmbLsbLsLsmbLsRs
bLsbLsLsmbLsLsmbLsbLsbsbRsRsmbsbRsLsbLsbLsbLsbsbLsLsmbLgbLgLsRsbsbLsLg
bLgbLgbLgLsbLsbLsbLgbLgbLsLsmbLsbLsbLsbLsRsbLsLsmbRsbRsbLsbsbLsLsRsmbL
sbLgLsbLgLsbLgLsbLgbLsbLsLsmbLsLsmbLsLsmbLsLsmbLsLsRsmbLsLsmbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 18; Drug: PCAP814 3 然 Apo 0.5 然
bRibLoRsbLobRcbLoLsmbsbLiLsbLsbsbsbsbRoRsmbRebsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 19; Drug: PCAP814 10 然 Apo 0.5 然
bRcbLsbRgbRsRibLsLsmbLgbsbRebRebRoLsbRgbLgLsRsbLibLobRgbLsbLgbRgbRebLi
bLgbLebLjbLobRobRsLsbRcbLebLcbRibRsbRibLhbRsbLjbRhbsbLgbRibRsRhbLsbRob
RhbRsbRcbRebRgbLibRsLsbLsbLgbLgbLjLsmbLgbLgLsbLgbRibLobLgbRcbLsbLgLsbL
gRhbLhLsLsmbRgbRjbLsRobLobRsbLsbLjbRhbLsbRcbRibLeRsRsmbsbRsRsRsmmbLsbR
sbRsbLebRebRobLgbRgbRsbLsbRsRsmbRgbLjbRiLgLgbLibRsbLibRjbReRsmbRsLsbLg
bLebLgbLjbLibRiLsbLgbLsbLgLsLsmbRibRibRgbLsbRsbLsbLsbRebRsbLsbLsbLsbRs
bRsbRebLebsbRsLsbLsLsmbLgLibLebLsbLhRsRsmbLjbRsbLcbLebRgbRhbLjbLsbRsRs
mbRjbLsbRebRcbLsLsLsmmbReLsbLibLgbLoRsbRgbRsbLebLsRsLsbRsbLebLsLgLgLsb
LjbRibRgRsRsmmbLjbLsLsmbLibRgLgLsbLoLgLsLsmbRgbRoRsRiRsRsmmmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 20; Drug: PCAP814 10 然 Apo 0.5 然
bLgLsLgbRsbRebRibRsbLgRsbLgLgLgbRsbLgbLsbLsbLsbRobLebRcbRebRsRsmbLsLsm
bLiLsbLsbRebLsbRsbRobLebLgbLgbLgbLgbRgbLsLsLsLsmmmbLsbLhLsbRsbRsLgbRsb
LebRebLobRhbRgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 21; Drug: PCAP814 10 然 Apo 0.5 然
bLjbRsLsbRsRsmbLsbLsLsmbLsbRobLsbRhbRsbLsbLsbLsRgbLgLsbRsbLsbLgLsbRsRs
mbLjbRjbRobRjbsbRsbLobsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 22; Drug: PCAP814 10 然 Apo 0.5 然
bRsRsmbLgbRgbRsbLiLsbLgbLsbLgbLsbLsbRsLsbLsbLgbLsbsbRgLsbLgRsbLsLsmbLs
bLsbRgbRgbLobRgLsbRgbRsbRsbRsbRgbRsbLgbRgbRsbRgbLsbRebRgbLibLeRobsbLsb
RsbLsLsmbLsRsbRcbRsbLsLsmbLsLgRsbsbRsbLgbRcRiLsRgLhbRebLgRobLhbLsbsbLg
bRsbLsbRsbLsbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 23; Drug: PCAP814 10 然 Apo 0.5 然
bLsbLjbLoRsbRiLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 24; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbsbLsRsLsbLsbRibRgbLebLcbRsRsmbRgbLsLobRebRsbLjbRjbRsbRsbLjbRsbR
sLsbRsbRsRgbLsbLsbLsRgbRgbRsbRgLsbLsbLsbLsbLsbLsLsmbRjbsbLsbLcbLobRjbL
obLsbRgbRsbLsbRsRsmbRcbLibLsbLgbRsbRsbRebLoRsbRsbRibLsbsbRsbsbLibRsbRg
bRsRsmbRgRsmbRiLsLsLsmmbRsLsbLjbLobLib

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 25; Drug: Control Apo 0.5 然
bRjbLgbLsbLjRsbLsbLsbLjLsmbLgLsbLgLsbLiLsbLhbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 26; Drug: Control Apo 0.5 然
bLsbRsRsmbLoRsRsmbLsbLsbLcbLcRsbLobLcbRsbsbLhbRsbRhRsmbLibLsLsmbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 27; Drug: Control Apo 0.5 然
bLhbRcbRobLobLebLebLebLibRebRcbLebRjbLobRcbLcbRobLobLobLobLebRebLcbLob
RsbRgbLcbLobLobLebRobRobRgbRibLebRobLobRobRcbRobRobLobRobRcbRcbRebRcbL
cbRobLhbRcbRebLobRobLebRcbLebRobLjbRcbRobRibRebLobLobRobRibRebRebRcbRc
bRebLobRobRobRcbRobLobRobRhbLebLibRcbRobLebRgbRobRsbRsbRebRgbRgbRsbRob
RibRobLebRebRebLcbLibLobRobRebLobRcbLibRcbRobRsbRcbLobLcbRcbRobRcbRcbR
obRcbLgbRobLcbLgbLobRobLcbLcbRebLsbRobRcbLcbRebRibLobLcbRobRebLobRcbLc
bRcbLobLobLsbRcbLobRobRebRobRibRobRobRcbRhbRobRobLcbLcbRcbLgbLebRobLob
LibLcbRcbLcbLcbRibRcbLobLebLebRobLebLobRebRebRcbRobLcbLibLebLibLhbRhbR
cbRcbRcbLobLcbRebRobRobLebLebLsbLobLebLobLcbLibLcbRgbRcbRobLebLobLibRi
bRcbLobLhbLobRebRibRcbRobRgbRhbLebRcbLcbLebLobRcbRobRcbRebLobLebRgbLob
LcbRobLcbLgbRobLobRebLhbLcbRebLobRobLobRobRcbRcbRebRebRobRobRsbLobLcbL
cbLobRgbRobLebRebLcbRobRobLebRibLcbRcbRcbRobLhbRsbLibLgbLgbLebRobLebLi
bLobRhbRobRobLobRobRcbRobRobLebLgbRibRebRobLebRebRcbRcbLobRcbRebRobRib
RcbRebRobRsbRebRcbRebRgbRebLcbLcbRobLobRobLsbLcbLcbRobRebLcbLebLobRhbR
ibLcbLobLebRibRebRobLibLgbRcbLobLgbRobRebRobLcbLobRhbLobLhbLgbLsbRobLo
bLcbLcbLsbLsbRsbRgbRebRebLgbLobLcbLobRgbRebRibRebRgbLobRgbRobLebLgbReb
RobRcbLobLcbRebLobLobLobLibRobRibLobLgbLcbLobLebRcbRobLebRobLobLsbRebR
obLcbLobLsbRibLcbLebRobRibLgbRebRobRobRebLcbLcbLobRebLebLobLebRobLibRc
bRobRcbLsbRobLobRcbLcbRgbRobRobRibLobRcbLebLobRsbLsbRibLgbRebLobLcbReb
RebRcbLobLobRebRgbRebRobLobLcbRebRcbRobLsbRcbRobLgbLobLebLsbRobLobLcbL
gbLjbRebLobRobRobRobLsbLebRobLobRobLsbRcbRobRibLobLebRsbRobRobLobRobLi
bRcbRgbRobLcbRibLgbRobLibRobLobLcbRebLobLcbLobRibLobLobRgbRibRobLibLeb
LhbLebLcbRgbLobRcbLobLobLobRhbRcbRobLobRgbLcbLobLgbLobLcbRcbRhbLhbRcbR
cbRobLebRgbLobLebRobRobRobLcbRobLobLobRebRobLcbLobRcbRebRcbRcbLcbLebRe
bLcbLibLgbLebLobLebLibRcbRebLebRcbRibLsbRebLhbLgbLebRobRobLgbRebLebLob
LobLhbLgbRobLibRobRibLcbLobLobLobLgbLobLgbLebLibRobLebRobLebLcbRjbRgbR
obRsbLhbRsbLobRcbRebLibRgbRobRobRibRibLebRobLobLobLgbLobRebRibLobLgbLc
bRebLcbRhbRebRebRcbLebLibLobRibRsbRobLebLebRebLobLobLebRobRibRgbRcbLcb
RgbRobRobLobLcbRebLebRebLobRibLobRebLebRsbRobRebRobLcbLgbLobRjbRsbRcbL
obRcbLgbLobRibLobLgbRebLobRibLsbRebLobRgbRobLebLobRgbRebLebRcbRibRjbRo
bLgbLibRobRgbLsbRobLgbRebLobLcbLebRebRobRebLcbRobLhbRobLhbLebLibLebRib
LcbRobRobRobLcbRobLobLebRobLebRcbLobRgbRgbRobRobRebRobLgbLebRcbLobRebL
cbLobRcbLcbRebLebLobLsbRobRobLobRobRobLebRobRobLgbLgbRcbRobLobLcbRebLg
bRebRobLibRsbRobRobLgbLobRgbRobRsbRobLgbLcbLobRobLobRebLcbRebLobRcbRob
RcbRsbRobRobLobRgbRcbLgbLobRgbRobLobRobRcbLobLcbLobLebRgbRhbLobLibRhbR
gbLebLobRebLibRobLobRibLibLebRsbRebLobLobLobRebLcbRcbRobLobLebRobRobLc
bLgbRobLgbRobRcbLebLgbRobRgbRobLobLcbRibLebRobLgbLobRebLobRcbRcbLobLob
LsbRobLebLobLcbLgbLcbLebRobLobLgbRibLobLobLobLobLebLobLebLibRobLobRobR
obLcbLobLobLibRobRobLsbRgbRebLebLobRebRobLcbRobLcbRobLobLobLobLebLobLi
bLgbLebRebRobLcbRebRibRobRobRcbRebRebRcbRobLibLebLobLobRibRobRobRobRcb
RobRcbLobRcbRobLsbLcbRcbRebRcbRcbRobRhbRcbLobLebRobLobRobLebLcbLobLobL
ebRibRebLgbLobLobRebLcbLobRebRobRgbLebLcbRebLebLobRibLebRobLebLobRebLo
bRsbRebRobRobRcbRobLebRgbRhbLebLcbRobLebLsbRob

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 28; Drug: Control Apo 0.5 然
bReRsmbRobRsRsmbLsbLsbLsbRsbLebRsbLobLsbLsbRsbRcbLgLsbRjbRobRjbLsLsmbR
sLsbRgbLgLsRsbRhbLobLsbLjbLeLsbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 29; Drug: Control Apo 0.5 然
bLsbLgLsbRsbRsbRjRsmbsbsbsbsbRhbLsbLsbRcbRsbRiRsmbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 30; Drug: Control Apo 0.5 然
bLiLsbLjbRcbLsbRjbRgbLjbRgbRibRgRsmbLsbRgbRsbRsbRibRgbRgbRgbRgLsbRsbRg
bRgbRgRsmbRsRsmbRibRgbLcbRjbRcb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 31; Drug: PCAP814 1 然 Apo 0.5 然
bLsbLsbLibRoRsmbLsbRgbRgbRsbRgbRgbRsbRsRsRsmmbRgbLsLsmbRobLsbLsRsbRsbL
cbsbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 32; Drug: PCAP814 1 然 Apo 0.5 然
bLibLsbRsbLgLsbLgLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 33; Drug: PCAP814 1 然 Apo 0.5 然
bRhbLcb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 34; Drug: PCAP814 1 然 Apo 0.5 然
bLgbLibRgbLibLgbLgbRgbRsLsbLibLsbLsbLgbLgbRgbLibLsbLsbLgbRsbLgbRsbLgbs
bLibLsbRhbLibLibRgLsbLgbRgbLsRsbLiLsbRsbLibLsLsmbLgRsbRgbLgbLsbLgbLibL
ibsbsbRsbRibLgbLsbLibLgbRsRsmbRjbLgbLsbLibRsbsbRjbLsbsbLibRsbLsLsmbLsb
RsbsbLsbLgbLobRgRsRsmmbLsbRjRsmbLcbRibLsbLsbLcbRgbLibLiRsbRgbLsbLgbLgb
RibLhbLibRsbLsbLgbLsbLgbRsbRsbLsbRsbLsbLsbLgbLsbLsbLgbRsLsbLgbLgbRgbLi
RsbRhbLgLsbLsbRebRibRsbLobLgbRhbLjLsmbLibRjRhbRibLcbRhbLgbLjbLiRsbRjbR
ibRiRsmbLjbLib

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 35; Drug: PCAP814 1 然 Apo 0.5 然
bLsbRsbLsbRsbRsbRsbsbRsbRiRsRsmmbRibRobLibRgbLibsbLgbLgbLsbRibLsbLsbRs
RsmbRibRsbRsbRsbRsRsmbLsRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 36; Drug: PCAP814 1 然 Apo 0.5 然
bRsbLsbLsRsbRsbLsbLsRsLsbLsbLsbRsbRsbLsbLsbLsRsbLsbLsLsmbLsbRsLsbsbsbs
bLgbLgbsbsbRsbLsbsbLsbLsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 37; Drug: PCAP814 3 然 Apo 0.5 然
bsbRsLsbLsLsmbRsbLsbRsbLsbLsbRsLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 38; Drug: PCAP814 3 然 Apo 0.5 然
bRobsbRsbRsbRgbRcbLcbLcbLgbLobLsbsbLebRoRsmbRebLibRsbLsRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 39; Drug: PCAP814 3 然 Apo 0.5 然
bRobLsbsbLsbLsLsmbRhbLsLsLsLsmmmbLgLsbLiLsbLgLsbRcbLsLsLjLgLsmbRgbRgbR
gbLjLsLsmmbLsLsmbRebsbLibLobRibRgRsmbLjLsmbRobsbRibRebLsLsmbsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 40; Drug: PCAP814 3 然 Apo 0.5 然
bRsRsmbRsbRsbLsbRsbRsbRsbLsbRsbLsRsbLsRsbRsbRsbRsbRsbLsRsbRsRsmbRsbRcb
LsbRsbLsbRgbsbRsbsbRsbRgRsmbRsbLsLsRsmbRsbRsbLsbLsbRsbRsbRsbRsbLsbRsRs
mbRsRsmbLsbsbRsbRsbRsbLsRsbLebLhRsbLsbLsLobRsLsbLhbLsbLsLsmbLsbLobLjbL
sLsmbLsbRsbLcLsmbRsbLsbRhbRsRsmbRsRgbLsRsbLsbRgbRsbRgbRsbLsbRsbLsbRsbL
sbRsbRsbRsbRsLsbRsLsbRsbLsbRsbLsbRsRsmbRsbRsbRsbRsbsbRsbRsbRsLsbRsRsmb
RsbLsRsbRsRsmbRsLsbRsbRsbLsbLsbRsbLsRsRsmbRsbLsbLsbRgRiRsmbRobRsbLhbLo
bRcbRsRsmbLsbRsbRsbRsbLsbRsbRsbRgbsbRsRsmbRibRgbRsbRgRsmbRsbRhRsmbRgRs
mbRgLsbRsbRsbRsbRgRsmbRsRsmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 41; Drug: PCAP814 3 然 Apo 0.5 然
bLjRgbRsbRsbLsbReLiLsbRoRsmbLsbLsLsmbLgLsbRobLsbRgbLsbRsbRsRsRsmmbRebR
hbsbLsbRsbRsbRoRgRcbRibRsRibRibsbRgbRoRgRsmbReRsmbRiRsmbRgRsRsmmbRibRi
bRgbRibsbLsbLsbLsbsbLgLsLgbLsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 42; Drug: PCAP814 3 然 Apo 0.5 然
bRgbsbLsLsmbLobLsbRibRobLoRsbRibLgRsbRcbRgLsbLsbRgbRibRsbLjbRobRsLsbsb
RsbRsbLgRsbRsbRebRsbRsbRsbRsRsmbLsRsRsmbLsRsbRgRsmbRsbRsbRsbsbLibRjbLs
LcbRcbLsbLsbsbsbRsbsbsbsbsbLibLsbLebRgRsmbRsbRsbsbsbLjbRcRsmbRibRsbRib
RsRsmbRiLsbRsRsRsmmbRgbRibLsbRoRsmbRsbRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 43; Drug: PCAP814 10 然 Apo 0.5 然
bLgbRsbRgbLjbLsRsLsbRsbLsbLsbRebRsbLsbLsbRsbLsbRsbLebRgLgbRsLsbRsRgbsb
RsbLobLcbLobRiLibsbLgbLgLsbRiRsRsmmbRsbLgb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 44; Drug: PCAP814 10 然 Apo 0.5 然
bRsbRsbRsbLsbLsLsmbLsLsmbLsbLsbsbLibLsLsmbsbLsbsbLsbsbLsRsbLsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 45; Drug: PCAP814 10 然 Apo 0.5 然
bRsbLgbLobLsbRsbRsbRsLsbLsbLsbLsLsmbRsbLsbLsbRsbLsRsLsbLsbRsbRsbRsbRsb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 46; Drug: PCAP814 10 然 Apo 0.5 然
bRiLsbsbsbLsbsbLiLsbLsbRebRcLsbRgbRsbRsbLob

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 47; Drug: PCAP814 10 然 Apo 0.5 然
bLsLsRsmbLgbRsLsbLibRsbLsLsmbLgbLsLsmbLibLsbRsbLsLsmbRsbLibLsLsmbRsbLg
LsRsbLsLgbLjbLobRsbLsRsbRibRsbLsbsbRsbRsLsRsRsmbRsbRsbRibLsRsRsmbRsbRg
bRibRgbRcLsbLsbRgbLsLsmbRsbLibLsbLibLsbLsLsmbsbLsLsmbLsbRsRsmbLsbLsLsm
bsbLhbsbLsbLgbLgbsbLebLobRibRsRgbRgbLsRgbRsbLsRgbRsRsRsmmbRsbRsbRsbLsL
smbRgbRibLsbRgbRsbsbLsbsbRsbRsRgbRibLsbRebRsbRsbLsbsbLsbLcbsbRsbRgbRsb
RsRsmbRsbRsRibRsbRibLsRsRsRsmmbRsRsmbRsRsmbRsbRsRsmbRsbRgbRgbRhbsbRsRs
LsmbRibLsbsbRsRsmbRgRsmbRgbRgRsmbRsLsbRsbRgbLsRgRsmbRgRgbRebRgRsLsmbRs
bRsRsLsmbsbsbsbRsRsRsmmbRsbRsRsmbRgRsmbRsLsbRgbLsRsbRsbRgRsRsRsmmmbLsb
LgbLsbLsbLsLsmbLsbLgLgbRsbLsLsRsmbLsbRebRibsbLsRsbLiLgbLsbLgbRsbLsLsLs
mmb

>ZF Recording 2016-06-02; tW: 300s; Start: 131801; End: 132301;
Recording: 13-1; Individual: 48; Drug: PCAP814 10 然 Apo 0.5 然
bLgRsbLsbLsbRcbLiRjbRgbLsLsmbRsbRsbLgbLsbLsRsLsbLsbLsLsmbLsLsmbLsbLsLs
mbRsbLsLsLsmmbLsRsbLgbRsLsbRebLobRgbLsLsmbLsLsmbLsLsLsmmbLibLsLsmbLibL
sbLsbsbLsbsbLgRsLsbLgRsbLsLsLgmbRsLsbRsbLsbLsLsmbLsLsmbLibRobLsbLsLsLs
LsmmmbRsbLsbLgbLebLibsbsbLsbLibLsbRsRjbRsbRsRgbLgbReLgRsbRsRsLsmbLibRj
bLsRsb

